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ABSTRACT
This thesis investigated the characteristics of sarcoplasmic reticulum (SR) calcium uptake and 
release from permeabilised cardiac myocytes: focusing on adenosine trisphosphate calcium 
pump (C ^^ -ATPase pump), the ryanodine receptor (RyR) and the non-specific SR leak. In 
order to do this, the following aims were investigated.
1. Cell viability: do balled-up cells contribute to total cell protein?
2. Is the rate of calcium uptake and leak affected by SR calcium load, RuR and by varying 
the oxalate concentration?
3. How sensitive is this preparation to stimulatory and inhibitory concentrations of 
ryanodine?
4. To what extent is the caffeine-mediated calcium leak blocked by ryanodine and 
ruthenium red (RuR)?
5. What aie the characteristics of the RuR/ryanodine insensitive SR leak?
Method
Cardiac myocytes from New Zealand White, male rabbits were dissociated using the 
Langendorff retrograde perfusion system. The cells were permeabilized with 100p.g/ml p- 
escin, and measurements of SR calcium uptake were made using the fluorescent indicator 
Fura-2 (10|iM).
Calcium Uptake Versus protein Measurements
The protein measurements of permeabilised cardiac myocytes indicated that the 
haemocytometer was an accurate and consistent method of cell counting and that rod shaped 
myocytes did not influence the total protein concentration to a significant degree. Therefore, 
balled-up cells contribute to total cellular protein and may retain functional calcium pumps as a 
greater number of cells were observed to induce an increase in the calcium uptake rate 
constant, i.e. a greater number of cells give rise to more functional pumps available to 
sequester calcium.
Characteristics of Calcium Leak
A significant leak, referred to as the non specific leak, exists through the RyR at 1|0.M free 
calcium concentration and is independent of conventional RyR activity. In the absence of a 
calcium challenge, an SR calcium leak was not observed suggesting that the SR calcium 
content is negligible at the start of the experiment but with a single calcium challenge, a 
sufficient SR load was generated to sustain a leak. It was noted that 3 calcium challenges 
produced reproducible calcium transients, induced a large SR leak gradient in the presence of 
5|LIM thapsigargin, as well as generating a large steady state calcium level in the presence of 
10|iM ionomycin. This suggests that the sequential additions of calcium to the cuvette system 
caused a progressive increase in the luminal free calcium concentration and SR calcium load. 
In this study, 10 or 20mM oxalate effectively clamped intracellular calcium concentration in 
order to facilitate calcium uptake into the SR. This was noted by a faster rate of decay, a lower 
SR leak gradient and a reduction in the amount of calcium available for release.
Ryanodine Mediated Caicium leak
In response to repeated calcium challenges in the absence of RuR or ryanodine, a gradual 
increase in the rate of uptake of the calcium transient was observed which could arise from the 
gradual phosphorylation of phospholamban.
Low concentrations of ryanodine (0.3|iM and 3|xM) were observed to induce a 
sustained increase in the SR calcium leak from the RyR. High concentrations of ryanodine 
(30p.M, 300p-M and 3mM) induced an increase in the calcium leak from the SR for a short 
period before a reduction in the SR leak was noted and, during the given time frame, oxalate 
supported cuvette based experiments favour a block with 3mM ryanodine. This is consistent 
with the literature that suggest high concentrations of ryanodine are required to decrease the 
opening probability of the RyR and that RyR possess two binding sites for ryanodine (a high 
affinity and a low affinity site). The leak produced in the presence of 0.3|im ryanodine was not 
inhibited with 5)iM RuR and a slight slowing of the rate of uptake was observed with the 
addition of 5|xM RuR in the presence of 3mM ryanodine. Therefore, 5|iM RuR in the presence
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of 3mM ryanodine or repeated calcium challenges may enhance the detrimental effects of 
SERCA2A noted by Kargacin & Kargacin (1998).
Caffeine Mediated Calcium Leak
In this study it was observed that caffeine mediated calcium release from the SR of 
permeabilised cardiac myocytes occurred in a dose dependent manner and that even in the 
presence of high concentrations of caffeine (up to 20mM), the SR accumulated a significant 
amount of calcium but only in the presence of ATP. At caffeine concentrations above 20mM, 
calcium reuptake was observed to be incomplete.
At low intracellular calcium concentration (in the absence of calcium challenges) 
40mM was required to induce a significant release of calcium from the SR, a release that was 
greater than that produced with 20mM caffeine. However, in the presence of activating calcium 
concentrations, as low as 2mM caffeine was observed to induce an SR leak.
3mM ryanodine as well as 5(4,M RuR inhibited caffeine mediated calcium release and, 
varying the oxalate concentration did not significantly affect the ryanodine block of the 
caffeine mediated leak.
SR calcium Leak and Bastadin Mix
In isolated cardiac muscle preparations thapsigargin unmasks an SR calcium leak. A portion of 
this leak was blocked with the addition of 5|iM RuR and 3mM ryanodine but only when the 
free calcium concentration exceeded 500nM. This indicates that the RyR contributes greatly to 
the SR leak under these conditions. Interestingly, the fraction of the SR leak that remained in 
the presence of blocking concentrations of RuR or ryanodine was inhibited by 20|lM Bastadin 
mix (5-10 Bastadin Mix), therefore a component of the SR leak may be due to the RyR being 
in an open configuration that can be blocked by Bastadin.
In conclusion, balled-up cells were included in the cell count for the cuvette based 
uptake studies as they were deemed as viable cells and may retain functional pumps. The 
gradual increase in the rate of calcium uptake of the calcium transient observed in response to 
repeated calcium challenges could arise from the gradual phosphorylation of phospholamban. 
A substantial leak exists through the RyR under control conditions as 5pM was observed to
vii
induce a significant increase in the rate of calcium uptake. The non specific leak unmasked by 
5p,M thapsigargin is RuR/ryanodine insensitive and is influenced by SR calcium load and 
oxalate concentration. The oxalate supported cuvette based experiments favour 3mM 
ryanodine and 5|tM RuR in order to block the SR calcium leak observed in the presence of a 
calcium challenge as well as blocking caffeine mediated SR leak. The inhibition by 20fiM 
Bastadin mix of the SR leak that remained in the presence of blocking concentrations of RuR 
or ryanodine indicated that a component of the SR leak may be due to the RyR being in an 
open configuration.
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CHAPTER ONE
INTRODUCTION
LL THE SARCOPLASMIC RETICULUM NETWORK
The SR membrane, like all other biological membranes, consists of a phospholipid bilayer 
containing a number of intrinsic membrane proteins. The SR is a specialised form of the 
endoplasmic reticulum (ER) that pervades all cell types (Porter, 1956; Porter & Palade, 1957) and 
from its deposition in relation to the myofibrils (Bennett & Porter, 1953) indicates a functional role 
in muscle contractility (Franzini-Armstrong, 1999). The SR is a calcium reservoir which has two 
functions in imposing fast changes in intracellular calcium concentrations: accumulation of calcium 
drawn from the intracellular medium to induce muscle relaxation and calcium release to promote 
muscle contraction. Calcium release occurs through the RyR (Schneider & Chandler, 1973) whereas 
calcium uptake occurs through the Ca^^-ATPase pump (MacLennan, 1970; Raeymaekers & 
Hasselbach, 1981; referred to from here on in as the SR calcium pump).
As reviewed in Bers 2003, the SR membrane consists of a closed set of anastomosing 
tubules coursing over the myofibrils and can be divided into two regions: the subsarcolemmal 
cisternae or terminal cisternae (TC). The TC are dilated extensions of the SR that expand into 
flattened sacs near the transverse tubular system (T-tubules) and contain the calcium channels 
through which calcium flows to initiate contraction. The second region is the much more extensive 
sarcotubular network that contains a densely packed array of calcium pumps. In the heart, TC are 
found beneath the plasma membrane and alongside the T-tubules, whereas the sarcotubular network 
surrounds the contractile proteins in the centre of the sarcomere. The T-tubules are invaginations of 
the sarcolemma (SL), extending into a series of fine traverse tubules that run into the cell’s interior. 
The lumina of these tubules are continuous with the bulk interstitial fluid (Huxley, 1964) and in 
cardiac muscle play a key role in Excitation-Contraction coupling (E-C Coupling) by possessing 
essential features necessary to transmit the surface membrane depolarisation rapidly into the interior 
of the cell (Sun et a l ,  1995). Membrane depolarization opens voltage operated calcium channels 
(VOCC) in the SL allowing the passage of calcium ions into the cell (Schneider & Chandler, 1973). 
However, the calcium ions entering the cell from the extracellular space are not sufficient to induce 
contraction of the myofibrils but serve as a trigger to release calcium from intracellular calcium
stores and together, these mechanisms activate the numerous myofibrils almost simultaneously 
(Fabiato, 1983).
1.1.1. The Terminal Cisternae
As reviewed in Bers 2003, the TC are dilated extensions of the SR that assume a flattened saccular 
shape near the T-tubules as well as the SL. The junction between these membrane systems is termed 
a dyad, as the T-tubule associate with a single TC in cardiac muscle. These dyads consist of two 
membrane proteins. The first protein is the L-type calcium channel of the plasma membrane and t- 
tubules, often referred to as the dihydropyridine receptor (DHPR). This protein acts as a voltage 
sensor as well as a calcium channel; the action of which is necessary for initiating calcium release 
from the SR. The other protein is the “foot” protein which projects from the TC into the space 
within the dyad, is termed the RyR and is the major route for calcium release from the SR to the 
cytoplasm.
1.1.2. Calcium Binding Protein: Calsequestrin
Calsequestrin (CSQ) is one of the major protein components of the SR and was first identified in 
1971 by Maclennan and Wong (Maclennaii & Wong et a l, 1971). It is located in the lumen of the 
junctional SR and acts by increasing the total capacity of the SR lumen for calcium while 
maintaining a relatively high free calcium concentration, thus allowing a large gradient in ionic 
calcium concentration between SR lumen and the myofibrils.
Extensive studies on its physiochemical properties have revealed it is a highly acidic 
(Maclennan et a l,  1971; Ikemoto et a l ,  1974), water soluble protein with a molecular mass of 
60kDa (Kawasaki & Kasai, 1994) and possesses calcium binding properties (Maclennan et a l,  
1971; Meissener et a l,  1973; Ikemoto et a l ,  1974) with a large capacity (^40mol/mol) and a 
relatively low affinity (Kassoc=10^M’ )^. CSQ is not accessible at the cytoplasmic membrane 
(Mickalak et a l ,  1980: Hidalgo & Ikemoto, 1977) but seems to be anchored to the internal surface 
of the membrane. Triadin and the structurally related protein junction also co-localise to the 
junctional region and therefore, it has been suggested that these integral proteins maybe required for 
physically coupling CSQ to the RyR (Zhang et a l,  1997).
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CSQ has been linked to the regulation of the calcium release channel and Ikemoto et a l, 
(1989) demonstrated that calcium released from SR vesicles was abolished by selective depletion of 
CSQ; the amount and rate constant of calcium release was investigated as a function of the extent of 
calcium loading. It was found that the amount of calcium release increased monotonically in 
parallel to calcium loading, that the rate constant sharply increased at partial calcium loading, and 
that subsequent loading reduced the rate constant. Thus, the kinetic properties of induced calcium 
release show significant variation depending on the level of calcium bound to CSQ (Ikemoto et a l, 
1989).
CSQ has been shown to be a target of Casein Kinase II and recent research links the 
phosphorylation state of the protein to SR calcium release. The results from this work showed that 
CSQ selectively controls the activity of the RyR at ImM free luminal calcium concentration 
depending on its phosphorylation state. In its dephosphorylated state, CSQ enhanced the open 
probability (Po) of the channel, thus implying that dephosphorylated CSQ can regulate calcium 
release from the SR. This correlates with the fact that CSQ has been found to exist in close 
proximity to the RyR and that the binding of calcium to CSQ leads to a conformational change in 
the RyR.
As CSQ exists mainly in the phosphorylated state in the SR (Szegedi et a l,  1999), this 
would imply that dephoshorylation of the protein by a phosphatase of CSQ is a means of 
physiological regulation of CSQ and may be part of an as yet unidentified calcium responsive 
signalling cascade within the SR.
L2. EXCITATION-CONTRACTION COUPLING
Contraction of cardiac muscle is initiated through an increase of the intracellular calcium 
concentration. Two possible mechanisms have been suggested to contribute to this increase in 
intracellular calcium concentration; calcium entry via Voltage Dependent Calcium Channels and 
Calcium Induced Calcium Release (CICR) (Figure 1,1).
1.2.1. Voltage Dependent Calcium Channels
Calcium entry via voltage dependent calcium channels requires depolarization of the muscle 
membrane to open the VOCC (L-type channels). The spread of excitation is due to local electrical 
currents depolarizing the cellular membrane to threshold, thereby generating action potentials. 
These action potentials propagate along the T-tubule system in a unidirectional manner activating 
L-type calcium channels in the sarcolemma to release calcium into the cytoplasm of the cell. The 
rise in calcium through this method is insufficient to initiate contraction of the muscle but is 
amplified by the release of calcium from intracellular stores, such as the SR.
1.2.2. Calcium Induced Calcium Release
Cytoplasmic calcium binds to the RyR in the SR and exerts a positive feedback mechanism on the 
channel to. release calcium from the internal store. The trigger for this release is calcium itself and 
is therefore termed CICR, the most widely accepted mechanism in cardiac muscle.
1.3. THE CALCIUM ATP-ase PUMP: SERCA2
The SR calcium pump is responsible for rapidly lowering the cytoplasmic calcium concentration by 
pumping calcium into the lumen of the SR, and hence facilitates relaxation. Failure to refill the SR 
calcium pool would result in an inability of the cell to respond to repeated challenges (Grover et a l, 
1992). The pump activity not only determines the rate and extent of relaxation, but also the rate and 
amplitude of contraction, since these are determined by the amount of calcium sequestered by the 
SR and the calcium gradient between the SR and the cytosol at the time calcium release occurs 
(Movsesian et a l, 1998).
1.3.1. Structure of the Ca^^-ATPase Pump
The Ca^^-ATPase pump (SR calcium pump) is a magnesium activated ATPase pump with a 
molecular mass of 110-115kDa and comprises of a unique polypeptide of 994 amino acids. The 
polypeptide contains 2-3 disulfide bonds, the reduction of which leads to virtually total inhibition of 
calcium uptake into the lumen of the SR (Mintz et a l,  1997) as well as possessing 24 Cysteine 
residues which react with thiol (SH) reagents. Of these 24 cysteine residues, nine are protected by
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ATP and may be involved in the ATP binding site and ATP-induced conformational changes 
(Mintz et aL, 1997).
The proposed structure of the SR calcium pump contains a transmembrane domain and two 
large cytoplasmic domains (Lauger, 1991). The transmembrane region is formed by 10 a-helices 
joined by five luminal short loops and four cytoplasmic loops (Mintz et al., 1997). The cytoplasmic 
domains of the molecule are connected to the transmembrane segments by a ‘stalk’ consisting of 
amphiphathic a-helices (Lauger, 1991). The total height of the SR calcium pump is 120Â and 70% 
of its mass can be located in the cytoplasmic domain, 25% in the membrane and 5% in the lumen 
(Tanford, 1984). The catalytic site, comprising the ATP binding site and the phosphorylation site, 
is located in the cytoplasmic part of the molecule whereas the transport sites (calcium binding sites) 
are thought to be buried in the membrane (Mintz et al., 1997). The nucleotide binding domain and 
the calcium binding sites (separated by 40Â) interact at each step of the transport cycle to 
translocate two calcium ions into the lumen of the SR (Mintz et a l,  1997).
Although the calcium binding sites contain carboxyl groups, chemical studies have 
confirmed that they are hydrophobic in nature (Mintz et a l,  1997). Site-directed mutagenesis 
studies in the M4, M5 and M6 membrane regions have shown that Glu^^^, Glu^^\ Asn^^^, Thr^^^ and 
Asp®°® are essential for calcium transport, calcium-dependent phosphorylation by ATP as well as 
calcium occlusion. Alteration of these amino acid residues resulted in complete loss of calcium 
transport and of calcium dependent phosphorylation of ATP (Lauger, 1991; Mintz et a l,  1997). It 
was discovered that Glu^°^ and Asn’®^ are associated with one calcium binding site, whereas GW^^ 
and Thr™ are associated with another, whilst Asp^°^ is associated with them both. This suggests 
that the two calcium binding sites are distinguishable and that M4, M5, M6 and M8 form the 
channel (Mintz et a l ,  1997).
1.3.2. Isoforms of the SR Calcium Pump
Based on cloning and characterisation of cDNA and genomic DNA, there are several isoforms of
the SR calcium pump, encoded for by three genes; SERCAl, SERCA2 and SERCA3 (Grover et a l,
1992). SERCAl gene encodes the SR calcium pump isoforms expressed mainly in the fast twitch
skeletal muscle; SERCA2 gene encodes the isoforms expressed in the slow twitch skeletal, cardiac
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or smooth muscle, brain, stomach mucosa, liver, kidney and several other tissues (Grover et al.,
1992) and SERCA3 is expressed mainly in the large intestine and spleen at high levels; in brain, 
stomach, uterus, skeletal muscle and heart at intermediate levels and in several other tissues in 
lower levels (Grover et a l ,  1992). All three isoforms contain the protein sequence for binding of 
ATP. SERCAl and SERCA2 pump proteins can bind phospholamban, and SERCA3 protein has 
been reported to have potential sites for the cAMP-dependent protein kinase phosphorylation but it 
remains to be shown that it is phosphorylated and/or regulated in this manner (Grover et a l,  1992).
The cardiac muscle RNA is spliced alternatively to produce the isoforms SERCA2a or 
SERCA2b. These isoforms differ in their 3’- sequences such that the last four amino acids of 
SERCA2a are replaced by 49 different ones to give rise to SERCA2b and the 3’-noncoding regions 
are also different. From the cDNA data it is predicted that SERCA2a encodes a protein of 1 lOkD, 
SERCA2b encodes a protein of 115kD and that the heart and the slow twitch skeletal muscle 
express mainly the isoform SERCA2a whereas smooth muscle, brain and most other tissues express 
SERCA2b.
1.3.3. Regulation o f SERCA 2 by Phospholamban
Unlike calcium channels, the calcium pump can move calcium against its own electrochemical 
gradient by using the energy created from the hydrolysis of ATP; transporting two calcium ions into 
the lumen of the SR for every molecule of ATP consumed. The activity of the pump is regulated by 
the phosphoprotein phospholamban (PLB).
PLB was discovered in the early 1970’s by Arnold Katz and is one of the major proteins 
phosphorylated upon adrenergic stimulation of cardiac myocytes. Katz demonstrated that 
phosphorylation of isolated cardiac SR membranes occurred mainly on a low molecular weight 
protein, named PLB from the Greek root words meaning “to receive phosphate”. PLB is a small 
transmembrane phosphoprotein comprising 52 amino acid residues, with a molecular mass of 
27kDa. In-vitro studies indicated that PLB is phosphorylated at three distinct sites by different 
protein kinases: serine 10 by protein kinase C; serine 16 by a cyclic adenosine 3’,5’- 
monophosphate/cyclic guanine monophosphate -dependent protein kinase (cAMP/cGMP- 
dependent protein kinase) and threonine 17 by a calcium/calmodulin-dependent protein kinase
(Ca^VCaM-dependent protein kinases) (Arkin et al., 1997; Rapundalo, 1998; Koss et al., 1996; 
Kadambi et al., 1997, Simmerman & Jones, 1998). Phosphorylation by either one of these three 
protein kinases results in stimulation of the SR calcium pump activity, leading to an elevation in the 
rate of calcium uptake (Koss et al., 1996). PLB is one of the few proteins to be phosphorylated by 
both cAMP-dependent and Ca^VCaM-dependent protein kinase. These phosphorylations occur 
independently of one another to produce equivalent effects (Simmerman et a i, 1998; Rapundalo, 
1998) and have been found to be adjacent on the same polypeptide (Simmerman et al., 1998).
Phosphorylated PLB was thought to function as a stimulator for the SR calcium pump 
enzyme due to the observation that PLB phosphorylation induced an increase in calcium uptake into 
the lumen of the SR. In the late 1980s it was discovered that this was not the case, and that 
dephosphorylated PLB is actually an inhibitor of the cardiac calcium pump at low ionized calcium 
concentrations (Simmerman et al., 1998). Upon phosphorylation, this inhibition is overcome 
(Jencks, 1989; Katz, 1996) leading to an increase in the enzymes apparent calcium affinity with 
little or no change in the maximum velocity (Vmax) (Koss et al., 1996, Simmerman et al., 1998). 
The suppression of the pump by PLB was further investigated, looking into the effects of 
phosphorylation on the kinetic level (Tada, 1980). On phosphorylation of PLB by cAMP-dependent 
protein kinase, a marked increase occurred in the rate of calcium binding to the enzyme and the rate 
at which acylphosphoprotein intermediate was formed (Tada, 1980). Whether phosphorylation of 
PLB affected the calcium-binding affinity of the pump directly, or caused an increase in calcium 
affinity by accelerating a kinetic step was unknown. However, Inesi et a l ,  (1989) measured 
calcium binding to the pump in cardiac SR using monoclonal antibodies directed against PLB. 
Antibody binding removed the inhibitory effect of PLB and shifted the concentration dependence to 
the left with no effect on the calcium affinity of the ATPase. It was concluded that PLB affects the 
kinetics of enzyme activation by bound calcium rather than the actual calcium binding affinity 
(Cantilina, 1993). Inesi et ah, (1989) supported this theory further with the evidence that the 
calcium affinity of cardiac SERCA2a is identical to that of fast twitch skeletal SERCA la  (devoid of 
PLB). PLB does not alter this stoichiometry or the positive cooperativity of calcium binding to 
SERCA in both cardiac and skeletal SR vesicles (Cantilina, 1993). On the basis of these results it
was proposed that PLB acts by inhibiting the slow isomeric transition after binding of the first 
calcium to the pump, without changing the overall equilibrium constant for calcium binding and 
that phosphorylation greatly accelerates this slow transition.
In order for phosphorylation of PLB to play a physiological role in regulating cardiac SR 
function and thereby myocardial contraction and relaxation, mechanisms must exist to 
dephosphorylate the protein and return it to its role as a functional inhibitor of SERCA2. Such a 
mechanism is fulfilled by protein phosphatases which hydrolyse the phosphodiester bonds formed 
by protein kinases. These endogenous protein phosphatases have been shown to dephosphorylate 
the protein kinase A (PKA) sites on PLB resulting in a decrease in the degree of stimulation of 
calcium transport activity (Rapundalo, 1998). Three distinct types of protein phosphatases have 
now been demonstrated to dephosphorylate PLB. A TLB-specific’ phosphatase, capable of 
dephosphorylating both PKA and Ca '^  ^ /CaM-dependent protein kinase activated phosphorylation 
sites; protein phosphatase 1 (PPl) which is capable of dephosphorylating PLB when PLB has been 
phosphorylated by PKA but not Ca^ '*' /CaM-dependent protein kinase phosphorylation sites; and 
protein phosphatase 2B (PP2B) which is capable of dephosphorylating PKA-activated PLB under 
certain conditions (Rapundalo, 1998). With the discovery of these cardiac SR-associated 
endogenous protein phosphatases, PLB can function as a reversible inhibitor of SERCA2 
(Rapundalo, 1998; Koss etal., 1996).
1.3.4. Structure of PLB
Several models based on amino acid sequence of the tertiary structure of PLB have been proposed. 
The protein consists of two domains; a hydrophilic cytoplasmically orientated domain (amino acids 
1-30) and a carboxy-terminal hydrophobic membrane spanning domain (amino acids 31-52) (Arkin 
et a l,  1997, Rapundalo, 1998; Koss e ta l ,  1996; Kadambi et a l, 1997; Simmerman, et a l, 1998). 
The cytoplasmic domain (domain 1) can be further divided into two sub-domains: domain la and 
domain lb  (Kadambi et a l, 1997). Domain la  contains the three phosphorylation sites for the three 
protein kinases, has a higher preponderance of charged amino acids and has been suggested to exist 
in a helical conformation. Domain lb  (amino acids 21-30) is highly polar and is proposed to be 
unstructured (Kadambi e ta l ,  1997).
The hydrophobic domain (domain 2) anchors the protein into the SR membrane and holds 
the multiple subunits together (Koss et a l, 1996; Kadambi et a l ,  1997; Simmerman et a l,  1998). It 
is proposed to have a helical structure but there is no evidence to suggest this domain interacts with 
the SERCA2 (Koss et al., 1996). Despite this, it is thought to be just as important in mediating the 
regulatory effects as seen during co-expression studies with SR calcium pump, the results of which 
revealed the domain was capable of modifying the calcium affinity of SERCA2 (Kadambi et a l,  
1997). Cysteine resides, C36, C41 and C46 (Arkin et a l,  1997) in the a-helical transmembrane 
domain provides for non-covalent interactions between monomeric forms and contribute to 
stabilisation of a pentameric structure of PLB (Arkin et a l, 1997). Domain 1 on the other hand 
mediates the regulatory effects of PLB on the SR calcium pump through protein-protein interaction. 
Specific residues among amino acids 2-18 in PLB interact with amino acids 336-412 (Koss et a l,  
1996; Kadambi et a l ,  1997) and 467-762 (Koss et a l ,  1996) in SERCA2 for functional 
modification. Both the cytoplasmic and transmembrane regions of PLB are essential for normal 
calcium pump regulation (Simmerman et a l,  1998). The cytoplasmic domain of PLB by itself is 
not inhibitory but instead modulates the inhibitory interactions in the transmembrane domains 
through a long-range coupling process (Simmerman et a l,  1998).
The oligomeric structure of PLB has been proposed to exist as a pentamer in the SR 
membrane as detected by sodium dodecyl sulfate polyacrylamide gels (SDS-page). The most 
populated forms of PLB are those of monomer and pentamer, and upon phosphorylation of the 
pentamer, 10 phosphorylation levels were revealed indicating each monomer contained two 
phosphorylation sites (Arkin et a l,  1997). No oligomerisation is seen in a peptide corresponding to 
the cytoplasmic domain providing evidence that the pentamerization of PLB is solely a function of 
its transmembrane segment, Domain2 (Arkin et a l,  1997; Simmerman et a l,  1998). Equilibrium 
exists between monomeric and pentameric states of PLB but phosphorylation by protein kinases 
shifts the equilibrium in favour of the pentameric form (Kadambi et a l ,  1997). Shifting the 
equilibrium in favour of the monomer form, using alanine scanning mutagenesis of the 
transmembrane domain 2, results in an increase in the inhibitory function (Kadambi et a l, 1997). 
As demonstrated by Autry et a l  (1997), PLB monomers are more effective SERCA2 inhibitors thus
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suggesting that the monomeric form of PLB is a more effective inhibitor than pentameric PLB. 
This dynamic equilibrium between PLB pentamers and monomers in the plane of the lipid 
membrane appears to be controlled by electrostatic interactions, and buffers of high ionic strength 
promote pentameric stability in the protein.
Electrostatic interactions have been shown to be an important factor in the ability of PLB to 
inhibit the pump. A change in surface membrane potential occurs after phosphorylation of PLB, 
and under high ionic strength conditions both the surface membrane potential and PLB 
phosphorylation effects on the apparent calcium affinity of the SR calcium pump are attenuated, 
supporting the idea that electrostatic interactions between cytoplasmic domain of PLB and the 
pump are involved in the regulatory mechanisms.
1.4. TRANSPORT OF CALCIUM ACROSS THE SR MEMBRANE
1.4.1. Reaction Cycle
In 1973, Makinose proposed a model for calcium transport and suggested that the pump can adopt 
two conformations during the calcium transport cycle: a theory that was later substantiated by De 
Meis et a l  in 1979. The reaction cycle describes a scheme whereby the SR calcium pump is 
phosphorylated and dephosphorylated; and an interconversion of conformational states of the 
protein result in the transport of two calcium ions through the SR membrane, against its 
concentration gradient, and into the lumen of the SR for every molecule of ATP hydrolysed 
(Lauger, 1991; Mintz et a l ,  1997; Ikemoto, 1982). An important feature of the SR calcium pump 
cycle is its total reversibility (Makinose, 1971; Makinose & Hasselbach, 1971). The ground state 
(which prevails in the absence of calcium) and the conformations distinguished by an external or 
internal calcium transport site denoted by Ei and E2 respectively, are the three conformational states 
in question (Ikemoto, 1982). Ei (calcium state) and E% (magnesium state) are distinguished by the 
fact that the former has the ability to form EP from ATP but not from P„ whereas E2 can form EP 
from P, but not ATP. The phosphorylation of the enzyme does not take place unless the enzyme 
changes from the ground state to Ei or E% (Ikemoto, 1982) (Figure 1.2).
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Step 1, the enzyme (Ei) binds two calcium ions sequentially at high affinity sites 
(Km~l|iM ). The calcium binding sites have a cytoplasmic orientation (Lauger, 1991; Ikemoto, 
1982) and after calcium binds, the pump becomes phosphorylated by ATP. The calcium-binding 
step is therefore the rate-limiting step of the cycle (Ikemoto, 1982).
Step 2, in the state Ca2*Ei*ATP, the terminal phosphate group of the bound ATP is 
transferred in a rapid reaction to an aspartyl residue of the enzyme, forming an acid-stable 
acylphosphate.
Step 3, synchronously with the phosphorylation reaction, the two bound calcium ions 
become occluded, i.e. they are retained in the channel and unable to exchange with either the free 
calcium in the cytoplasm or with the calcium in the lumen.
Step 4, the phosphoenzyme is unstable and undergoes a conformational change to E2; 
therefore the binding sites now face the lumen of the SR. In the E2 state the affinity for calcium is 
strongly reduced (Km -Im M ) and permits the release of the bound calcium into the lumen of the 
SR.
Step 5, following the release of calcium, the phosphoenzyme P-E2 is dephosphorylated. 
After transition back to conformation Ei, a new transport cycle can be initiated.
1.4.2. Calcium Binding and Dissociation Mechanisms
Inesi et al., (1980), proposed that calcium binding occurs as a two-step process, comprising fast
binding of a first calcium followed by a slow conformational change which allows binding of a
second calcium (Figure 1.3). A simple possibility for two sites being sequentially accessible from
the cytoplasm is a narrow channel with a deep site (high affinity) and a superficial site (low
affinity). In such a model the sites are not accessible simultaneously so that during the calcium-
binding process the first ion that is bound to the superficial site induces a conformational change
that increases the affinity of the site and reveals a second site of high affinity. Therefore the calcium
ions are transported and released in an ordered and sequential fashion, whereby the binding of
calcium to two high affinity sites is cooperative (Dupont, 1982).
In the absence of phosphorylation, the calcium ion bound to the superficial site can still
exchange with the medium. The binding of the two calcium ions can be described as having three
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substates of the calcium-uptake state (Ei). The first substate (the domain) is an open cavity and can 
bind only a single calcium ion. Once bound the cavity partially closes to generate a second calcium 
binding site (substate 2). Again, after the calcium ion binds to the site the cavity closes, leading to a 
state in which both ions are bound with high affinity (substate 3) (Lauger, 1991), Once the 
transport sites are saturated with calcium, ATPase becomes phosphorylatable by ATP and upon 
phosphorylation induces occlusion of the two bound calcium ions (Dupont, 1980). In this state, 
calcium cannot dissociate unless a slow conformational change occurs or reverse dephosphorylation 
is induced by ADP (Cantilina etal., 1993).
Calcium occlusion in the phosphorylated ATPase occurs together with a change in the 
accessibility of the calcium sites that become inaccessible from the cytoplasmic side and accessible 
from the luminal side (Dupont, 1980). However, the occluded calcium ions are still bound to 
ATPase and not dissociated inside the vesicle, as both EGTA and ADP are required for rapid 
dephosphorylation to induce calcium release on the cytoplasmic side (Mintz et al., 1997). Once the 
calcium sites have become accessible from the lumen, the affinity of calcium ions for the ATPase 
should decrease to allow their dissociation towards the SR lumen thus allowing the SR to store the 
calcium ions. It is thought that the calcium ion bound more deeply is the first to be released, 
whereas the superficial bound calcium ion is released more slowly (Lauger, 1991). This would be 
consistent with the idea of a narrow channel in the phosphoenzyme. Other theories have been 
developed that allow the occluded calcium ions to exchange positions, randomising the ions, 
allowing the first calcium ion bound to be the first or second to dissociate (Mintz et al., 1997).
1.5. CALCIUM EFFLUX MECHANISMS
The SR must possess calcium efflux as well as calcium uptake mechanisms in order to regulate 
intracellular free calcium. Two families of calcium release channels have been extensively 
characterized; the RyR and the inositol 1,4,5-trisphosphate receptor (IPgR). RyRs and IPgRs are 
distantly related, sharing some structural properties and both exhibiting biphasic dependencies on 
cytosolic calcium, such that they are activated at low (nM-p,M ranges) calcium concentrations and 
inhibited at high calcium concentrations (mM) (Bezprozvanny et al., 1991). However, RyRs are the
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major calcium release channels in striated muscle and cardiac muscle possesses 50- to 100- fold 
more RyR than IPgRs (Moschella & Marks, 1993).
The SR calcium pump may also contribute to an SR calcium efflux route and under certain 
conditions induce the reversal of the pump or the transition of the pump into an efflux channel 
(Figure 1.4).
1.5.1. The Ryanodine Receptor
One of the SR calcium efflux mechanisms is termed the RyR on the basis of the ability of the 
protein to bind ryanodine, a plant alkaloid. Ryanodine is a natural product found in the stem and 
root of Ryania speciosa, that grows as shrubs or trees in several tropical locations in central and 
South America including Trinidad and the Amazon basin (Sutko et a l, 1997). The wood from trees 
in the Ryania genus is known to contain toxic components; the crude extracts of which were used as 
an insecticide to induce muscle paralysis in insects (Rogers et a l,  1948; DeVault, 1983).
In striated muscle, RyRs are high conductance calcium channels. They are located in the 
triadic junctions, projecting into the junctional gap between the TC and T-tubules (Fleischer et al., 
1985; Block et a l,  1988; Fleisher & Inui, 1989) and corresponds to the “feet” structures observed in 
electron microscope images within the triads (Figure 1.5). However, RyRs also have been identified 
in SR structures that do not lie in contiguity with the sarcolemma such as corbular and expanded 
junctional SR, as well as in intracellular membranes of other cells and tissues such as brain, smooth 
muscle, endothelium liver and fibroblasts (Franzini-Armstrong & Jorgensen, 1994; Meissner,
1994).
1.5.1.1, Activation of SR Calcium Release via the DHPR
In skeletal muscle, calcium can be released from the SR as a result of direct electrical stimulation. 
During depolarisation of the T-tubules, the DHPR undergoes a conformational change transmitted 
through the bulbous heads of the RyR to induce the release of calcium from the SR through RyRs 
(Figure 1.5). It is thought that the DHPR, a slow activating calcium channel in the surface 
membrane, is structurally linked to the RyR as postulated by Schneider and Chandler (1973). It acts 
as the voltage sensor and alternate arrays of RyR tetramers are associated and aligned with four
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DHPR (tetrads), therefore there are two RyR for each DHPR tetrad in skeletal muscle (Franzini- 
Armstrong & Nunzi, 1983; Block et a l ,  1988; Protasi et al., 1997) and the interaction between 
DHPR and RyR, whether directly or indirectly, is required for the formation of tetrads (Sorrentino,
1995).
In cardiac muscle depolarisation of the transverse tubules activates the DHPR, initiating 
calcium influx into the dyadic space and activating the RyR via the process of CICR (Figure 1.5) 
thus contributing greatly to the rise in intracellular calcium concentration. The released calcium 
together with the calcium entering through the sarcolemma, increase the cytoplasmic concentration 
sufficiently to activate the contractile apparatus in myocytes.
In contrast to skeletal muscle, the cardiac muscle DHPRs are in close proximity of the RyR 
but have not been proven to have a direct link to the RyR, as they seem to lack the well ordered 
array of tetrads that are seen with skeletal muscle SR (Sun et al., 1995; Protasi et al., 1996; 
Franzini-Arm strong, 1999). From these findings, it is thought that the calcium flux through the 
DHPR diffuses into a restricted space to act as the activator of the immediate adjacent RyRs via 
CICR (Fabiato, 1983; Sham et al., 1995; Santana et al., 1996). Thus, entry of extracellular calcium 
through the DHPR is required for E-C coupling in cardiac muscle, whereas skeletal muscle 
contraction can occur in the absence of external calcium (Ashley et al., 1991). Also, in cardiac 
muscle, there are many more RyR than there are DHPR (Bers & Stiffel, 1993) and thus four to ten 
RyR might be associated with a single L-type calcium channel (one tetrad); activating a whole 
cluster of RyR and the temporal and spatial summation of these events would lead to the production 
of a calcium spark (Niggli, 1999). Both skeletal and cardiac RyR are clustered into arrays on the 
junctional SR such that each channel physically contacts four of its neighbours (Saito et al., 1988; 
Flutcher & Franzini-Armstrong, 1996; Franzini-Armstrong et al., 1999), possibly near where the 
FKBP interacts with the RyR (Wagenknect et al., 1996).
1.5.1.2. Stochastic and Coupled Gating
The stochastic gating theory proposed that RyRs operate independently and the activation of one 
RyR may elevate local calcium levels sufficiently to activate neighbouring RyRs (Figure 1.6a). The
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activation of neighbouring RyRs occur at different intrinsic latencies, and thus open and close 
randomly to generate a relatively slow, damped and irregular local calcium flux.
However, in contrast to the “stochastic gating” theory, Marx et a l (1998) proposed a theory 
termed “coupled gating” : a coordinated gating hypothesis where two or more RyR are mechanically 
linked and gate simultaneously (Figure 1.6b). Under these conditions, the RyRs open and close in a 
coordinated fashion, operating as functional units to generate large, fast local calcium release 
events. This concerted effect would speed the SR calcium release process but for this process to be 
physiologically important, clustering of RyR is critical. This mechanism also provides a method for 
simultaneously closing all the RyRs in the junctions thereby reducing the probability that individual 
RyRs channels will be reactivated stochastically by calcium fluxing through their neighbours (Marx 
et a l,  2001). This method of RyR inactivation is proposed to arise from a reduction in the SR 
content (due to calcium release via RyR) that signals the RyR to close, as the open probability of 
the channel (Po) depends, in part, on luminal calcium concentrations (Gyorke & Gyorke, 1998). 
Therefore, when the first RyR closes, all the RyRs in the junction will close due to coupled gating.
The RyR is closely associated with a number of proteins in the TC including, triadin 
(Caswell et a l,  1991), calsequestrin (Collins et al., 1990; Ikemoto et al., 1989), calmodulin 
(Tripathy et a l ,  1995), FKBP 12 (Jayaraman et al., 1992; Timmerman et al., 1993) and the 
immunophilin FK-506-binding protein, all of which have been shown to modulate the release of 
calcium from the TC.
1.5J.3. Ligand Modulation
The RyR is regulated by cytosolic calcium; the process of CICR. To date only calcium (Sitsapesan
& Williams, 1994) and annexin VI (Diaz-Munoz et a l,  1990) are thought to act on the luminal side
of the channel. Many other ligands alter the activity of the channel to stimulate or inhibit calcium
release but calcium is the primary activating ligand; being effective in the absence of all other
ligands (Sitsapesan & Williams, 1994a; Smith e ta l ,  1986). In the absence of calcium, the ligands
will not be able to activate the channel or if they do, the channel will not work at its maximal level
(Sitsapesan & Williams, 1994a). A few of the diverse array of ligands known to modulate the
function of ryanodine-sensitive calcium channels are caffeine (mM) (Palade, 1987; Ashley &
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Williams, 1988), cADP-ribose (mM)(Buck, 1992; Galione et al., 1991), ATP (mM) (Meissner, 
1986; Smith et al., 1986; Meissner & Henderson, 1987) and ryanodine (<10fxM) (Buck, 1992b, 
Ogawa, 1994; Meissner, 1986). They bind to specific sites on the cytosolic side of the RyR, 
increasing the Po of the channel to release calcium from the store. The Po of the channel is 
decreased by free magnesium (mM) (Ashley & Williams, 1990; Meissner et al., 1986; Laver et at., 
1997), tetracaine or procaine (|iM), by RuR (|iM) (Ma, 1993), ryanodine (>100|iM) (Buck, 1992b, 
Meissner, 1986; Rousseau et al., 1987) and by a decrease in the pH (Rousseau & Pinkos, 1990).
Radioactive ryanodine binding ([^H] ryanodine) studies in skeletal and cardiac muscle have 
revealed the existence of two classes of sites, a low affinity and a high affinity binding sites. High 
concentrations of ryanodine (10|iM-300|iM) interact with a low affinity binding sites to lock the 
channel in the closed position thereby inhibiting calcium release from the SR. Low concentrations 
of ryanodine (O.Olp-M-lOjlM) interact with high affinity binding sites to lock the release channel in 
a semi-open state (Coronado et al., 1994). This state produces an early rapid release of calcium 
until the stores are depleted. There is some controversy as to the ratio of high to low affinity binding 
sites although two groups have reported a ratio of 1:3 for high to low affinity binding sites (Pessah 
et al., 1991; Meissner et al., 1989). The mechanism by which bound ryanodine alters the activity of 
the calcium release channel is unknown, but tetrameric assembly is required for the binding of 
ryanodine at its high affinity site.
Another group of calcium releasing agents that affect ryanodine receptors are fatty acids and 
their metabolites. Glycolipid sphingosine has a dual effect, inducing release at high concentrations 
and inhibiting caffeine induced calcium release at low concentrations (Sabbadini et al., 1992). 
Arachidonic acid (Dettbarn et al., 1993) stearic acid (Cardoso & de Meis, 1993), and the fatty acid 
derivatives palmitoyl carnitine (El-Hayek et al., 1993) and palmitoyl coenzyme A (Connelly et al.,
1994) stimulated calcium release from skeletal and cardiac muscle. It was observed that palmitoyl 
carnitine increased the SR calcium permeability in nM free calcium and mM magnesium suggesting 
that palmitoyl carnitine may generate a small calcium leak from the SR in resting muscle cells. This 
leak could influence the resting cytosolic calcium and serve to bring the calcium release channel to 
threshold for activation by voltage or other signals (El-Hayek et a l,  1993).
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L5.1.4, Structure
The massive size of the RyRs may make them physically the largest ion channel. It is not clear why 
RyRs have an unusually high molecular mass (2.3Mda) (Jayaraman et a l , 1992) although, it has 
been suggested that the reason for this might lie within the numerous endogenous modulatory 
ligands known to regulate the activity of the receptor and therefore the gigantic cytoplasmic 
domains of these ion channels are scaffolds for regulators of channel function (Marx et al., 2000). 
The calcium release channel exists as a homotetramer; each monomer has a molecular weight of 
approximately 550kDa (Takeshima, 1989; Zorzato, 1990) and possesses over 5000 amino acids. 
The receptor comprises of two major components; the larger part is the N-terminus, forming the 
bulbous heads that project into the cytosol and comes into close contact with the T-tubular 
membrane. The second component is the C-terminus which is the smaller region and forms the 
calcium release channel (Berridge, 1993) often referred to as the “foot” region (Ferguson et al., 
1984), a term that was applied to the structure based on its appearance in electron micrographs of 
sectioned muscle before its molecular identity was known.
The RyR has been purified, cloned and sequenced from a variety of species and several 
isoforms have been identified, thus the RyR family is proving to be extensive. Three family 
members named RYRl-3 are encoded for by three separate genes, identified as ryrl, ryr2 and ryr3 
respectively. The expression of these genes do not appear to be tissue specific but each was 
predominantly expressed in mammalian skeletal muscle, cardiac muscle and in the brain, and 
smooth muscle respectively (Marks et al., 1989; Hakamata et al., 1992; Otsu et al., 1990). The 
gene for the RYRl was specifically localised to region 19ql3.1, on the long arm of human 
chromosome 19 whereas RYR2 gene was located to human chromosome 1 and RYR3 on 
chromosome 15 (Marks etal., 1989).
Sequence homologs of the three mammalian RyR isoforms are expressed also in 
nonmammalian vertebrates and have been termed a  (RYRl), p (RYR3) and cardiac (RYR2) (Airey 
et al., 1990; Ogawa, 1994). In addition, two alternatively spliced variants of RYRl and one variant 
of RYR2 have been identified (Sutko & Airey, 1996; Nakai et al., 1990; Zorzato et al., 1994; 
Futatsugi et al., 1995). These variants are expressed in both a tissue- and a developmental stage-
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specific manner, suggesting that they may have different functional properties and/or may be 
regulated in different ways (Futatsugi et a l,  1995).
I.5.Ï.5. Phosphorylation
RyR were found to be phosphorylated by exogenous calmodulin-dependent protein kinase, by 
exogenous catalytic subunit of cAMP-dependent protein kinase (PKA), and by guanine 3’, 5’-cyclic 
monophosphate dependent protein kinase (PKG) (Seiler et a l,  1984). The phosphorylation rates for 
each of these kinases were similar, only that of protein kinase C-dependent phosphorylation 
occurred at a relatively slow rate (Takasago e ta l ,  1991). Phosphorylation of the cardiac receptor by 
PKA, PKG or protein kinase C (PKG) increased [^H]ryanodine binding by approximately 20% 
(Takasago et at., 1991). In contrast CaM kinase dependent phosphorylation decreased 
[^Hjryanodine binding by approximately 40% (Takasago et a l ,  1991). The altered ryanodine 
binding reflects different levels of channel activity since ryanodine can only bind to the channel 
once it is in the open state (Takasago et at., 1991). It was observed that endogenous and exogenous 
CaM kinase reduced the activation of the cardiac receptor channel incorporated into lipid bilayers 
(Witcher et al, 1991), whereas cAMP dependent phosphorylation of the cardiac ryanodine receptor 
may be involved in the positive ionotropic effects of (3-adrenergic agonists (Yoshida et a l,  1992).
1.5.1.6. Regulation by Intraluminal Calcium
Work carried out by Endo (1977) with skinned skeletal muscle fibres revealed that luminal calcium 
may play a role in regulating SR calcium release and that a loading threshold was required before 
calcium could be released. Fabiato & Fabiato (1979) later demonstrated that the magnitude of 
CICR in skinned cardiac cells was increased as the calcium loading of the SR was increased and 
that two types of CICR in skinned cardiac cells exist. The first one involves an increase of calcium 
concentration at the cytoplasmic side of the SR to trigger a time and calcium dependent activation. 
The second one involves the spontaneous release of calcium that requires calcium overload of the 
SR and may involve calcium binding to an intraluminal site (Fabiato, 1992) and since then luminal 
dependence of CICR has been shown in isolated SR vesicles (Sitsapesan & Williams, 1994).
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It was initially thought that luminal calcium flowed through the pore of the RyR to act on 
the cytoplasmic calcium binding sites (Tripathy & Meissner, 1996; Hermann-Frank & Lehmann- 
Horn, 1996). However work carried out by Ching et al., (2000) on cardiac RyR incorporated into 
bilayers proved otherwise by using the application of trypsin to digest binding sites exposed on the 
luminal side of the bilayer, thereby providing strong evidence for the existence of luminally located 
calcium activation and inhibition sites on the cardiac RyR channel itself or on a closely associated 
protein that regulates RyR gating. Thus luminal calcium was found not to flow through the channel 
pore and act on the cytosolic calcium binding sites (Sitsapesan & Williams, 1997; Lukyanenko et 
al., 1996) but may bind to sites present within the channel pore or on the luminal face of the 
channel (Sitsapesan & Williams, 1997).
Another factor influencing luminal calcium content is calsequestrin. It is not known to what 
extent SR calcium is bound to this protein, nor at what stage the buffering capacity is reached and 
whether activation of RyR leads to a conformational change in calsequestrin thus leading to a rapid 
dissociation of calcium, that ultimately result in an increase in the calcium concentration at the 
luminal side of the RyR (Sitsapesan & Williams, 1997).
1.5.1.7. Calcium Sparks, Quarks and Waves
Calcium sparks is the term used to describe the localised transient rise of fluorescence observed in 
cardiac myocytes loaded with the dye fluo-3 first reported by Cheng et al,. 1993. Calcium sparks 
are localized, discrete SR calcium release events produced by the gating of RyRs and were first 
characterised in cardiac myocytes by Cheng et al., (1993). It is thought that the electrically evoked 
calcium transients that activate contraction arise from the spatial and temporal summation of 
multiple sparks (Cheng et al., 1993; Cannell et al., 1994; Cannell et al., 1995; Lopez-Lopez et al.,
1995) therefore, sparks represent the elementary event underlying E-C coupling (Cannell et al., 
1994). Sparks originate at the T-tubules probably at the dyadic junction and can arise spontaneously 
(although spontaneous calcium sparks do not occur in cardiac muscle under normal physiological 
conditions (Wier et a l,  1997)), as well as in response to electrical stimulation of the cell, triggered 
by local intracellular calcium concentrations which are first established in the region of the RyR by
the opening of a single L-type calcium channel (Lopez-Lopez et a l ,  1995; Santana et a l, 1996).
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There is a great deal of uncertainty as to whether single or multiple RyRs (Stern et al., 1997) are 
involved in the generation of a single calcium spark. Evidence based on anatomical data showed 
that RyRs generally occur in clusters in the dyadic junction (Bers, 1991). Marx et al., (1998) 
demonstrated that coupled gating can exist between RyRs (Marx et a l ,  1998) and Bers & Fill 
(1998) discussed the potential of coordinated gating between RyRs. These results together with the 
fact that the calcium flux through a single RyR (<0.5pA (Mejia-Alverez et al., 1998) is 
considerably smaller than the flux of calcium associated with a spark (3pA, Blatter et al. 1997; 
~4pA, Cheng et al., 1993), indicates that spark generation is more likely to be due to a cluster of 
RyR gating in concert, rather than through a single RyR (Figure 1.7A). A hypothesis stabilised by 
the discovery of smaller calcium release events termed “quarks” observed by Lipp & Niggli, 
(1996). Quarks represent the release of calcium from a single RyR thus implying that a number of 
RyRs must gate in concert to produce the larger calcium ‘spark’ however, it is unclear whether 
quarks occur during normal EC coupling.
Under normal cellular calcium loading conditions, sparks remain localized, random events 
but when the extracellular calcium concentration is elevated (as seen with calcium overload); sparks 
give rise to the initiation and propagation of calcium waves (Cheng et al., 1996; Lukyanenko et al., 
1996, 1999: Figure 1.7B). During slow propagating waves or waves in the presence of EGTA 
(Lukyanenko & Gyorke, 1999), discrete calcium release events (similar to sparks) can be detected 
in the wave front. The discrete events appear to recruit other sparks in the wave front so that the 
wave progresses in a saltatory manner (Cheng et al., 1996; Lukyanenko & Gyorke, 1999) and this 
salutatory manner is known as fire-diffuse (Keizer et al., 1998).
1.5.1.8. FK506 Binding Protein
FK506 is a macrocyclic lactone used clinically as a potent immunosuppressant for the prevention of
allograft rejection in organ transplantation (Spencer et al., 1997). FK506 binds to the ubiquitous
FK506 binding protein (FKBP), FKBP12. FKBP12 is a 12kDa soluble member of the
immunophilin family (Marks, 1996b) and there are at least six members of the FKBP family that
range from 12-52 kDa, all named according to their molecular masses (Lam et a l,  1995; Timerman
et al., 1996). All of the known FKBP family members display enzymatic activity, cis-trans peptidyl-
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propyl isomerization (Rotamase), thought to be essential for protein folding during protein synthesis 
(Schmid, 1993). The enzymatic activity is unrelated to immunosuppression and is inhibited when 
FK506 or Rapamycin bind to the rotamase active site (Bierer, 1990). Thus far, only FKBP12 and 
FKBP 12.6 were found in complex with the immunosuppressive drug to target calcineurin, a 
Ca^VCaM-dependent serine-threonine phosphatase (Marks, 1996; Lam et a l, 1995) in T- 
lymphocytes. Once bound, the complex inhibits calcineurin function, blocking IL-2 transcription 
thereby preventing T cell activation and consequent immune response (Thomson, et a l,  1995).
FKBP12 can be found in many cell types and is very well conserved from plants and yeast 
to humans (Kay, 1996), and participates in a variety of cellular processes such as, neurotransmitter 
release, nerve growth and calcium release from the RyR (Snyder et al., 1998). In skeletal muscle, 
FKBP12 is physically associated with RyRl (Jayaraman et al., 1992; Marks et a l, 1990, 1989) 
whereas in cardiac muscle FKBP12.6 is physically associated with RyR2 (Timerman et a l,  1994; 
Mehran, et a l ,  1993) (Figure 1.5). Cardiac RyR2 binds FKBP12.6 with high specificity whereas 
skeletal RyRl binds both FKBP12 and FKBP12.6 (Timmerman et a l ,  1996). The two proteins 
copurify during sucrose density gradient centrifugation and co-localize to the TC of the SR 
(Jayaraman et a l ,  1992). The association of FKBP 12 with the calcium release channel suggests that 
FKBP12 may modulate the calcium channel; a distinct action from the ligand-activated 
immunosuppression and inhibition of proliferation.
FKBP 12 was first cloned in 1994 and comprises of 108 amino acids. It was found to be 
closely related to FKBP 12.6 as FKBP 12.6 possesses 85% amino acid sequence identity to FKBP 12. 
Both FKBP 12 and FKBP12.6 have equal affinities for FK506 and are equipotent mediators of 
calcineurin inhibition by FK506. One molecule of FKBP12/12.6 is associated with each monomer 
of the RyR, giving rise to 4 molecules of FKBP12/12.6 per tetramer (Nakai et a l, 1990, Timerman, 
et a l,  1993, Lam et a l,  1995). If FKBP is stripped from the receptor by addition of FK506, the 
channel displays a large number of subconductance states (Brillantes et a l,  1994). This increases 
both the mean open times and open probability of the channel causing the channel to become 
‘leaky’ (Ahern et a l ,  1994; Brillantes et a l,  1994; Mayrleitner et a l,  1994), reducing the net 
accumulation of calcium in the SR thus depleting the stores. FKBP12 also stablises the interaction
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between different RyRs thereby enhancing coupled gating of a cluster of RyR (Marks, 1996). As a 
result, releasing agents such as caffeine (Timerman et al., 1993; Brillantes et a l,  1994) and calcium 
(Mayrleitner et a l ,  1994; Timerman et a l,  1993) increase calcium flux at lower concentrations and 
higher concentrations of magnesium (Timerman et a l,  1993) are required for inactivation. These 
effects are reversed when FKBP12 is rebound to the RyR, and the channel can open to its full 
conductive state (Brillantes et a l ,  1994) indicating FKBP 12 enhances the cooperativity among the 
four subunits and is essential for stabilizing the native full conductance gating behaviour of the 
channel (Marks, 1996; Pessah et a l ,  1997). However, studies using Xenopus oocytes revealed that 
recombinant RyRl was capable of forming an intracellular calcium release channel that was 
activated by caffeine in the absence of FKBP 12, suggesting that FKBP 12 is not required for the 
tetrameric formation of the channel structure (Marks, 1996b).
The occurrence of subconductance states may not always be observed upon the removal of 
FKBP from the RyR. Work conducted by Timerman et al (1996) found that the removal of FKBP 
from canine cardiac RyR with FK590 had no effect on channel function, whereas Barg et al (1997) 
reported an increase in Po of rabbit RyR 1 on the removal of FKBP, an effect reversed with the 
addition of FKBP 12 or 12.6 however, no subconductance states were seen.
1.5.1.9. Bastadin
Bastadins are a class of macrocyclic bromotyrosine derivatives synthesized by the marine sponge 
lanthella basta and were recently reported as novel modulators of RyR function (Mack et a l,  1994; 
Pessah et a l,  1997). A few different isoforms of bastadin (5, 7, 10 and 19) have been isolated and 
exhibit unprecedented activity towards skeletal muscle SR; the individual actions of which are 
highly dependent on the molecular structure.
The potency of bastadin 5 was noted to be 3-fold greater than that of bastadin 7 (Mack et a l,
1994) and in skeletal muscle, bastadin 5 and 7 behave as full agonists by enhancing the occupancy
of [^H] Ryanodine with its high affinity sites and the concomitant decrease in the tendency for low
affinity ryanodine binding (Mack et a l, 1994). Bastadin 19, on the other hand, is a weak partial
agonist and can effectively diminish the actions of bastadin 5 (Mack et a l ,  1994). The mechanism
by which bastadins enhance the number of high affinity binding sites for [^HJRyanodine on the SR
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membrane is not fully understood, however equilibrium kinetic studies have revealed multiple high 
and low affinity binding sites for the alkaloid that appear to be allosterically coupled (Wang et aL,
1993) and maybe related to the subconductance behaviour of the channel (Buck et al, 1992b). In 
bilayer lipid membrane studies, bastadin 5 dramatically slowed single channel gating kinetics 
without significantly altering unitary conductance or Po (Chen et al., 1999).
From work earned out by Chen et al., (1999) it was discovered that bastadin 10 produces a 
concentration dependent (l-15pM ) stimulation of calcium release from actively loaded SR vesicles 
in the absence of stimulatory concentrations of extra vesicular calcium (Chen et al, 1999), thus 
shortening closed dwell times and stabilizing the full open state of the channel. On addition of 
lOjiM RuR and lOfxM ryanodine, to a bastadin 10 modified channel, a block of the leak was 
observed with RuR and half conductance was observed with ryanodine. This suggests that bastadin 
10 mediates its actions on channel gating through site distinct from ryanodine/RuR effector sites. 
Also, the effects of bastadin 10 are reversible, being abolished with the addition of FK506 or 
rapamycin and reconstituted by recombinant FKBP12.
It has been suggested that the actions of bastadin on SR channel function could be mediated 
either by a direct interaction with a site on FKBP or within the FKBP-RyR protein-protein 
boundary, since the effects of bastadin 5 were antagonised by FK506 (Pessah et a l,  1997). In 
contrast to FK506, bastadin 5 does not promote dissociation of the FKBP-RyR complex, but 
enhances the effect of FK506 to dissociate the FKBP from RyR. It stabilizes the full conductance 
gating transitions to significantly increase both the open and closed dwell times equally, whereas 
FK506 promotes subconducting gating behaviour. FK506 on its own enhances steady state loading 
capacity of SR vesicles which can be enhanced further with the addition of ryanodine channel 
blockers whereas bastadin 5 alone significantly reduces steady state loading capacity of the SR, but 
only in the presence of ryanodine channel blockers enhances calcium loading (Pessah et al., 1997).
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1.5.2. CALCIUM ATPase PUMP MEDIATED EFFLUX ROUTES
1.5.2.1. Myocardial Ischaemia: Increase in Pi
Myocardial ischaemia can be characterized by reduced blood flow depriving the heart of substrates 
leading to the accumulation of metabolites. Ischaemia is very difficult to study experimentally 
especially for preparations of cardiac tissue that have no blood supply, such as isolated cells which 
lack direct experimental equivalent to ischaemia. In this situation, anoxia is often used to observe 
the main mechanical features of ischaemia. This involves the removal of all or most of the oxygen 
in a perfused system supplying tissues, or using agents that inhibit oxidative phosphorylation such 
as cyanide (Allen et aL, 1989).
In the first few minutes of anoxia, inhibition of aerobic metabolism is accompanied by a 
pronounced decrease in contractile force (Allen & Orchard, 1987). During this phase, the 
intracellular concentration of ATP remains constant as ADP is rephosphorylated by creatine 
phosphate (CrP); a reaction catalysed by the enzyme creatine phosphokinase. The intracellular CrP 
concentration reduces rapidly from 15-20mM down to undetectable levels and simultaneously 
inorganic phosphate levels (P,) increase from 2 to 20mM (Steele, McAnish & Smith, 1996). After 
depletion of CrP, ATP synthesis continues via anaerobic glycolosis, resulting in lactic acid 
production and an associated decrease in intracellular pH (Bailey et al., 1981). With prolonged 
periods of anoxia, anaerobic glycolosis ceases and a further increase in intracellular P, concentration 
occurs due to the net hydrolysis of ATP (Steele, McAnish & Smith, 1996).
Previous studies have shown that Pz decreases myofilament calcium sensitivity and 
maximum calcium-activated force (Kentish, 1986). More recent work on ‘skinned’ preparations 
suggests that increasing P, may influence the regulation of calcium by the SR; that mM levels of P, 
markedly reduce the amount of calcium available for release from the SR during systole (Smith & 
Steele, 1992; Steele, McAinosh & Smith, 1995) and as a result the inhibitory action of P, may be an 
important contributor to the rapid fall in contractility.
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1.5.2.2. Calcium Phosphate Precipitation
Possible inhibitory actions of P, on SR of skinned fibres involve actions within the SR lumen, on 
SR calcium channels or SR calcium pumps. Fryer et a i ,  (1995) have suggested that the decrease in 
releasable calcium may result from calcium phosphate precipitation within the SR. Like oxalate, P, 
enters the SR by diffusion where precipitation of calcium phosphate occurs if the solubility product 
is exceeded (Makinose & Hasselbach, 1965). Precipitation reduces the free concentration of 
calcium within the SR, thereby increasing and prolonging calcium uptake from the surrounding 
medium. This process is limited only by the eventual rupture of the SR membrane during calcium 
phosphate crystallisation (Feher & Lipford, 1995). However, no evidence of precipitation occurred 
in experiments carried out on cardiac muscle, even at a concentration of Pi (60mM) exceeding that 
known to occur within the cytosol during prolonged anoxia (38-40mM) (Allen & Orchard, 1987). 
The absence of precipitation suggests some other action reduces intraluminal calcium to such an 
extent that the solubility product for calcium phosphate is not exceeded (Steele, McAnish & Smith,
1996).
1.5.2.3. Effects of Pi on Cardiac RyR
It was thought that P,- may also act on the cardiac RyR to increase calcium efflux via this route. 
Steele, McAnish & Smith, (1996) showed that this was not the case and in fact, on addition of 
ryanodine, Pz-induced calcium release from skinned fibres was unaffected. This suggests that P, - 
induced calcium release does not result from direct activation of the SR calcium channel nor is it 
amplified by CICR mechanisms associated with the SR calcium release channels; although a 
ryanodine insensitive calcium efflux pathway cannot be ruled out.
1.5.2.4. Pump Reversal
Another inhibitory action of P,- on cardiac SR, to increase calcium efflux, could be mediated by the 
SR calcium pump. There are two mechanisms by which the pump can achieve this; pump reversal 
or pump channel transition. Reversal of the SR calcium pump would require mM levels of ADP as 
well as a calcium concentration gradient across the SR membrane in order to provide the energy 
required for ATP synthesis (Hasselbach, 1978). In the absence of an ATP regenerating system,
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ADP concentrations would be expected to increase due to the presence of cellular ATPases. 
Micromolar levels of ADP have been shown to stimulate a rapid exchange between intra and 
extravesicular calcium (Waas & Hasselbach, 1981), but has little effect on the SR calcium content 
as calcium influx and efflux are increased to a similar extent in the presence of ADP alone (Waas & 
Hasselbach, 1981; Feher & Briggs, 1983; Soler et al., 1990). However, calcium efflux was found to 
increase upon addition of millimolar levels of P, and the concentration of ADP increased from 
60|liM (Smith & Steele, 1992), a level close to optimal levels for pump reversal (Barlogie et al., 
1971), to 120jiM. Similar values were measured in cardiac muscle during anoxia and ischaemia 
(Allen et al., 1985). So the inhibitory effects of Pz may result from a dual action of Pz and ADP 
(produced by cellular ATPases) to induce a net calcium efflux via the SR calcium pump, rather than 
inhibition of calcium uptake per se (Steele, McAnish & Smith, 1995). This action helps explain 
why calcium phosphate precipitation was not observed even in the presence of 60mM Pz because as 
the concentration of Pz increases, the calcium content of the SR decreases so the solubility product 
is never exceeded.
Rephosphorylating ADP to ATP by phosphenolpyruvate and pyruvate kinase can reduce Pz- 
induced calcium efflux of the SR. However, this provides unfavourable conditions for pump 
reversal because as ADP concentration decrease, this forces the pump to revert back to its original 
status of pumping two calcium into the lumen of the SR for every molecule of ATP utilised. Steele, 
McAnish & Smith (1995) have shown that creatine phosphokinase is retained after saponin 
treatment so even in the absence of these ATP regenerating systems, additions of creatine phosphate 
alone may interact with endogenous creatine phosphokinase to reduce the ADP concentration, 
thereby inhibiting Pz-induced calcium efflux via pump reversal. The effects of CrP have been 
shown to be due to reversal of the inhibitory actions of Pz and not as a result of increasing the 
calcium content of the SR by other means (Steele, McAnish & Smith, 1995). In preventing calcium 
efflux with the introduction of CrP, free luminal calcium concentrations will increase and if Pz 
concentration within the lumen is high, precipitation of calcium phosphate can occur. This will 
have no bearing in anoxia or ischaemia, since CrP concentrations fall as Pz concentrations increase.
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1.5.2.5. Pump Channel Transition
Alternatively, some studies have suggested that under certain conditions, the SR calcium pump can 
mediate a fast efflux of calcium from the SR in an ‘uncoupled’ or substrate free state. Under these 
circumstances, the SR calcium pump acts as a channel and can mediate calcium leak from the SR. 
This mode of SR calcium pump is only seen in substrate free conditions or in presence of agents 
that inhibit substrate binding (e.g arsenate). Furthermore, Pz concentrations above 4mM appear to 
block the uncoupled mode of the calcium pump (De Meis & Inesi, 1992).
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Depolarisation of the SL
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Figure 1.1: E-C  Coupling Mechanisms. The intracellular calcium concentration is increased 
through two routes: voltage dependent calcium release pathway and CICR. Voltage dependent 
calcium release requires depolarisation of the cellular membrane to generate an action potential. 
The action potential propagates along the T-tubules, opening the VOCC to induce influx of calcium 
into the cytoplasm. This route also involves a direct link of the SL/T-tubule with the SR and 
depolarisation of the cellular membrane shifts the “voltage sensor” (DHPR) of the L-type calcium 
channel to allow influx of calcium into the cell. The second mechanism is CICR and involves the 
rise in intracellular calcium to induce the release of calcium from the SR via the RyR. All these 
mechanisms lead to muscle contraction.
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Figure 1.3: Representation of the movement of calcium across the SR membrane via the SR 
calcium pump. The calcium binding mechanism is a two step process: 1) the first calcium ion 
binds with high affinity to induce a conformational change of the protein and reveals the second 
binding site. 2) The second calcium ion binds with low affinity and is interchangeable with the 
medium until ATPase becomes phosphorylated. Once the ATPase is phosphorylated, both calcium 
ions are occluded, making them inaccessible. However, upon ATPase dephosphorylation, the 
binding sites can be accessed on the luminal side of the SR and the affinity for calcium is reduced, 
thus releasing calcium into the lumen of the SR.
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Figure 1.4: Sim plified diagram to show the calcium efflux routes in the SR. It is essential that the 
calcium uptake and release mechanisms in the SR are tightly controlled. As the SR is the main 
calcium store, providing rapid calcium exchange with the cytosol to induce contraction and 
relaxation in cardiac muscle. The efflux mechanisms include; the ryandodine receptor (RyR); the 
inositol trisphosphate receptor (IP3R); reversal of Ca^^-ATPase pump (under certain physiological 
conditions) and the passive SR leak. To buffer intraluminal calcium, the SR contains accessory 
proteins such as calsequestrin (CSQ).
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Figure 1.6: The proposed theories to induce calcium release in striated muscle. A) The stochastic 
gating theory proposes that the RyR operate independently of one another. The calcium released 
form one RyR increases the local calcium levels in the dyadic junction to stimulate the 
neighbouring RyR via CICR, thus the RyR open and close randomly. B) The coordinated-gating 
theory proposes that the RyR are mechanically linked to operate in a coordinated manner and thus 
give rise to fast local calcium release events.
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Figure 1.7: Coordinated SR calcium release via RyR clusters. A) Clusters of RyR are distributed 
along the SR and upon stimulation; small ealeium release events called quarks summate to produce 
a calcium spark. B) When the cells are exposed to a maximal stimuli, calcium sparks summate to 
form a calcium wave and is then transmitted through the cell to induce the release of calcium 
neighbouring cells via CICR.
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CHAPTER TWO
METHODS AND MATERIALS
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2J, PREPARING CELLS FOR CALCIUM UPTAKE MEASUREMENTS
2.1.1. Rabbit Models: Coronary Artery Ligated, Sham and Control
A coronary artery ligation model of left ventricular dysfunction was used in these studies as 
described by Pye et al., (1996). Experiments were undertaken in adult New Zealand White male 
rabbits (2.5-3kg) and the surgery was performed by technieians in the animal house at Glasgow 
Royal Infirmary. General anaesthesia was induced using Hypnorm and maintained with Halothane 
and Nitrous Oxide/Oxygen. After induction, a left thoracotomy was performed and the large 
circumflex branch of the left coronary artery was identified and occluded approximately midway 
between the left atrial appendage and the cardial apex. This procedure gives rise to a large 
homogenous infarct in view of the minimal collateral circulation in the rabbit. Intravenous 
Quinidine was administered to minimise perioperative ventricular fibrillation. Post operative 
analgesia was provided and prophylactic antibiotics were administered. Animal were monitored for 
signs of distress and were withdrawn from the experimental protocol in cases of weight loss greater 
than 20% of baseline, evidence of overt infection or severe distress.
Sham operated animals were prepared in an identical manner, but the coronary artery was 
not tied. Following surgery, animals were allowed to recover for 8 weeks prior to being sacrifieed 
for in vitro experimentation. Control animals were not subjected to an operation.
Prior to sacrifice, all animals underwent echocardiographic examination to assess the degree 
of left ventricular dysfunction produced by the experimental infarct. This was undertaken using a 5 
MHz focused paediatric transducer under light sedation with Hypnorm. M -mode measurements of 
ventricular end diastolic diameter was made and area ejection fraction was calculated from 2-D 
measurements of end systolic and end diastolic dimensions in the short axis (Pye et al., 1996).
2.1.2. Harvesting
New Zealand White, adult, male rabbits (2.5-3kg) were subjected to deep anaesthesia via the 
marginal ear vein with an intravenous injection of 500U heparin together with a terminal overdose 
of sodium pentobarbitone (lOOmg/kg). The thoracic cavity was opened, the heart quickly excised 
then placed into a beaker of ice cold calcium free Krebs. These procedures were carried out by the
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technicians Aileen Rankin and Anne Ward or me and unless otherwise stated, all the procedures 
after this point were carried out by me.
2.1.3. Isolating Cardiac Myocytes
To dissociate cardiac myocytes from an isolated whole heart, the excised heart was quickly 
mounted and tied via the aorta onto the cannula of a Langendorff retrograde perfusion system. The 
heart was trimmed removing fat and connective tissues. 200mls of calcium free Krebs (Table 2.2), 
maintained at 37°C and bubbled with 100% O2, was perfused through the heart at a rate of 
25mls/min to remove blood and calcium. The calcium free Krebs solution was made the previous 
day and the glucose was added on the day of the cell isolation. The heart was then perfused with an 
enzyme solution containing 3mg of protease (Type XIV) and 50mg of collagenase (Type 1), 
dissolved in 75mls of calcium free Krebs (Table 2.2). The enzyme was collected as it passed 
through the heart and then re-circulated once the initial volume of enzyme had been through. The 
recirculating enzyme was continued for 10 minutes to allow initial digestion of connective tissue 
until the left ventricular tissue became soft. The heart was then perfused with lOOmls of 0.2% BSA 
solution (0.2% BSA, lOmM Creatine, l l .lm M  Glucose, 20mM HEPES, 5.4mM KCl, 3.5mM 
MgCli, 120mM NaCl, 0.52mM NaH2P04, 20mM Taurine) before the heart was cut down. The atria 
were discarded and the left and right ventricle were placed into a petri dish containing lOmM 
Ethylene bis[oxyethylenenitrilo]tetraacetic acid (EGTA) solution (Table 2.2). The tissue was finely 
chopped into small sections before the myocytes were dissociated by lightly titurating the solution 
for about ten minutes. The cell suspension was filtered through 250pm nylon mesh before being 
spun gently for 2 minutes with a hand spinner. The supernatant was discarded and cell pellet 
resuspended in lOmM EGTA with ImM ATP and 40mM CrP (Table 2.2) before being 
permeabilized with P-escin (Chapter 2.1.3). The cells were kept at room temperature (22°C) during 
the experiment.
In order to make comparative measurements of SR calcium uptake rates in myocytes, it was
necessary to standardise the preparation as myocyte yield of rods varied between dissociations. The
dissociation produces both rod shaped myocytes and myocytes that are balled-up. In our preparation
both rods and balled-up cells were counted, as balled-up cells may retain functional SR material
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(Chapter 3). The cells were counted using a haemocytometer where balled-up cells as well as rod 
shaped cells were counted. To obtain 1x10^ cells total cells per ml (a standard concentration to 
provide valid comparison of calcium uptake rates) the suspension was either concentrated by 
centrifugation or diluted to give the desired concentration of cells. Then a recount took place to 
confirm myocytes concentration.
2.1.4. Chemical Skinning Procedure
P-escin is a saponin ester. Saponins are non-cardiac active alkaloids, some of which are extracted 
from plants and are available commercially (Sigma and BDH). At certain concentrations, saponins 
have been reported to selectively bind cholesterol residues in the sarcolemma (Ohtsuki et a l,  1978), 
causing the formation of 10-50nm holes (Seeman, 1967). P-escin has little or no effect on the 
membranes of intra-cellular organelles, thus permeabilised cells retain an active SR component 
(Endo & lino, 1980). This is believed to be due to these internal membranes contain less cholesterol 
then the sarcolemma (Martinosi, 1968; Waku, Uda & Nakazawa 1971). The technique allows for 
the passage of substances through the sarcolemma membrane and into the interior of the cell thus 
allowing the regulation of the intracellular environment of the cardiac myocyte under these 
experimental conditions.
2.1.4.1. fi-escin concentration curve
To ascertain the P-escin concentration required to ‘skin’ 100% of the cell population, the following 
protocol was carried out. 1x10^ cells were bathed in 3mM EGTA (-InM  calcium) at pH 7.0 then 
incubated in P-escin for 2 mins, increasing the P-escin concentration from O-lOOOpg/ml. The cells 
were then spun down with a hand spinner, the supernatant was discarded and the pellet resuspended 
in 3mM EGTA. Counting the cells using a haemocytometer allowed for the determination of the 
percentage of rod shaped cells present after permeabilisation. In order to observe the effects of P- 
escin permeabilisation in the presence of a high calcium concentration, the same procedure was 
carried out but in the presence of 3mM CaEGTA (~10pM calcium). This level of calcium, if given 
access to the intracellular space, would cause a sustained contraction. Therefore the percentage of
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cells forming hypercontracted balls, in the presence of lOpM calcium, reflect the cells that were 
rendered hyperpermeable by the p-escin treatment.
From figure 2.1, it was noted that increasing the calcium concentration from InM to lOpM 
in the presence of 0-lpg/m l P-escin, caused 50% of the myocytes to contract. This suggests that 
prior to P-escin treatment, the cells are hyperpermeable, possessing damaged membranes as a result 
of the isolation procedure. In the presence of lOpg/ml of p-escin, 80-90% of the cells 
hypercontracted indicating that a significant concentration of the cells were skinned, with 100% 
occurring in the presence of lOOpg/ml and lOOOpg/ml. However, lOOOpg/ml of p-escin also 
induced 100% hypercontraction of the cells in the presence of the low calcium concentration 
solution. From this data we can conclude that lOOOpg/ml of P-escin damages myocytes and 
therefore stimulates contraction of the cells in the absence of calcium.
2.1.4.2. Skinning of dissociated myocytes
Skinning the cells is achieved prior to each experiment. In this study, lOOpg/ml of P-escin was used 
to achieve the skinning of close to 100% the cell population without damaging a significant 
proportion of the myocytes. lOOpg P-escin was added to 1ml of cells, gently shaken for a minute 
then the cells were spun down with a hand spinner. The supernatant was discarded and the cells 
were resuspended in 0.05R (Table 2.2), before a last spin and resuspension in the final volume of 
0.05R. This allows both P-escin and lOmM EGTA to be effectively removed from the solution.
2.2, MEASURING CHANGES IN INTRACELLULAR CALCIUM
2.2.1. Cuvette System
1x10^ of the permeabilised cells were added to a closed cuvette system (Fig. 2.2), containing a mock
intracellular solution mimicking the cell’s intracellular environment (Table 2.2, 0.05R), along with
the following drugs (Table 2.3). The cells suspension was constantly stirred at 20-22°C to prevent
cells settling and the stirrer speed was not changed between experiments. Mg ATP was added to
supply the energy required for myofibril contraction; CrP to regenerate ATP from ADP; HEPES to
maintain physiological environment and buffer H^; KiOxalate to maintain a low intraluminal
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calcium concentration within the SR thus facilitating calcium uptake; K2EGTA to reduce 
intracellular ealeium concentration; Ruthenium Red (RuR) to inhibit calcium uptake/release by the 
mitochondria and to inhibit calcium induced calcium release from the ryanodine receptor (RyR); 
0.033mM oligomycin and 0.0ImM CCCP were used to inhibit mitochondrial activity.
2.2.2. Fura-2
The changes in the free intracellular calcium concentration were measured with the fluorescent 
indicator Fura-2 (lOpM). The fluorescent ratio was produced due to excitation at 340nm and 380nm 
from a xenon arc light source and a spinning wheel system (Cairn Research Ltd, Kent, UK) at 
30Hz. The fluorescence evoked was passed to a photomultiplier and the output signal correlated 
with the excitation filter using circuitry on the spectrophotometer (Cairn Research Ltd, Kent, UK). 
A ratiometric measurement of free calcium concentration was calculated from the fluorescence at 
340 and 380nm and stored to disc using the program Newtape (Francis Burton, 1990) as well as to a 
chart recorder.
2.2.3. Oxalate
Oxalate was used to prevent the increase in free calcium concentration inside the SR (that would 
otherwise slow the rate of net uptake) by the precipitation of calcium-oxalate inside the SR 
(Madeira, 1982). A consequence of this is that the rate of SR ealeium uptake can stay at the same 
rate determined by the free calcium in the suspension (rather than limited by high free calcium 
inside the SR). It has been shown that crystallization of calcium-oxalate inside the SR does not 
reach equilibrium at any time during calcium uptake (Feher & Briggs, 1980), and thus will continue 
to buffer intraluminal calcium. It is well documented that SR calcium leak depends on SR calcium 
content (Bassani, J. W. M. et a l ,  1995; Smith & Steele, 1998; Shannon T.R. et a l ,  2000) as well as 
the free calcium concentration in the mock intracellular solution (Ashley & Williams, 1988, 1989, 
1990).
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2,2,4. Calibration curve for Fura-2 measurement of free calcium
The relationship between calcium concentration and fluorescence ratio was established with a series 
of calibration experiments. The calibration experiments required a variety of solutions, containing 
increasing calcium concentrations (Table 2.5). These solutions were prepared from the stock 
solutions; lOmM EGTA (Table 2.4) and lOmM CaEGTA (Table 2.4). The calcium concentration 
in these solutions was calculated using the program React (Godfrey Smith 1990) with the binding 
constants for EGTA taken from Smith & Miller (1985) and the binding constants for ATP and CrP 
were taken from Fabiato & Fabiato (1975b).
The data for the calibration curve were produced by adding 1.5mls of the calcium solution 
(Table 2.5) to a cuvette together with lOjiM Fura-2 and a stirrer bar. Each cuvette was then placed 
into the spectrophotometer and the fluorescence ratio produced at 340 and 380nM was noted. A 
calibration curve was then plotted for Fura-2 fluorescence ratio against the calcium concentration. 
The relationship was found to be sigmoidal and can be described by the following equation [1]:
[1] Cs?* = K d  X  [(R -  Rml.) /  (Rmax -  R)]
Where ‘R ’ is the measured Fura-2 ratio, ‘Rmin’ is the ratio in calcium free solutions, ‘Rmax’ is the 
ratio at saturating calcium concentrations and K* is constant (Grynkiewicz et al. 1985). A curve 
was then fitted to the data points using the equation [2]:
(1 +  X ) X Kd
(Grynkiewicz et al. 1985)
Here R (Fura-2 ratio) is a function of the calcium concentration and dependent on the constants 
Rmax, Rmin and K d- The curve was fitted by iterative variations of these constants until the best fit 
was found. This was achieved using the program Origin (Microcal Software). Utilising the 
constants calculated from this curve fitting, calcium concentrations could then be calculated from 
any given Fura-2 ratio using equation [1].
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2.3. MEASUREMENT OF PROTEIN CONCENTRATION
The protein content for the cell solution after each experiment was determined using Coomassay 
dye and a 96 well plate.
2.3.1. Preparation for protein assay
An aliquot of the cell suspension solution was transferred from the cuvette into a 1.5ml Eppendorf 
tube and placed on ice to minimise protein degradation. If the cell suspensions were frozen with 
liquid nitrogen at the end of the experimental day, then the Eppendorfs were placed into a water 
bath and left to defrost.
The concentration of the standards required as a reference for the plate reader were made 
from a 2mg/ml BSA stock solution and deionised water (dH^O) was used to dilute the BSA stock 
solution; the dilutions were as follows, 0.1 mg/ml, 0.25mg/ml, 0.5mg/ml, 0.75mg/ml, 1 mg/ml.
The protein samples were then diluted with dHgO and two dilutions of the protein samples 
were made to make sure one of the readings measured was within the limits of the standards. The 
first dilution was in the ratio 1:1 (25 pi of sample was added to 25 pi of dHsO) and the second 
dilution was in the ratio 1:4 (lOpl of the sample was added to 40pl of dHgO). These dilutions were 
repeated for each new sample and a few samples were collected before the plate was run. If the 
colour change of the protein samples, upon addition of the dye, was out with the range of the 
standards then a more dilute protein sample was prepared.
2.3.2. Plating the samples and standards
lOpl of the standards were plated out in triplicate into columns B through to C. In column A the 
background buffer was added to act as the blank. So in row 2, 0.1 mg/ml of BSA was added in 
triplicate then in row 3, 0.25mg/ml of BSA, row 4 0.5mg/ml and so on. Once standards were 
plated, 200pl of the dye was introduced to the standards to make sure the triplicates were the same 
colour, if not then the plate had to be redone because it is important to get the standards as accurate 
as possible so that the sample reading would be accurately read. A standard curve for the protein 
standards was produced in order to calculate the protein concentration of the samples (Figure 2.3).
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lOpl of the samples were plated in triplicate and for the first few samples; 200pl of the dye 
was added to the wells, in order to check that the samples were within the standard range. If the 
colour change of the samples were within the colour range of the standards the rest of the samples, 
were then plated out. If not, then a more diluted sample was prepared and plated for each new 
sample. Once all the samples were plated, 200pl of the dye was added to each well, making sure 
there were not any bubbles in the wells as this interferes with the plate reading. If bubbles were 
present, they were removed by bursting them with a clean needle. The plate was then read at 
595nm, the computer automatically calculated the protein eontent and the results were printed out.
2.4. DATA RECORDING, ANALYSIS AND CURVE FITTING
During the experiment, the raw data was plotted in real time on chart paper, and the output voltage 
from the spectrophotometer for the individual wavelengths and the ratio were stored on hard disc 
for later analysis. The analysis of the digitised fluorescent ratio and wavelengths required the 
program QA (Francis Burton, 1990); the areas of interest within the data sets were selected for, and 
the digitised data was then converted into calcium concentrations using the parameters provided by 
the Fura-2 calibration curves. These values were plotted using the program Origin (Microcal 
software). Mono- and bi-exponential curves were fitted to the uptake time course using the inbuilt 
fitting routines, below 700nM calcium concentration and the best fit was provided by the Bi­
exponential decay. From this plot, two time constants for each decay curve were calculated and 
noted as ti and tz; ti was taken to reflect the fast phase of calcium uptake time course and tz was 
taken to reflect the slow phase of calcium uptake time course. However, only ti was utilised in the 
comparison of the calcium uptake rate between experiments as tz values were found to vary greatly 
within one experiment while the faster component, ti, was more consistent and represented the 
major component of calcium uptake under these conditions. Therefore only ti was used in the 
analysis.
The relationship of the ratio of Fura-2 fluorescence at 340nM and 380nM to calcium
concentration was described in chapter 2.3.2. The relationship is sigmoidal (Figure 2.4) and
depends on the constants Rmin, Rmax and Kd. These constants vary depending upon several
properties of the system in use, in particular, the optical properties of the system and the presence of
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other chemicals within the solution. For these reasons it was necessary to plot a calibration curve 
for these experiments. This was achieved as described previously in chapter 2.3.2, combining 
different ratios of lOmM EGTA and lOmM CaEGTA (individual solution composition, Table 2.4; 
Ratio mix, Table 2.5) to create a range of calcium concentrations before measuring the ratio of 
fluorescence at 340 and 380nM. The addition of high concentrations of RuR affected the 
fluorescence properties of Fura-2, quenching the fluorescent signal of both wavelengths. Therefore, 
when RuR concentration exceeded 5|iM, a calibration curve was plotted in the presence and in the 
absence of RuR. The constants produced from the calibration curves were then used to compute the 
time constant (ti) for the rate of calcium decay. Table 2.6 displays the constants produced from the 
Fura-2 and RuR calibration curves.
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COMPOUND SUPPLIER SOLVENT
ATP (disodium salt) Sigma dHzO
Bastadin mix(5-12) Calbiochem Methanol
p-escin Sigma dHzO
BSA Sigma dHzO
CaClz BDH -
Caffeine Sigma dHzO
CCCP Calbiochem EtOH
Collagenase (Type 1) Worthing Chemicals -
CrP (disodium salt) Fluka dHzO
DTT Sigma EtOH
EGTA Sigma dHzO
Fura-2 Molecular Probes dHzO
Glucose Fischer dHzO
Heparin - -
Hepes Sigma dHzO
lonomycin Calbiochem DMSO
k C L BDH -
KH2P04 BDH dHzO
MgClz BDH -
NaCl BDH -
NaHCOa BDH dHzO
Oligomycin Calbiochem EtOH
Oxalate Sigma dHzO
Phenobarbitone - -
Protease (Type XIV) Sigma dHzO
Rapamycin Calbiochem -
RuR Sigma dHzO
Thapsigargin Calbiochem DMSO
Table 2.1: List of drugs and compounds used in the experimental protocol.
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Solution Composition
Compound Ca^  ^Free Krebs Ca^  ^Free Krebs 0.05R ATP + CrP
(mM) + lOmM EGTA 
(mM)
(mM) (mM)
ATP - 1 - 20
Creatine 10 - - - •
CrP - 4 - 40
EGTA - 10 0.05 0.05
Glucose 11.1 11.1 - -
HEPES 20 20 25 25
KCL 5.4 5.4 120 100
MgClz 6H2O 3.5 7.0 1 19.75
NaCl 120 120 40 -
NaH2P04 0.52 0.52 - -
Taurine 20 20 - -
Table 2.2: List of chemicals required to make calcium free Krebs (pH 7.25 @ 37°C), 0.05R (pH 7 
@ 22®C), 0.05R with ATP and CrP, and lOmM EGTA (pH 7 @ 22°C). The solvent used was 
distilled water (dHzO).
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COMPOUND CONCENTRATION
(mM)
Fura-2 0.01
Oxalate 0.02
RuR 0.005
ATP 5
CrP 15
DTT 0.1
CCCP 0.01
Oligomycin 0.033
Table 2.3: List of chemicals added to the cuvette system. The concentrations of the solutions listed 
were added to the cuvette system at the start of each experiment unless otherwise stated. Oxalate, 
RuR, ATP and CrP were all dissolved in dH^O, pH to 7 using KOH, at 20-22®C.
SOLUTION COM POSITION 
(mM)
COM POUND lOmM EGTA lOmM CaEGTA
EGTA 10 -
CaEGTA - 10
HEPES 25 25
KCL 120 120
NaCl 40 40
MgCl 1 1
Table 2.4: List of chemicals required to make lOmM EGTA and lOmM CaEGTA stock solutions 
for Fura-2 calibration curve. The final solution was pH to 7 using KOH, at 20-22°C and the solvent 
used was dH^O.
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RATIO of 
EG TA :CaEG TA
Volume
(mis)
[Ca^+]
(M)
1:0 5 - 0.2E-09
10:1 5 0.5 4.0E-08
3:1 3 1 1.2E-07
1:1 2 2 0.375E-06
1:3 1 3 1.12E-06
1:10 0.5 5 4E-06
0:1 - 5 6.0E-05
Table 2.5; Summarizes the ratios and volumes required to make up increasing calcium 
concentrations using lOmM EGTA and lOmM CaEGTA stock solution. The stock solutions were 
made prior to experiment, pH to 7 with KOH at 20-22°C.
Constants No RuR 5pM  RuR 13.3p,M RuR
Rmin 0.8pM ± 0.09 0.79pM ±0.009 0.77pM ±0.008
Rmax 10.8pM + 0.25 10.9|xM ±0.28 11.09pM ±0.28
K d 1.43|iM ±0.1 1.3pM ±0.08 1.9pm ± 0.04
Table 2.6; Values for the constants, Rmin, Rmax and Kd produced from calibration curves in the 
absence, in the presence of 5pM RuR and in the presence of 13.3pM RuR.
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Figure 2.1: The effects o f  increasing fi-escin concentrations in the presence o f  InM  and lOjjM  
calcium in cardiac myocytes. 1 x 10^  cells were incubated in 3mM EGTA (-InM  Ca^ )^ then 
3mM EGTA and P-escin for 2 minutes,[-■-] or 3M CaEGTA (~10|iM Ca^ )^ and P-escin for 2 
minutes, [-•-]. In the presence of 0 - lp,M/ml P-escin, increasing the calcium concentration from 
InM to lOpM caused 50% of the myocytes to contract, compared to 80 - 90 in lOpg/ml P-escin and 
100% in the presence of lOOpg/ml P-escin. No significant contraction occurred in InM calcium, 
until lOOOflg/ml. The data was expressed as mean ± s.e.m. (n = 13) and the difference was considered 
significant at P<0.05. ANOVA with a Tukey post hoc test was used for multiple comparisons.
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Solution composition (mM)
120 KCl 
5 MgATP 
15 PCr 
1 MgPermeabilised rabbit ventricular 
myocytes suspension 
(1x10* cells/ml)
25 HEPES 
20 KfOxalate 
0.05 K,EGTA 
0.01 Fum2 
pH 7.0 (20-21'C)
1.5 ml
u/v light (340nm/380nm)
Stirrer
Figure 2.2: Diagram o f  the cuvette system. Apparatus used to measure changes in intracellular 
calcium concentrations of permeabilised cardiac myocyte cell suspension.
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Figure 2.3: Calibration curve fo r  the protein standards. Where Absorption (nm) is plotted against 
the Bovine Serum Albumin concentration ([BSA]) to give a sigmoidal relationship (mean ± s.e.m., n 
= 13).
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R uR (13 .3 iiM )
1E-41E-51E-61E-7IE-81E-91E-10
[Ca'1(M)
Figure 2.4: Calibration curves for Fura-2 (_■ _), 3.3|JM RuR ( .. .a . .. )  and 13.3fiM RuR ( o ). The
ratio of the Fura-2 fluorescence is plotted against the calcium concentration to give a sigmoidal relationship. 
The data was expressed as mean ± s.e.m. (n = 10) and the difference was considered significant at P<0.05. 
ANOVA with a Tukey post hoc test was used for multiple comparisons.
53
CHAPTER THREE
CALCIUM UPTAKE V PROTEIN 
MEASUREMENT
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3 J  RELATIONSHIP BETW EEN TOTAL PROTEIN AND YIELD OF RODS
Figure 3.1 shows the linear relationship between total protein and cell number. No difference is 
observed between the three experim ental groups, control, ligation and sham. Although more of a linear 
relationship occurred over the cell num ber range 5-15x10^ producing a total protein level between 1- 
3mg. The yield of rods present ranged from 10-50 percent as seen in figure3.2.
In Figure 3.2, the yield o f rods ranged from 10-50% and no relationship was detectable between 
the total num ber of cells per mg of protein and the percentage yield of rods. Therefore, no protein 
degradation was observed as the percentage yield of rods decreased, indicating the rod cell count does 
not influence the total protein to a significant degree, where as total cell number has a linear 
relationship with total protein, implying balled-up cells contribute to total protein. Overall, the yield of 
rods does not influence total protein, whereas total cell num ber does.
3.2 RELATIONSHIP BETW EEN CALCIUM UPTAKE RATE, CELL NUMBER  
AND YIELD OF RODS
Figure 3.3 is a typieal experim ental trace showing the calcium uptake protocol. Addition of an aliquot 
of calcium chloride (10p,l of lOmM) increases the total calcium concentration within the cuvette by 
67p.M and causes a rapid increase o f the free calcium concentration to approx. 1.6|iM. Over the 
following 12 m inutes, the calcium  decayed below lOOnM. This was repeated three times, noting the 
reproducibility o f the transients. Addition of thapsigargin (5pM ) caused an increase in the calcium 
concentration within the cuvette. This represents a linear calcium leak from  the SR, since thapsigargin 
inhibits the calcium uptake processes. High concentrations o f thapsigargin (5|xM) were used to ensure 
effective inhibition of caleium  pump activity. Assessing the calcium  content of the SR with 
thapsigargin would not be practical since previous work (data not shown) has shown this would take 
over 3 hours so we increased calcium leak from  the SR by the addition o f lonomycin (lOpM ), 15 
minutes after the addition of thapsigargin.
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Figure 3,4 shows a weak linear relationship between the rate constant (ti) for calcium uptake 
and cell num ber and increasing the cell num ber produces an increase in rate constant. This could be 
explained in terms of calcium  pumps; the more cells you have, the m ore functional pumps that would 
be present to take up calcium, thereby increasing the rate constant for calcium  uptake into the SR.
Figure 3.5 displays the relationship between the rate constant (ti) for calcium uptake and 
percentage yield o f rods. From  the figure, no relationship is observed suggesting that the increase in 
functional pumps observed in  figure 3.4 is not due to an increase in the percentage yield of rods. As 
more rods would lead to an increase in rate constant, but no trend is observed.
Figure 3.6 shows the linear relationship between the rate constant for calcium uptake against 
total protein. Increasing the protein concentration increases the rate constant for calcium uptake. 
Similar results are displayed in figure 3.4, where the rate constant was plotted against cell number. 
However the relationship in figure 3.4 is not a good as that seen here. F igure 3.4 has a lower R value, 
o f 0.683 where as here we have an R value of 0.85.
3.3 CALCIUM BUFFERING
This chapter concentrates on calcium buffering within the cuvette system  in order to determine the 
calcium binding capacity o f the solution containing the cardiac myocytes. Several studies have 
provided experim ental inform ation about the intiacellular calcium buffering capacity and have thus 
shown that total calcium  binding in some systems may be underestim ated because o f calcium binding 
to unknown sites, to the mitochondrial surface and to high affinity binding sites in the sarcolemma 
(Hove-M adsen & Bers, 1993; Fabiato, 1983). M easuring passive calcium  buffering proves difficult in 
the presence o f calcium  uptake and calcium  release from intracellular com partments. To inhibit these 
specific calcium regulatory m echanisms, 5jiM thapsigargin was introduced to inhibit calcium uptake 
into the SR (Llopis et al., 1991; Sagara & Inesi, 1991) and 5p,M RuR to inhibit calcium release from 
the m itochondria as well as from the SR (M cCormack et a i ,  1989; W im satt et al., 1990).
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Figure 3.7 displays the relationship o f bound and free calcium within the cuvette system. To 
assess whether caleium  binds to non-specific sites within the cuvette, calcium was added in  the 
presence o f 50fiM EOT A. This was referred to as the blank as the solution did not contain cardiac 
myocytes. It was noted that the calcium  buffering in the presence of EG TA solution fitted that of the 
EGTA calcium binding curve model. Indicating little or no calcium  binds to the apparatus used. On 
introduction of 2 0 |liM  oxalate in the presence of 50|xM EGTA, the m easured free calcium increased 
rapidly to a concentration o f 2|xM then gradually plateaued in the presence of an increasing total 
calcium concentration where the curve superimposed the EGTA m odel up to 4|0,M free calcium. The 
absence of calcium saturation as seen with EGTA alone indicates a buffering mechanism was initiated, 
which was not significantly effected by increasing concentrations of cardiac myocytes until the free 
calcium concentiation reached 3jLiM. Additional buffering was noted for 2x10^ cells/ml as the total 
calcium concentration increased above 3|liM . However, in the cuvette system used in this investigation, 
the total free calcium  concentration observed fell within the range 0-3 |iM  and therefore no additional 
calculations had to be m ade to correct for calcium  binding to unknown sites as all the graphs were 
superimposable below 3fiM (Figure 3.7B).
3.4 DISCUSSION
Figures 3.1, 3.4 and 3.6, em phasize the point that cell num ber correlates well with protein 
concentration, whereas percentage yield o f rods does not, figure 3.2 and 3.5. This implies, that amount 
of total protein does not depend on the yield of rod, so therefore balled cells m ust contribute to total 
protein. The fact that increasing cell number, or total protein can increase the rate of calcium uptake 
into the SR suggests m ore cells with functional pumps leads us to think about balled cells, and their 
calcium pumps. These data implies that balled cells may indeed have functional pumps, thus contribute 
to the total protein concentration.
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Figure 3.1: The relationship between total protein and cell number. The solution composition, bathing 
the cells during the experiment, is as follows; 0.05R (Table 2.2), 20mM Oxalate, 25pM RuR, lOpM 
Fura-2, 5mM ATP, 15mM CrP, 0.1 pM DTT, lOpMCCCP and 33pM Oligomycin. The relationship 
was explained with the use o f Linear Regression (n = 100).
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Figure 3.2: The relationship between the total number o f cells per mg of protein and the percentage 
yield of rods. The solution composition, bathing the cells during the experiment, is as follows; 0.05R  
(table 2.2), 20mM Oxalate, 25pM RuR, lOpM Fura-2, 5mM ATP, 15mM CrP, 0.1 pM DTT, 
lOpM CCCP and 33pM Oligomycin. (n = 134)
59
2 .0
[Ca"]
(^M)
1.0 
0.5 
O.OJ 1000s
25 mM RhRr:
10|aM lonol
Figure 3.3: A  typ ica l ex perim en ta l trace sh ow in g  the calcium  u ptake p r o to c o l  An addition o f an 
aliquot o f calcium chloride (67jiM) caused a rapid increase of the free calcium concentration to approx. 
1.6|xM. Over the following 12 minutes, the calcium decayed below lOOnM. Another two aliquots of 
calcium were added in the presence o f 25pM RuR, 12 minutes apart before the preparation was 
subjected to 5pM Thapsigargin. The leak induced with Thapsigargin was enhanced with lOpM 
ionomycin, both being incubated for 15 minutes. The solution composition, bathing the cells prior to 
the additions indicated in the figure, is as follows; 0.05R (table 2.2), 20mM Oxalate, lOpM Fura-2, 
5mM ATP, 15mM CrP, 0.1 pM DTT, lOpM CCCP and 33pM Oligomycin.
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Figure 3.4: The relationship between the rate constant (ti) for calcium uptake and the cell number. The 
solution composition, bathing the cells during the experiment, is as follows; 0.05R (table 2.2), 20mM  
Oxalate, 25pM RuR, lOpM Fura-2, 5mM ATP, 15mM CrP, 0.1 pM DTT, lOpMCCCP 
and 33pM Oligomycin. (n = 124)
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Figure 3.5: The relationship between the rate constant (ti) for calcium uptake and percentage yield 
of rods. The solution composition bathing the cells during the experiment is as follows; 0.05R 
(table 2.2), 20mM Oxalate, 25|iM RuR, 10|iM Fura-2, 5mM ATP, 15mM CrP, 0.1 pM DTT, 
lOpM CCCP and 33pM Oligomycin (n = 127).
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Figure 3.6: The relationship between the rate constant for calcium uptake against total protein. The 
solution composition bathing the cells during the experiment, is as follows; 0.05R (table 2.2), 20mM  
Oxalate, 25pM RuR, lOpM Fura-2, 5mM ATP, 15mM CrP, 0.1 pM DTT, lOpMCCCP 
and 33pM Oligomycin. The relationship was explained with the use of Linear Regression (n = 82).
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Figure 3.7: Displays the relationship of bound and free calcium within the cuvette system. (A) Aliquots of 
calcium were introduced to the system in the presence of 50pM EGTA, 5|iM thapsigargin and 5|iM RuR. It was 
noted that the calcium buffering in the presence of the EGTA solution, fitted that of the EGTA calcium binding 
curve model. On introduction of 20pM oxalate to the 50|iM EGTA solution, the measured free calcium 
increased rapidly to a concentration of 2fiM then gradually plateaued. It was also observed that the oxalate and 
EGTA curve superimposed the EGTA model up to 4|iM free calcium. The absence of calcium saturation noted 
with EGTA alone, indicates a buffering mechanism was initiated with oxalate, which was not significantly 
affected by increasing concentrations of cardiac myocytes until the free calcium concentration reached 3pM. 
Additional buffering was noted for 2x10^ cells/ml as the total calcium concentration increased above 3|iM. (B) 
Emphasise that all the graphs in 3.7A are superimposable below 3pM. (mean ± s.e.m., n = 5).
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CHAPTER FOUR
CHARACTERISTICS OF SR CALCIUM
LEAK
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4.1. INTRODUCTION
As previously discussed (Chapter 1), there are only two recognised calcium release channels in the 
SR of striated muscle, the RyR2 and the IP3R. However, the RyR is the major calcium release 
channel in skeletal and in ventricular cardiomyocytes. (Brilliantes et al., 1992; Moschella & Marks,
1993)
The aim of this study involved investigating the characteristics of the calcium efflux from 
the SR of cardiac myocytes in the absence of RyR activity. The ability to study the properties of SR 
calcium leak was made available with the use of the drugs listed below, and the inhibition of 
SERCA by thapsigargin was used to determine whether the behaviour of the non-specific leak was 
consistent with the characteristics of a calcium channel.
4.1.1. Ruthenium  Red
RuR is one of the most potent inhibitors of the calcium release channel (Zucchi & Ronca-Testoni, 
1997). It decreases the rate of calcium release from the SR (Gyorke et al., 1997) at concentrations 
ranging from InM  to 20pM (Miyamoto & Racker, 1981; Palade, 1987; Meissner & Henderson, 
1987; Kim et al., 1983) and thereby induces an increase in the rate of calcium uptake. As well as 
having effects on the RyR, RuR also inhibits calcium uptake and release from the mitochondria 
(Gincel et al., 2001; Bemardi, et al., 1984), alters the calcium sensitivity of myofilaments (Zhu et 
al., 1992) and changes the electrical properties of cell membranes (Zacharova et al., 1990).
RuR is an inorganic polycationic dye with a linear structure consisting of three RuR atoms 
linked by two oxo-bridges, 14 amine groups and has a valence of 6 (see [1]). It is a highly charged 
molecule and therefore its permeation through membranes of intact cells is considered difficult but 
studies have revealed the molecule can diffuse slowly through intact papillary muscles (Tanaka et 
a l,  1997).
[1] [(NH3)5Ru-0-Ru(NH3)4-0-Ru(NH3)5]^^ (Fletcher et al., 1961)
RuR is thought to block the calcium permeation through the RyR, but the mechanism for its 
action is unclear. Work carried out by Ma (1993), on the skeletal muscle calcium release channel
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(CRC) reconstituted into planar lipid bilayers, proposed that multiple RuR molecules are involved 
in the inhibition of calcium release from the SR. A Hill Coefficient of -2  was obtained from the 
dose response curve of the RuR block on the RyR, suggesting that RuR binds to more than one site 
within the CRC conduction pore in a cooperative manner (Mai, 1994; Lai et a i,  1988). One RuR 
molecule was found to be sufficient to block the channel, but an additional molecule will ensure the 
channel remains in its closed state (Ma, 1993). The highly asymmetric nature of the block indicates 
that RuR is unlikely to permeate the open channel {cis to trans). Trans RuR has been observed to 
induce a similar affinity to that of cis but with a coefficient of 1, suggesting that a simple binding 
site can be approached from the luminal side of the CRC (Ma, 1993). The RuR block is also 
concentration and voltage dependent: a stronger block being observed with higher RuR 
concentrations and with large positive voltages (large positive voltages favour the movement of 
RuR molecules into the channel pore). However, work carried out on isolated channels suggests that 
RuR acts primarily by reducing the overall availability of the channels by inducing long closures 
(Rousseau & Meissner, 1989; Ashley & Williams, 1990).
It is unclear as to whether RuR competes with the calcium for the calcium activation sites on 
the RyR. Chen & MacLennan (1994) found that RuR binds to several calcium binding proteins, 
suggesting that RuR competes with calcium for the calcium activation sites. In support of this 
theory, the studies undertaken by Zimanyi & Pessah (1991) revealed that RuR decreases [^H] 
ryanodine binding by competitive inhibition, as did Imagawa et al. (1987). Also, Alves & de Meis 
(1986) and Kargacin & Kargacin, (1998) found that RuR competes with calcium for the high 
affinity binding sites of the skeletal and cardiac muscle Ca^^ -ATPase respectively. While Xu et al. 
(1999) and Chu et al. (1990) favour the non-competitive inhibition.
4.1.2. Thapsigargin
Thapsigargin, a naturally occurring tumour promoting sesquiterpene lactone (Norregaard et al.,
1994) isolated from the plant Thapsia gargan/ca(Christensen, 1988), is a highly specific inhibitor of 
the SR and ER Ca^ "^  -ATPase pumps (Thastrup et al., 1990; Lytton, et a l ,  1991). Its mode of action 
is to empty intracellular calcium stores as a consequence of inhibiting the uptake pathway (Thastrup
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et a l,  1990) without affecting sarcolemmal calcium currents (Kirby et al., 1992) and thus it is 
utilised in calcium studies to define and manipulate intracellular calcium pools.
Thapsigargin inhibits SERCA 2A by binding to the low affinity state (E2) of the enzyme. As 
discussed in Chapter 1.4.1, the reaction cycle describes a scheme where the pump is phosphorylated 
and dephosphorylated, and an interconversion of conformational states of the protein results in the 
transport of two calcium ions through the SR membrane against its concentration gradient, into the 
lumen of the SR for every molecule of ATP hydrolysed (Lauger, 1991 ; Mintz et al., 1997; Ikemoto, 
1982). Calcium binding occurs when the enzyme is in a high affinity state (Ei) and the release of 
calcium occurs when the enzyme is in a low affinity state (E2). The shift in states from Ei to E2 is 
caused by the hydrolysis of ATP via the formation of a phosphorylated intermediate (EP). 
Thapsigargin acts to inhibit the enzyme in its high affinity state (E2) (Kijima et al., 1991). The 
sensitivity of the Ca^^-ATPase to thapsigargin is lower in cardiac muscle than in skeletal muscle, 
however the sensitivity is increased in cardiac muscle by phosphorylation. Since PLB also binds to 
the E2 form of SERCA 2A, and PLB is modulated by phosphorylation, it has been suggested that 
the binding sites of thapsigargin and phospholamban may occur in close proximity to each other on 
the enzyme (Kijima et al., 1991).
4.1.3. lonomycin
lonomycin is a monocarboxylic acid ionophore. It is known as an ionophore due to its ability to 
complex and carry cations across lipophilic membranes (Pressman, 1976). lonomycin is relatively 
nonselective, possessing the ability to transport several divalent and trivalent cations (Wang et al., 
1998; Liu & Hermann, 1978). One calcium ion is transported across membranes complexes to one 
ionomycin molecule and each calcium ion is exchanged for 2 protons so that the process is 
elecroneutral (Stiles et al., 1991; Toepilitz et al., 1979; Erdahl et al., 1995). Thus avoiding 
ionomycin-mediated depolarisation of the membrane, which would affect voltage gated channels 
instead of ionomycin’s actions being due to a direct elevation of cytosolic calcium concentrations 
per se. The driving force for transport is therefore a transmembrane calcium or proton gradient 
(Erdahl et al., 1995).
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A limited amount of experimental work has been published on the effect of ionomycin on 
cardiac myocytes however; low doses of ionomycin have been shown to cause the release of 
calcium from the SR in vascular smooth muscle (Smith et al., 1989). The basis for the selective 
action of ionomycin at low doses is probably due to the relatively low affinity of ionomycin for 
calcium: higher calcium concentrations within the SR compared to extracellular concentrations, 
means the predominant effect of ionomycin is to transport calcium across the SR membranes rather 
than the sarcolemma.
4.2, METHODS
Cardiac myocytes were prepared for calcium leak studies as previously described in Chapter 2. 
1x10® permeabilised cells suspended in 0.05R solution were transferred to the closed cuvette system 
and changes in the intracellular free calcium concentrations were detected using the fluorescent 
indicator Fura-2. Unless stated otherwise, the compounds listed in Table 2.3 were also introduced to 
the closed cuvette system. Following a three minute incubation to allow the cells to reach an 
equilibrium with the mock intracellular environment, the cells were then subjected to the following 
experimental protocols.
4.3, RESULTS
To investigate the involvement of the RuR insensitive SR leak under various conditions, the 
following studies were conducted on permeabilised cardiac myoctyes. All the experiments 
discussed below are in the presence of 25pM RuR unless otherwise stated.
4.3.1. E ffect o f  R uR  on SR Leak
Figure 4.1 A, is a typical experimental trace to compare the time course of the calcium transients in 
the presence and in the absence of RuR. A control transient was established in the absence of RuR 
by adding a bolus of calcium (67pM). This increased the free calcium to ~3pM, before decaying 
back to the diastolic level in a 12 minute period. 25 pM RuR was then introduced to the preparation 
prior to a calcium bolus to assess the contribution of the RyR to the SR leak. In the presence of 
RuR the rate constant of decay is increased significantly (w/o RuR = 0.09s‘* ± 0.01; with RuR =
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0.16s‘‘ ± 0.03; P<0.5 (Fig. 4 .IB). This suggests that a significant SR leak exists through the RyR 
under these circumstances.
4.3.2. SR  Leak in the Presence and Absence o f  SR Calcium
Fig. 4.2 displays typical experimental traces to show the effects of 5pM thapsigargin in the presence 
and in the absence of a calcium challenge. In Fig. 4.2A, 5pM thapsigargin was introduced to the 
cuvette system in the absence of a calcium challenge. After 25 minutes, lOpM ionomycin was 
added and then incubated for 12 minutes. It was observed that a linear leak was not produced in the 
presence of 5pM thapsigargin or lOpM ionomycin, in the absence of calcium (Fig. 4.3A).
In Fig. 4.2B, the introduction of an aliquot of calcium increased the free calcium 
concentration to IpM  before decaying back to diastolic levels. After 12 minutes, 5pM thapsigargin 
was added to the preparation and left for Ihr. It was noted that in the presence of a calcium 
challenge, 5pM thapsigargin induces a significant SR leak compared to the gradient produced in the 
absence of a calcium challenge (w/o calcium, m -  0.046 nMs'^ ± 0.042; single calcium challenge, m 
= 0.77nM s'  ^ ± 0.18; P<0.05 (Fig 4.3A). The leak in the presence of a calcium challenge is resistant 
to RuR, as 25pM RuR was present in the cuvette. This indicates that the leak observed is not due to 
the passage of calcium through the RuR sensitive RyR.
Rather than waiting several hours for thapsigargin to induce a steady state SR calcium
concentration (once the cytoplasmic and intra SR compartment had equilibriated), lOpM ionomycin
was introduced to the preparation to enhance the equilibriation process. Fig. 4.4A, is a typical
experimental trace showing the effects of 5|xM thapsigargin and lOpM ionomycin on SR leak after
the introduction of a single calcium challenge. Once the calcium transient decayed to diastolic
levels, 5pM thapsigargin was added to the preparation. After 12 minutes, lOpM ionomycin was
introduced. It is observed that thapsigargin induced a calcium leak from the SR and was enhanced
with the addition of ionomycin. The steady state calcium concentration (Css) produced in the
presence of lOp-M ionomycin was noted to increase significantly in the presence of a calcium
challenge, (w/o calcium, leak Css = 0.12pM ± 0.005; single calcium challenge, leak Css = 0.37pM
± 0.016; P<0.05 (Fig. 4.3B). This suggests that the calcium leak in the presence of the 5pM
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thapsigargin and 10|xM ionomycin treatment, after the preparation has been subjected to a calcium 
challenge, is due to calcium loss from the SR.
4.3.3. Effects o f  Calcium Load on SR  Leak
To assess if multiple calcium challenges increase the SR leak further, the same protocol as that 
described for Fig. 4.4A was followed but with two and three calcium challenges prior to the 
addition of 5pM thapsigargin and lOpM ionomycin. The experimental trace of 5pM thapsigargin 
and lOpM ionomycin in the presence of three calcium challenges is shown in Fig. 4.4B. Each 
calcium challenge was introduced at 12 minute intervals, allowing the transient to decay back to 
diastolic levels. 5pM Thapsigargin was added after the last calcium challenge and incubated for 12 
minutes. lOpM ionomycin was introduced and incubated for the same amount of time. Under these 
circumstances it was noted that in the presence of three calcium challenges, 5pM thapsigarin and 
lOpM ionomycin induced a larger SR leak, increasing the gradient and the Css of the SR leak 
significantly more than that observed for a single calcium challenge. These differences are 
emphasised in Fig. 4.5B and 4.5C respectively.
Fig. 4.6 summaries the effects of calcium load on the RuR resistant SR leak. The leak 
gradient induced in the presence of 5pM thapsigargin increased significantly from 0 calcium to 1, 2 
and 3 calcium challenges. However, calcium challenges 1 and 2 produced similar leak gradients 
whilst significantly increasing after 3 challenges. The leak Css induced with lOpM ionomycin 
follows a similar trend to that produced by the leak gradient and challenges 1 and 2 produced a non­
significant increase in Css before significantly increasing to challenge 3.
4.3.4. The Effects o f  Changing Oxalate Concentrations on SR Leak
The subsequent figures (Fig 4.7A, B and C) are all typical experimental traces to show the effects of 
changing oxalate concentration on the RuR-insensitive SR leak. From previous data it was observed 
that three calcium challenges were sufficient to produce reproducible calcium transients as well as 
sufficiently loading up the SR. After the third transient decayed back to minimum calcium levels, 
5pM thapsigargin was added to the cuvette system and incubated for 12 minutes before lOpM
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ionomycin was introduced. The results of 5mM, lOmM and 20mM oxalate on SR leak can be noted 
in Fig. 4.7A, B and C respectively.
The calcium transient decays (for the third calcium challenges) produced in the presence of 
5mM, lOmM and 20mM oxalate concentrations, were placed onto one graph (Fig. 4.8A). The leak 
gradients produced in the presence of the above oxalate concentrations were also cut and placed 
into onto a single graph (Fig. 4.8B) as with the leak Css (Fig. 4.9C) in order to emphasise the 
effects of various oxalate concentrations on SR leak. From Fig. 4.8A, it is observed that 20mM 
oxalate produced a transient that declines to minimum levels faster than either 5mM or lOmM 
oxalate. Also 5mM and lOmM oxalate produced similar calcium transient decays and the rate of 
decay for the calcium transients in the presence of various oxalate concentrations were calculated 
and displayed as a bar graph (Fig.4.9À). 5mM and lOmM oxalate produced similar rates of decay 
(5mM = 0.097s'^ ± 0.02; lOmM = 0.1 s'* + 0.01; P>0.05 (Fig. 4.9A) where as 20mM oxalate 
produced a rate of decay significantly faster than 5mM and lOmM oxalate (20mm = 0.34 s'* ± 0.03; 
P<0.05 (Fig. 4.9A).
In Fig. 4.8B, 5mM oxalate induced a significant increase in the leak gradient compared with 
20mM oxalate (5mM Ox = 2.9nMs'* ± 0.46; 0.74nMs'* ± 0.19; P<0.005 (Fig. 4.9B) and from Fig 
4.8C, 5mM induced a significant increase in the leak Css compared with 20mM oxalate (5mM Ox = 
4.2|xM ± 1.25; 20mM Ox = 0.68pM ± 0.16; P<0.05 (Fig. 4.9C). Indicating a larger SR leak exists in 
the presence of low oxalate concentrations.
4.4 DISCUSSION
It is important for cells to regulate SR leak. Any abnormalities in leak, whether it is through the 
non-specific leak or through the RyR, can lead to altered SR calcium content. Diastolic calcium 
concentration is regulated by sarcolemma extrusion (i.e. mainly Na^VCa^”^ exchanger) however an 
increase in the calcium leak from the SR during diastole can lead to a reduced SR calcium content 
and therefore reduced calcium transient and contraction.
From the data presented in this chapter, a significant SR leak exists in the presence of 
repeated calcium challenges. A component of this leak can be blocked by RuR; a potent inhibitor of
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the CRC (Zucchi & Ronca-Testoni, 1997), However, a significant leak remains in the presence of 
RuR, suggesting that a leak pathway exists in cardiac muscle SR that is independent of RyR 
activity. Little is known about this non-specific leak although a few theories have arisen and will be 
discussed in more detail later in this thesis (Chapter 7).
In this preparation a concentration of 25pM RuR was used to ensure maximal inhibition of 
calcium leak via the RyR as well as inhibiting calcium sequestration via the mitochondria (Hove- 
Madsen &Bers, 1993). The concentration of RuR utilised in other studies varied between 0.08- 
20pM, depending on the experimental technique [>20pM in horaogenates in skeletal and cardiac 
muscle (Feher et aL, 1988); lOpM in SR vesicle work in skeletal and cardiac muscle (Xu et aL, 
1999); 20pM in heavy fraction vesicles (Kim, 1983); 12pM in purified SR cardiac vesicles 
(Chamberlain et al., 1984); IpM  RuR blocked RyR calcium release, 5pM blocked caffeine induced 
calcium release from rabbit skeletal SR fractions (Palade, 1987); 25|iM permeablised ventricular 
myocytes (Hove-Madsen & Bers, 1993)].
It was discovered that high concentrations of RuR might slow SR calcium uptake causing a 
decrease in rate of calcium uptake (Kargacin & Kargacin, 1998). This study showed that RuR acted 
by altering the calcium sensitivity of the SR calcium uptake with no detectable effect on the Hill 
coefficient or maximum uptake rate (Kargacin & Kargacin, 1998). This effect is likely to arise from 
direct action of RuR on SR Ca^"^-ATPase and would occur independently of any effects of RuR on 
the RyR (Kargacin & Kargacin, 1998). A direct action of RuR was reported by Alves de Meis 
(1986) who found that RuR competes with calcium for the high affinity binding sites on the skeletal 
muscle SR Ca^^ -ATPase as well as inhibiting calcium binding to calcium binding proteins. With 
this in mind, the RuR concentration in this study was reduced to avoid this detrimental effect on 
SERCA 2A. However, as discussed above, the level of RuR used would be expected to fully 
(>99%) inhibit RyR activity. Therefore it is unlikely that the remaining calcium leak pathway is via 
conventional RyR2.
In addition to RuR influencing SR leak: calcium load and oxalate concentration both affect 
the characteristics of calcium leak. Oxalate was used to prevent the increase in free calcium
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concentration inside the SR (that would otherwise slow the rate of net uptake) by the precipitation 
of calcium-oxalate inside the SR (Madeira, 1982). A consequence of this is that the rate of SR 
calcium uptake can stay at the same rate determined by the free calcium in the suspension (rather 
than limited by high free calcium inside the SR). It has been shown that crystallization of calcium- 
oxalate inside the SR does not reach equilibrium at any time during calcium uptake (Feher & 
Briggs, 1980), and thus will continue to buffer luminal calcium. It is well documented that SR 
calcium leak depends on SR calcium content (Bassani et ah, 1995; Smith & Steele, 1998; Shannon 
et al., 2000) as well as the free calcium concentration in the mock intracellular solution. If the SR 
luminal calcium concentration was low (due to oxalate precipitation of calcium) then a calcium leak 
from the SR would be low, due to the lowered calcium concentration gradient across the SR 
membrane. The reduced calcium leak at higher oxalate concentrations could account for the faster 
rate of uptake (Fig. 4.9A). Therefore, the calcium concentration within the lumen of the SR plays a 
vital role in calcium regulation and evidence to suggest that lumen calcium influences the CRC has 
been published (Fabiato, 1992; Sitsapesan & Williams, 1994; Bassani et al., 1995; Lukyanenko et 
al., 1996; Gyorke et al., 1997; Gyorke & gyorke, 1998) and state that the loading of the SR directly 
alters the gain of the EC Coupling and therefore a higher SR calcium content leads to a greater 
release of calcium for any given calcium trigger (Bassani et al., 1995; Lukyanenko, et al., 1996). 
The effect of luminal calcium on calcium release from the RyR is discussed in more detail in 
Chapter 5.4.1.1.
It was discovered that calcium leak was not detectable in this preparation without the 
addition of calcium to the system, suggesting that at the start of the experiment, the SR calcium 
content was negligible. However, with the addition of only one bolus of calcium, sufficient SR load 
was generated to sustain a calcium leak. The rate of leak and Css are influenced by the number of 
calcium challenges added to the system (calcium load): rate of calcium leak being higher than the 
three separate calcium challenges (Fig. 4.6A & B). The most likely explanation for these results is 
that sequential additions of calcium to the system cause a progressive increase in the lumenal free 
calcium concentration and total SR load. Increased free calcium within the SR will increase the 
calcium concentration gradient across the leak pathway and increased total calcium in the SR will
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result in a higher Css. The increase in the rate constant with progressive calcium challenges is 
discussed in more detail in Chapter 5 (section 5,4.1.1).
It was interesting to note the pronounced effects of oxalate concentration on SR the calcium 
leak rate. This would suggest that the influence of oxalate on the rate of calcium uptake and the 
steady state calcium concentration is not simply due to the stimulation of SERCA but a reduced 
leak of calcium would also contribute to the change in the net calcium uptake rate.
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Figure 4.1; Effect o f  RuR on SR calcium leak. (A) Typical experimental trace displaying the 
calcium transient in the presence and in the absence of 25|iM RuR. Where a control transient was 
established before the addition of RuR, added after a 12 minute interval. The solution composition, 
bathing the cells prior to the additions indicated in the figure, is as follows; 0.05R (table 2.2), 
20mM Oxalate, lO i^M Fura-2, 5mM ATP, 15mM CrP, 0.1 |iM DTT, lO^MCCCP 
and 33|xM Oligomycin. (B) The mean data for the effect of RuR on the rate constant of decay of 
the calcium transient, (mean ± s.e.m., n = 4, * denotes P<0.05). Significance was tested using a 
paired students t-test.
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Figure 4.2; SR leak in the presence and absence o f S R  calcium. (A) Typical experimental trace to 
show the effects of 5pM thapsigargin and lOpM ionomycin in the presence of diastolic calcium 
concentrations. 5pM Thapsigargin was introduced to the preparation in the absence of a calcium 
challenge. After 12 minutes, 10|iM ionomycin was added. (B) A typical experimental trace to show 
the effects of 5pM thapsigargin in the presence of a calcium challenge. The calcium challenge 
increased the free calcium concentration to lp.M before decaying back to diastolic levels before 
5|xM thapsigargin was introduced. The solution composition, bathing the cells prior to the additions 
indicated in the figure, is as follows; 0.05R (table 2.2), 20mM Oxalate, 10|iM Fura-2, 25|iM RuR, 
5mM ATP, 15mM CrP, 0.1 ^ iM DTT, IG i^M CCCP and 33pM Oligomycin.
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Figure 4.3: Mean data to show the effect o f  calcium load on SR calcium leak. (A) The following 
bar graph displays the gradient of thapsigargin-induced leak in the presence and absence of calcium 
load. (B) Displays the mean steady state calcium concentration (Css) induced by lOpM ionomycin 
and 5pM Thapsigargin in the presence and absence of a calcium load (mean ± s.e.m; n = 3 (0 
calcium challenge), n = 4 (1 calcium challenge); * denotes p<0.05). Significance was tested using 
an unpaired students t-test.
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Figure 4.4: Typical experim ental traces to display the effects o f  calcium load on SR leak induced 
by thapsigargin and ionomycin. (A) A single calcium challenge was added prior to 5pM 
thapsigargin. lOpM ionomycin was introduced after 12 minutes, to enhance the equilibriation 
process (time taken for intra luminal and cytoplasmic calcium to reach a steady state calcium 
concentration). (B) Same protocol as (A) was followed except three calcium challenges were 
introduced to the preparation, 12 minutes apart prior to 5pM thapsigargin and lOpM ionomycin. 
The solution composition, bathing the cells prior to the additions indicated in the figure, is as 
follows; 0.05R (table 2.2), 20mM Oxalate, lOpM Fura-2, 25pM RuR, 5mM ATP, 15mM CrP, 
0.1 pM DTT, lOpM CCCP and 33pM Oligomycin.
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Figure 4.5: Effects o f calcium load on SR leak. The solution composition, bathing the cells prior to the 
additions stated below, is as follows; 0.05R (table 2.2), 20mM Oxalate, lOpM Fura-2, 25|iM RuR, 5mM 
ATP, 15mM CrP, 0.1 pM DTT, lOpMCCCP and 33pM Oligomycin. (A) Displays the calcium transient
decays for 1 (----- ) and 3 ( ------) calcium challenges prior to thapsigargin addition. (B) The gradients for the
calcium leak produced after the injection of 5pM thapsigargin in the presence of 1 ( ----- ) and 3 ( )
calcium challenges. (C) lOpM ionomycin enhanced the Thapsigargin-induced leak, in the presence of 1
( ___ ) and 3 ( ) calcium challenges. Where the leak reached a steady state calcium concentration after
about 12 minutes.
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Figure 4.6: Summary o f  the mean results o f  calcium load on thapsigargin and ionomycin  
induced SR leak. (A) Displays the mean leak gradient induced by 5pM Thapsigargin after 1, 2 & 3 
calcium challenges. (B) Displays the mean Css induced by 5pM Thapsigargin and lOpM ionomycin 
after 1, 2 & 3 calcium challenges, (mean ± s.e.m; n = 4 (1 & 2 calcium challenges), n = 10 (3 
calcium challenges); * denotes p<0.05, ** denotes p<0.005). (C) The mean rate constant for the 
transients after the addition of 1 ,2  and 3 calcium challenges, (mean ± s.e.m; n = 20; * denotes 
p<0.05). Significance was using an ANOVA with a Tukey post hoc test.
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Figure 4.7: Typical experim ental traces produced by various oxalate concentration  The solution 
composition, bathing the cells prior to the additions stated below, is as follows; 0.05R (table 2.2), 10p.M 
Fura-2, 25|xM RuR, 5mM ATP, 15mM CrP, 0.1|O.M DTT, lOp-M CCCP and 33|iM Oligomycin. Three 
calcium transients induced reproducible calcium transients prior to assessing the SR leak with 
thapsigargin and ionomycin. After the control transient was established, 5|iM thapsigargin was 
introduced to the preparation and left to incubate for 12 minutes before 10|iM ionomycin was 
added: in the presence of 5mM oxalate (A); lOmM oxalate (B); and 20mM oxalate (C).
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Figure 4.8: Effects o f  oxalate concentration on SR leak. The solution composition, bathing the 
cells prior to the additions stated below, is as follows; 0.05R (table 2.2), 10|iM Fura-2, 25|i.M RuR, 
5mM ATP, 15mM CrP, 0.1 pM DTT, lOpMCCCP and 33pM Oligomycin. (A) Displays the
calcium transient decays in the presence of 20mM (-----); lOmM ( ) and 5mM oxalate ( ----  )
prior to thapsigargin addition. (B) The gradients for the calcium leak produced after the injection of
5pM thapsigargin in the presence of 20mM (-----); lOmM (----- ) and 5mM oxalate ( _ ). (C)
lOpM ionomycin enhanced the thapsigargin-induced leak in the presence of 20mM ( ---- ); lOmM
( ) and 5mM oxalate ( ------ ) and the leak reached a steady state calcium concentration after
about 12 minutes.
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Figure 4.9; M ean data to show the effect o f  various oxalate concentration on SR calcium leak.
(A) The mean data for the effect of 5mM, lOmM and 2mM oxalate on the rate constant for calcium 
decay (mean ± s.e.m; n = 6 (5mM oxalate), n = 3 (lOmM oxalate), n=l 1 (20mM oxalate). (B) The 
following bar graph displays the mean thapsigargin-induced SR leak gradient for 5mM, lOmM and 
20mM oxalate (mean ± s.e.m; n = 4). (C) The bar graph shows the steady state calcium
concentration (Css) of the thapsigargin leak, enhanced by the addition of lOpM ionomycin in the 
presence of 5mM, lOmM and 20mM oxalate (mean ± s.e.m; n = 4; * denotes p<0.05). Significance 
was using an ANOVA with a Tukey post hoc test.
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CHAPTER FIVE
RYANODINE MEDIATED CALCIUM
LEAK
5.1. INTRODUCTION
The complex regulation and gating characteristics of the RyR are very important to the function of 
this SR calcium release channel. A great deal of information on the RyR has been gathered from 
work canied out on controlled environments such as SR vesicles (Meissner & Henderson, 1987; 
Bers, 1991) and the reconstitution of the RyR into lipid bilayers (Meissner, 1986; Rousseau & 
Meissner, 1989; Rousseau et al., 1987; Gyorke & Fill, 1993; Valdivia et al., 1995; Schiefer, et al.,
1995) and the most frequent isoforms studied at the single channel level include the cardiac RyR 
(RyR2) and the skeletal muscle RyR (RyRl). However, it is also important to study this channel 
under normal physiological conditions as the RyR is clearly regulated by a variety of agents and is 
highly sensitive to environmental changes such as pH, ionic strength, temperature, membrane 
potential and phosphorylation.
In this chapter permeabilised ventricular myocyte preparations were used to examine the 
properties of the calcium leak from the SR. The effects were interpreted with reference to previous 
work carried out on SR vesicles and isolated RyR2.
5.2. METHODS
Cardiac myocytes were prepared for calcium leak studies as previously described in Chapter 2. 
1x10^ permeabilised cells were transferred to the closed cuvette system where changes in the mock 
intracellular free calcium concentrations were detected using the fluorescent indicator Fura-2. 
Following a three minute incubation, to allow the cells to reach an equilibrium with the mock 
intracellular solution surrounding the myocytes, 3 aliquots of 8-lOpl of lOmM calcium chloride 
were added in the presence of 20mM oxalate, to raise the free calcium concentration to l-2pM  
which decayed in an exponential fashion back to minimum calcium level (-lOOnM). Three aliquots 
introduced at 12 minutes apart, were found to be adequate to generate reproducible calcium 
transient decays.
The experiments investigating the effect of RuR on SR calcium leak (5.3.1), required the 
addition of 5pM RuR at an early interval of the experiment, noted as calcium challenge #1 (figure 
5.1) and at a late interval of the experiment, noted as calcium challenge #4 (figure 5.2). The action 
of RuR was studied by calculating the rate of change of the calcium transients and normalising them 
to the control transient. These responses were then compared with the responses from experiments 
in the absence of RuR.
The experiments investigating the effect of ryanodine on SR calcium leak (5.3.2) required 
the addition of ryanodine after a control transient was established. The action of ryanodine (0.3p.M, 
3pM, 30pM, 300p.M and 3mM) was studied by monitoring the response to four further calcium 
challenges and in the presence of 5|xM RuR prior to the last calcium challenge. The protocol was 
repeated for the full range of ryanodine concentrations. The action of ryanodine was studied by 
calculating the rate of change of the calcium transients and normalising them to the control 
transient. These responses were then compared with the responses from experiments in the absence 
of ryanodine.
5.3. RESULTS
5.3.1. The Effects o f  Ruthenium  Red on SR Calcium Leak
To investigate the effects of increasing concentrations of ryanodine on SR calcium leak, control 
experiments were established in order to normalise the experimental data allowing a valid 
comparison to be made. Control experiments consisted of the addition of 5 aliquots of calcium (12 
minutes apart) to the permeabilised muscle preparation after sufficiently loading the SR. This was 
repeated in the presence of 5|xM RuR to assess SR leak under normal conditions as well as 
investigating the extent of the RuR block at various points in the experiment.
Figure 5.1 is a typical experimental trace showing the calcium uptake protocol for this 
chapter in the presence of an early addition of RuR, After the control transient decayed back to 
minimum calcium levels, 5pM RuR was introduced to the preparation followed by a bolus of
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calcium then another 4 calcium additions were introduced at 12 minute intervals.
Figure 5.2 is a typical experimental trace showing the calcium uptake protocol in the 
presence of a late addition of RuR. The same protocol was followed as that described for figure 5.1, 
the only difference being, RuR was added before the last calcium transient instead of after the 
control.
Figure 5.3 describes the rate of change of calcium concentration (dCa^Vdt) analysis carried 
out for this chapter. The digitilised traces were converted into calcium concentrations as previously 
described in Chapter 2.5 (Panel A). Once converted, dCa^^/dt was measured at each time interval 
and plotted against the corresponding calcium concentration (Panel B) using the program Origin 
(Microcal software). The value of dCa^Vdt at ~lp.M (±0.2|iM) was used as a measure of the 
calcium flux through the RyR.
The subsequent figures illustrate the mean changes in dCa^Vdt (here after referred to as the 
rate of decay) for the control, as well as for the effects of the early and late additions of 5|xM RuR 
on permeabilised cardiac myocyte preparations. The results are displayed as a line graph with the 
rate of decay plotted against the cumulative calcium challenges. In the upper panel (A), the raw 
(uncorrected) changes in the rate of decay are shown. In the lower panel (B), the changes in the rate 
of decay are corrected for the changes observed under control conditions.
From figure 5.4(A), it is observed that the rate of decay for the control progressively 
increased from 0.76 to 1.06 during the first four challenges (# -2 to # 1), peaking at 1.06 for 
challenge #1 before decreasing over the remaining three challenges (#2 to #4) but to a lesser degree. 
The graph for the early addition of RuR follows a similar trend to that observed for the control over 
the challenges # -2 to #0. Then at challenge #1, 5pM RuR was introduced to the cuvette system 
resulting in a significant increase in the rate of decay above control levels due to the inhibition of 
RyR mediated calcium leak from the SR. Thereafter the changes in rate of decay almost parallel 
those seen in the control from #1 to #3. After #4, the rate of decay decreases sharply from 1.21 to 
1.09. In figure 5.4(B), 5\iM  RuR significantly increases the rate of decay -20%  above the control
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value as seen with the raw data. The subsequent calcium challenges induce an 11% increase in the 
rate (#2 and #3) before declining 20% with the last calcium challenge.
Figure 5.5 displays the results for the late addition of RuR. The graphs follow a similar 
trend to the control over the first 6 challenges (# -2  to #3). Then at challenge #4, 5pM RuR was 
introduced to the preparation. The rate of decay increased significantly above control levels, to a 
value similar to that observed when RuR was added at challenge #1 (figure 5.4). In figure 5.5(B) 
the addition of 5pM RuR significantly increased the rate of decay for the normalised data -35% 
above the control value.
Figure 5.6 displays the results for early and late addition of RuR, Where 5pM RuR was 
introduced after the challenge #1 as well as after challenge #4. This diagram follows a similar trend 
to figure 5.4 for both the raw and the normalised data over the first 6 challenges (# -2  to #3) 
however, the rate of decay after the addition of RuR at challenge #4 induced a slight slowing of the 
rate of decay.
5.3.2 Effects o f  Ryanodine on SR Calcium Leak
From the results discussed on early and late additions of RuR, it was discovered that high 
concentrations of RuR might slow calcium uptake into the SR causing a decrease in the rate of 
decay (Kargacin & Kargacin, 1998). With this in mind, investigating increasing concentrations of 
ryanodine on the rate of calcium decay over subsequent calcium challenges in the permeabilised 
cardiac myocyte preparation would not only allow the observation of the individual effects over a 
set period of time but would determine the concentration of ryanodine best suited to replace RuR. 
Therefore the desired concentration would exert a full block on the RyR within a relatively fast time 
frame.
Figures 5.8A, B and C are typical experimental traces displaying the effects of ryanodine on 
the rate of decay in permeabilised cardiac myocytes. An aliquot of calcium increases the total 
calcium concentration in the cuvette by 67|xM and causes a rapid increase in the free calcium to 
approximately 2.5|iiM. Another two aliquots of calcium were introduced to the preparation to allow
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reproducible calcium transients before ryanodine was added.
In figure 5.8A, 3p,M ryanodine caused an immediate slowing of the rate of decay, thus 
failing to block the RyR but instead produced an opening of the RyR with a slow time course of the 
calcium transient resulting in an increased leak from the SR. and an elevation in the minimum 
calcium level. An additional calcium challenges in the presence of 3 |liM  ryanodine induced a further 
decrease in the rate of decay to produce an elevation of the minimum caleium level with each 
additional calcium challenge. 5|iM RuR was introduced to the cuvette system at the end of the 
protocol. This caused a pronounced increase in the rate of calcium decay, consistent with a RuR 
blocking action on the RyR. However, upon the introduction of an aliquot of calcium, the rate of 
decay was still much slower than the control. The protocol described above, was repeated for the 
full range of ryanodine concentrations (30, 300|rM and 3mM) but only the experimental traces for 
3pM, 300|i,M and 3mM ryanodine are shown.
In figure 5.8B, 300|aM ryanodine produced a decrease in the rate of decay in the presence of 
a calcium challenge thus stimulating calcium release from the SR, resulting in an elevated minimum 
calcium level. However, subsequent aliquots of calcium produced a progressive increase in the rate 
of decay suggesting that a gradual block of the RyR took place. Even in the presence of a gradual 
block, 300|iM failed to bring the minimum calcium concentration down to the control level but 
instead produced a new steady state level that was slightly decreased in the presence of 5p,M RuR. 
It was also noted that 5|iM  RuR increased the rate of decay of the calcium transient, suggesting that 
300pM did not produce a full block on SR leak.
3mM ryanodine (figure 5.8C) induced a decline in the rate of calcium decay but to a lesser 
degree than that observed in 300pM ryanodine. However, it was noted that the calcium transient 
decayed back to control levels and on subsequent additions of calcium, the rate of decay increased. 
This suggests that a block on the RyR occurred with 3mM ryanodine. The introduction of 5jam 
RuR to the cuvette system failed to significantly increase the rate of decay further. Indicating that 
3mM sufficiently blocked the RyR mediated calcium leak from the SR.
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The following diagrams illustrate the mean changes in the rate of decay for the increasing 
concentrations of ryanodine (0.3|LiM, 3|aM, 30|aM, 300|aM and 3mM). The results are presented as a 
line graph with the rate of decay of the calcium transient plotted against cumulative calcium 
challenges. In the upper panel (A) the raw (uncorrected) changes in the rate of decay (dCa^Vdt) are 
shown. In the lower panels (B) the changes in the rate of decay were corrected for the changes 
observed under control conditions.
Figure 5.9 illustrates the mean results for the cumulative calcium challenges in the presence 
of 0.3|xM ryanodine. It is observed that the rate of decay for 0.3p.M ryanodine followed a similar 
trend to that of the control over the challenges #0 to #2, increasing by 5% during challenge #1 and 
then decreased by 3% during challenge #2. Thereafter, as the number of calcium challenge 
increased, the rate of decay decreased by 35% in the presence of 0.3|iM ryanodine due to ryanodine 
increasing the Po of the RyR. During challenge #4, 5|im RuR was introduced to the cuvette system 
but failed to exert a block on the RyR medicated leak under these conditions, as noted by the 
continued decline in the rate of decay. In figure 5.9(B), the changes in the rates of decay for 0.3p.M 
ryanodine were normalised to the control and followed a similar trend as that seen for the raw data. 
However, an initial increase in the rate of decay above control levels was observed in the presence 
of 0.3pM ryanodine after the first challenge. This effect was not significant and thereafter the rate 
of decay declined by 43%. As seen in figure 5.9(A), 5|iM RuR did not reduce the rate of decay and 
therefore failed to exert a block on the RyR in the presence of the large SR leak.
Figure 5.10 displays the mean results for 3|iM ryanodine on SR leak in the presence of 
cumulative challenges of calcium. It was observed that 3pM ryanodine induced a significant decline 
in the rate of decay after the first calcium challenge (-40% of the control) and to a lesser degree 
after #1. 5pM RuR was introduced to the preparation at challenge #4, resulting in an increase in the 
rate of decay by -16% . A value approximately the same as that seen after challenge #1. In figure 
5.10(B), the normalised data follow a similar trend as that seen with the raw data although the 
decline seen with challenge #2 and #3 is less marked (uncorrected 16%, normalised 8.6%).
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The mean effeet of 30|xM ryanodine in the presence of cumulative calcium challenges is 
displayed in figure 5.11. The normalised data produced a similar trend to that of the raw data and on 
addition of 30pM ryanodine, a -34%  decline in the rate of decay occurred. This decline was less 
marked after challenges #2 and then increased -20%  over challenges #3 and #4. The increase in the 
rate of decay after the introduction of 5p,M RuR at #4 suggests a significant SR leak still exists in 
this preparation.
Figure 5.12 illustrates the mean results for 300pM ryanodine in the presence of cumulative 
calcium challenges. It was noted that 300pM ryanodine induced a -62%  decline in the rate of decay 
after the first calcium challenge. Thereafter the successive calcium challenges induced a gradual 
blocking effect on the RyR that was more pronounced than with 30|xM ryanodine (Fig 5.11). The 
rate of decay increased by 23% from challenge #1 to #2; by %17 from #2 to #3 and then by -20% 
in the presence of 5|rM RuR. This suggests that 300|iM ryanodine increases the Po of the RyR 
before a gradual blocking effect can occur. Although within this time period, 300pM failed to exert 
a full block on the RyR as a slight increase in the rate of decay was noted in 5p.M RuR.
Figure 5.13 displays the results for 3mM ryanodine in the presence of cumulative calcium 
challenges. 3mM ryanodine produced a 45% decline in the rate of decay before successive 
calcium challenges induced a rapid block on SR calcium release via the RyR. Challenge #2 induced 
a 34% increase in the rate of decay and after #3 the rate of decay increased back to control levels. 
In the presence of 5pM RuR the rate of decay declined by 9% to a rate similar to that produced by 
#2.
5.4 DISCUSSION
5.4.1. The Effects o f  R uR  on SR  Leak
The results for the mean changes in the rate decay for the control, as well as for the effects of the 
early and late additions of 5p,M RuR on permeabilised cardiac myocyte preparations are 
summarised in figure 5.7. The early addition of RuR induced a rapid increase in the rate of decay
95
suggesting that under control conditions a significant leak exists through the RyR at Ip-M calcium. 
Thereafter, subsequent changes in the rate of decay paralleled those seen in control conditions (Fig. 
5.7, panel A). This suggests that the slow progressive decrease in the rate of decay over the time 
course of the experiment was not due to changes in RyR activity under control conditions. The late 
addition of RuR induced a rapid increase in the rate of decay to a value similar to that seen with the 
early RuR addition suggesting that the RyR activity is not affected during this protocol. The effects 
of RuR on the rate of decay can be seen more clearly when the values are normalised for the 
changes that occur under these conditions (Fig. 5.7, panel B). From the normalised data it appears 
that the continued presence of RuR causes a progressive decrease in the rate of decay. This was not 
due to increased RyR activity since additional RuR did not reverse this effect. It is suspected that 
this result arose from a progressive effect of RuR on SERCA2 (Kargacin & Kargacin, 1998). This is 
supported by the observation that higher concentrations of RuR (25pM) introduced to the 
preparation after the 5pM block, in the presence of subsequent calcium challenges, depressed the 
rate of decay further and was therefore more effective at slowing calcium uptake (data not shown). 
Although with a subsequent late addition of RuR in the presence of an early addition in the same 
preparation (Fig. 5.6), no significant decrease in the rate of decay was observed when compared to 
the preparation where a late addition of RuR was absent (Fig. 5.4). This suggests that 5pM RuR 
does not produce a significant effect on SERCA2a. However, as stated above, higher concentrations 
of RuR did produce a decline in the rate of decay. For this reason, lower concentrations of RuR 
were used in this study to minimise the side effects on SERCA.
The cause of the progressive increase and decrease in the rate of decay seen in figure 5.4A 
(control) is not known but some theories include
a) intrinsic changes in SERCA2 activity and the SR calcium leak.
b) Changes in the solution composition that indirectly affects these proteins.
5.4.1.1. Intrinsic changes in SERCA2 activity and the SR calcium leak
The successive calcium challenges (#-2 to #1) observed in the control (Fig. 5.4A) lead to an initial
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increase in the rate of decay of the calcium transient. This progressive increase could arise from 
the gradual phosphorylation of PLB: the phosphoprotein regulating the activity of SERCA2. 
Inactivation of the RyR could also account for an increase in the rate of decay, shifting the 
equilibrium in favour of calcium uptake via Ca '^  ^ -ATPase pump due to the loss of competition of 
the leak through the RyR. However, upon addition of 5pM RuR a substantial increase in the rate of 
decay was observed indicating an SR leak exists in the presence of IpM  calcium in this skinned 
cardiac muscle preparation. If inactivation did occur, a less pronounced blocking effect with 5pM 
RuR would have been expected to ensue. As previously stated, this muscle preparation requires at 
least 3 aliquots of calcium before reproducible time courses occurred and it is well documented that 
SR calcium leak depends on SR calcium content (Bassani et al., 1995; Smith & Steele, 1998; 
Shannon et a l ,  2000) as well as the free calcium concentration in the mock intracellular solution 
(Williams & Ashley, 1988). If the SR luminal calcium concentration was low (due to oxalate 
precipitation of calcium) then a calcium leak from the SR would be slight, thus giving rise to an 
increase in calcium uptake noted by a faster rate of decay upon initial calcium challenges, which is 
what was observed in this study. Therefore, phosphorylation of phospholamban seems a likely 
candidate for the increase in the rate of decay shown in figure 5.4, giving rise to a larger SR calcium 
pool available for release.
There is mounting evidence to suggest that calcium release channels in the SR can be 
influenced by luminal calcium (Fabiato, 1992; Sitsapesan & Williams, 1994; Bassani et al., 1995; 
Lukyanenko et al., 1996; Gyorke et al., 1997; Gyorke & Gyorke, 1998) and that the loading of the 
SR directly alters the gain of the EC Coupling and therefore a higher SR calcium content leads to a 
greater release of calcium for any given calcium trigger (Bassani et al., 1995; Lukyanenko, et al.,
1996). An increased luminal calcium content leads to the generation of caleium sparks and the 
propagation of calcium waves; a calcium waves arises from the spatial and temporal summation of 
sparks (Cannell et al,, 1994; Lopez-Lopez et al., 1995; Cheng et a i ,  1996). Under normal 
conditions, almost all sparks remain localised and die out without inducing the release of calcium in 
adjacent release sites (Cheng et al., 1993; Lukyanenko et a l,  1996). However, under conditions of
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increased cellular calcium load, sparks increase in amplitude and frequency to become the 
initiation sites for calcium wave propagation (Cheng et al., 1993; Cheng et al., 1996; Lukyanenko 
et al, 1996; Satoh et al., 1997). An increased resting calcium level and an elevated intraluminal 
calcium can induce a calcium spark from a local release site.
Calcium sequestered into the SR by the calcium pump can act at an intraluminal calcium 
binding site(s) (Takamatsu & Wier, 1990; Fabiato, 1992). Sitsapesan & Williams (1994) have 
shown that calcium acting on an intraluminal site of the RyR can induce calcium release in lipid 
bilayers (Sitsapesan & Williams, 1997; Lukanenko et a i,  1996). The precise locations for the 
luminal activation and inhibition binding sites have yet to be located; they could be situated on the 
RyR or on a protein associated with the receptor. However, as demonstrated in chapter 4, the use of 
20mM oxalate would reduce the luminal calcium concentration to ~6pM. Under these conditions 
luminal regulation would not be considered an important factor determining the activity of RyR on 
addition of RuR or ryanodine. So therefore, in our preparation, oxalate would prevent the initiation 
of calcium sparks and calcium induced waves in cardiac myocytes under these conditions.
5.4.1.2 Changes in solution composition that indirectly affect SERCA2 and RyR activity
The changes in solution chemistry may be linked to changes associated with the metabolic activity 
of the cells. A decrease in rate of decay of calcium uptake via SERCA2 could be explained by a 
fall in CrP levels within the preparation.
An elevation of the intracellular calcium concentration, whether through sarcolemma 
calcium channels or release from intracellular stores, activates the SR calcium pump. The pump 
transports two calcium ions into the lumen of the SR for every ATP consumed in the reaction. ATP 
levels are buffered with the addition of CrP to the preparation thus providing a source of ATP 
regeneration. If CrP levels were to fall, inorganic phosphate (P/) levels would increase. Under these 
circumstances, insufficient ATP regeneration would ensue leading to a decrease in ATP 
concentration and therefore decreased pump activity. To test this hypothesis, lOmM CrP was 
introduced at the end of the protocol. If the preparation had an insufficient concentration of CrP, on
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its addition an increase in the rate of decay would have been expected to occur. However, no 
change in the calcium uptake rate was observed (data not shown). Thus it is unlikely that this 
metabolic change can account for the fall in the rate of decay seen in figure 5.4A.
Other candidates influencing the rate of calcium uptake are H^ ions and P/ (Smith et al., 
2000; Smith & Steele, 1998). The breakdown of MgATP to MgADP and P/ is accompanied by the 
release of protons. During the breakdown of MgATP, -0.7 moles H^ ions are released at neutral pH 
(Wilkie, 1979). CrP breakdown absorbs -0 .4  moles H'*' ions (Moisescu & Theileczek, 1978) and 
thus the net effect of ATP breakdown is that of a slight acidosis where the presence of 25mM Hepes 
should be sufficient to buffer the pH and prevent large changes. However, measurements are 
required to confirm this.
5.4.2. The Effects o f  Ryanodine on SR Leak
The results for the normalised and raw relative changes in the rate decay for the effects of the 
individual ryanodine concentrations on permeabilised cardiac myocyte are summarised figure 5.14. 
In this preparation, low concentrations of ryanodine (0.3pM, 3pM) induced a sustained increase in 
SR calcium leak from the RyR and it was observed that 0.3JO.M did not exert an effect till after the 
second calcium challenge. High concentrations (30pM, 300|xM and 3mM) increased the Po of the 
ryanodine receptor for a short period before a reduction in the SR calcium leak was noted. 
Interestingly 3|iM and 3mM exerted similar rates of decay after the first calcium challenge, where 
as 30|iM and 300pM induced a slowing in the rate of decay which was 20% more than that 
observed with 3pM or 3mM. A relatively fast block on SR occurred with 3mM where as 300pM 
failed to block the SR leak in the given time frame for the oxalate supported experiments and also 
failed to reduce the calcium level back to the minimal level. Thus the preparation used in this study 
favoured a block with 3mM ryanodine whereas the literature states that 300|iM ryanodine (Ma, 
1993) blocks the calcium release channel. In support of our studies, that higher ryanodine 
concentrations are required to induce a block on the RyR, study carried out by Masumiya et al., 
2001 on RyR incorporated into lipid bilayers noted that 500pM ryanodine was unable to induce a
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complete block of calcium release from the RyR. Therefore, the effect of ryanodine depends on a 
variety of factors including the method used (SR vesicles maybe more sensitive to ryanodine and 
therefore requires a lower concentration of ryanodine), the animal species as well as the length of 
time of ryanodine incubation and temperature.
The slow time course of the calcium transient produced during the effects of ryanodine on 
calcium uptake are consistent with the slow binding of ryanodine to the RyR at this temperature 
(22°C) (Smith et a l ,  1988).
These results compliment the literature suggesting the RyR possess two binding sites for 
ryanodine: a low affinity and a high affinity binding site (Lai et a l ,  1989; McCrew et al., 1989; 
Meissner, Rousseau & Lai, 1989; Pessah & Zimanyi, 1991; Wang et a l,  1993). Low 
concentrations of ryanodine bind to the high affinity binding site to induce a long lived open state. 
High concentrations of ryanodine bind to the low affinity binding site to exert a block on SR leak. 
Lai et al (1989) demonstrated that there is one high affinity and three low affinity binding sites per 
tetramer of the RyR. The binding of ryanodine to the RyR is very slow. Consequently the effects of 
ryanodine are slow to develop (Bers & Perez-Reyes, 1999; Alderston & Feher, 1987). The high 
affinity binding site is only accessible when the channel site is in an open configuration and thus led 
to the suggestion that this binding region is located in the pore of the channel (Tanna et a l,  2000). 
Recent investigations have demonstrated that mutations of residues located in the trans membrane 
regions of the RyR modify the ability of the receptor to bind ryanodine (Zhao et a l ,  1999; Gao et 
a l,  2000). The effects of ryanodine require an active RyR either by increased calcium 
concentrations, decreased Mg "^ ,^ ATP or caffeine.
In this study, the RyR activity was noted in the presence of ImM Mg "^ .^ It is thought that 
physiological concentrations of Mg^ "*" cause a reduction in the open probability of all isoforms of the 
RyR to inhibit calcium release (Tinker & Williams, 1992). In order for Mg^ "*" to induce inhibition, it 
competes with calcium for the calcium activation/inhibition sites (Ashley & Williams, 1990; 
Meissner et a l ,  1986; Laver et a l ,  1997). The affinity and efficacy of Mg^ '*' for the calcium 
inhibition site is much greater than that for the activation site, thus Mg^ "*" binds to the high affinity
1 0 0
binding site to inhibit calcium release (Du et al., 2000). However in this preparation, the presence 
of activating calcium levels as well as a ligand can stimulate the RyR even in the presence of ImM 
Mg"+.
It was observed that 5|iM RuR failed to block the large SR leak induced by 0.3|xM 
ryanodine. The reason for this is unknown; the leak could be so large that 5|xM RuR may be 
ineffective thus higher concentrations of RuR maybe required. However, higher concentrations of 
RuR were not used in this study because, as stated previously, Kargacin & Kargacin (1998) 
proposed that high concentrations of RuR have a detrimental effect on SERCA2A, altering the 
calcium sensitivity of the SR calcium uptake with no detectable effect on the Hill coefficient or 
maximum uptake rate (Kargacin & Kargacin, 1998) and that the effect of RuR on SERCA2A is 
likely to arise from direct action of RuR on SR Ca^^-ATP-ase and would occur independently of 
any effects of RuR on the RyR. A direct action of RuR was reported by Alves de Meis (1986) who 
found that RuR competes with calcium for the high affinity binding sites on the skeletal muscle SR 
Ca^ "^  -ATPase as well as inhibiting calcium binding to calcium binding proteins. However, as 
discussed in chapter 5.3.3,1, 5pM RuR did not produce a significant effect on SERCA2A. The 
results in this chapter suggest that RuR can have a blocking effect on RyR in the presence of 3pM, 
30|xM and 300pM ryanodine but no further block was observed in the presence of 3mM ryanodine, 
in fact the results suggest a slight increase in calcium release (not significant). It is unlikely that 
RuR displaces ryanodine from the RyR since the affinity of the RyR for ryanodine is very high. 
However, there are other pathways through which RuR may mediate an effect. Netticadan et al., 
(1996) have shown that RuR exerts a concentration dependent inhibition of the phosphorylation of 
the RyR by both endogenous and exogenous CaM-K, whereas low concentrations of ryanodine 
(0.25 - lp,M) stimulate CaM-K mediated phorphorylation. RuR can act by binding to multiple sites 
located in the conduction pore of the calcium release channel. This block is cooperative with a Hill 
Coefficent of 2; one molecule is sufficient to block the channel and additional binding of RuR keeps 
the channel in a closed state (Ma, 1993). Thus RuR occludes the calcium release channel to induce 
closure and in doing so produces a conformation change in the protein thus rendering the CaM-K
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phosphorylation site inaccessible (Netticadan, 1996). Under these circumstances 5|xM RuR, in the 
presence of 3mM ryanodine and repeated calcium challenges, may enhance the detrimental effects 
on SERCA2A as discussed previously. Further work is required to determine the details of the 
interaction between RuR and ryanodine at the RyR.
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Fig 5.1; A typical experim ental trace fo r  an early addition o f  RuR. After a control transient was 
established, 5piM RuR was introduced to the preparation prior to a calcium bolus (67pM). The free 
calcium in the cuvette increased to 1.6|iM and then decayed back to diastolic levels before another 
3 calcium challenges were added at 12 minute intervals. The solution composition, bathing the cells 
prior to the additions indicated in the figure, is as follows; 0.05R (table 2.2), 20mM Oxalate, lOpM 
Fura-2, 5mM ATP, 15mM CrP, 0.1 |iM DTT, lOpM CCCP and 33|iM Oligomycin.
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Figure 5.2: Typical experim ental trace fo r  a late addition o f  RuR. After a control transient was 
established, 3 successive calcium challenges were added at 12 minute intervals before 5^M RuR 
was introduced to the preparation prior to a calcium bolus (67|iM). The solution composition, 
bathing the cells prior to the additions indicated in the figure, is as follows; 0.05R (table 2.2), 
20mM Oxalate, 10|iM Fura-2, 5mM ATP, 15mM CrP, 0.1 DTT, lOpMCCCP 
and 33|0.M Oligomycin.
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Figure 5.3: Description o f  the dCa^*/dt analysis. (A) The digitised traces converted into calcium 
concentrations using the parameters provided by the Fura-2 calibration curves. These values were 
plotted using the program Origin (Microcal software), where a bi-exponential curve was fitted 
below 700nM calcium concentration. (B) The plot of the rate of change of calcium at each calcium 
concentration (dCa^Vdt), derived from the curve shown in panel A. The value of dCa^Vdt at -IpM  
(±0.2|iM) was used as a measure of flux through the RyR. The solution composition, bathing the 
cells prior to the RuR addition indicated in the figure, is as follows; 0.05R (table 2.2), 20mM 
Oxalate, lOpM Fura-2, 5mM ATP, 15mM CrP, 0.1 |iM DTT, 10p.M CCCP and 33|iM Oligomycin.
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Figure 5.4: The raw and norm alised mean rate o f  decay fo r  the early addition o f  RuR. (A)
Displays the raw mean data for the rate of decay in the presence and in the absence (■•") of
5|iM RuR, plotted against the increasing calcium challenges. 5|iM RuR was added at calcium 
challenge #1. (B) Displays the normalised mean data for the rate of decay in the presence (--■ -) 
and in the absence ( -# - )  of 5|liM RuR, plotted against the increasing calcium challenges. 5 i^M RuR 
was added at calcium challenge #1. (mean ±  s.e.m., * denotes P<0.05, ** denotes P<0.005). 
ANOVA with a Tukey post hoc test was used for multiple comparisons. The solution composition, 
bathing the cells prior to the RuR addition indicated in the figure, is as follows; 0.05R (table 2.2), 
20mM Oxalate, 10|iM Fura-2, 5mM ATP, 15mM CrP, O.ljiM DTT, lOpMCCCP 
and 33|i.M Oligomycin.
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Figure 5.5; The raw and norm alised mean rate o f  decayfor the late addition o f  RuR. (A) Displays 
the raw mean data for the rate of decay in the presence (- o- ) and in the absence (-#  ) of 5|iM RuR, 
plotted against the increasing calcium challenges. 5pM RuR was introduced to the cuvette system at 
calcium challenge #4. (B) Displays the normalised mean data for the rate of decay in the presence 
(- 0 - ) and in the absence ( -# - )  of 5|iM RuR, plotted against the increasing calcium challenges. 
5|iM RuR was added after #4. (mean ± s.e.m., * denotes P<0.05). Significance was tested using a 
students unpaired t-test. The solution composition, bathing the cells prior to the RuR addition 
indicated in the figure, is as follows; 0.05R (table 2.2), 20mM Oxalate, 10|iM Fura-2, 5mM ATP, 
15mM CrP, 0.1 pM DTT, lOpM CCCP and 33pM Oligomycin.
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Figure 5.6: The raw and norm alised mean rate o f  decay fo r  the early and late additions o f  RuR. 
(A) Displays the raw mean data for the rate of decay in the presence (-□ -) and in the absence ( -# -)  
of 5pM RuR, plotted against the increasing calcium challenges. 5|iM RuR was introduced to the 
cuvette system at calcium challenges #1 and #4. (B) Displays the normalised mean data for the rate 
of decay in the presence (-□ -)  and in the absence ( #  ) of 5pM RuR, plotted against the increasing 
calcium challenges. 5|iM RuR was added after #1 and #4. (mean ± s.e.m., * denotes P<0.05, ** 
denotes P<0.005). ANOVA with a Tukey post hoc test was used for multiple comparisons. The 
solution composition, bathing the cells prior to the RuR addition indicated in the figure, is as 
follows; 0.05R (table 2.2), 20mM Oxalate, lOpM Fura-2, 5mM ATP, 15mM CrP, 0.1 pM DTT, 
lOpM CCCP and 33pM Oligomycin.
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Figure 5.7: Summary o f  the raw and norm alized mean rate o f  decay produced in the presence  
and in the absence o f  RuR. (A) Shows the raw mean data for the rate of decay. (B) Displays the 
mean normalized data for the rate of decay. Both in the absence ( # - )  and in the presence of 5p.M 
RuR. 5|iM RuR was added at #1 only at #4 only (- o -) and at #1 and #4 in the same
preparation (-□ -). The solution composition, bathing the cells prior to the RuR addition indicated in 
the figure, is as follows; 0.05R (table 2.2), 20mM Oxalate, 10p.M Fura-2, 5mM ATP, 15mM CrP, 
0.1 p-M DTT, lOpM CCCP and 33pM Oligomycin.
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Figure 5.8: The effects o f  ryanodine and RuR on the rate o f  decay o f  successive calcium  
transients. (A) A typical experimental trace to show the effects of 3|iM Ry and 5|iM RuR on the 
rate of decay of the calcium transients. After a control transient was established, 3|iM Ry was 
introduced to the preparation. Then 5)iM RuR was added after the fourth calcium boli to assess the 
SR leak induced with Ry. (B) A typical experimental trace to display the effects of 300|iM Ry and 
5|xM RuR on the rate of decay of the calcium transients. (C) A typical experimental trace showing 
the effects of 3mM Ry and 5pM RuR on the rate of decay of the calcium transients. The solution 
composition, bathing the cells prior to the Ryanodine and RuR additions indicated in the figure, is 
as follows; 0.05R (table 2.2), 20mM Oxalate, lOpM Fura-2, 5mM ATP, 15mM CrP, 0.1 pM DTT, 
lOpM CCCP and 33pM Oligomycin.
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Figure 5.9: The effect o f  0.3 ryanodine on the rate o f  decay fo r  successive calcium transients. 
(A) Displays the mean raw (uncorrected) data for the rate of decay in the absence ( -#  ) and in the 
presence of 0.3|iM Ry ( - 0 - ) ,  plotted against successive calcium challenges. (B) Displays the 
normalised mean data for the rate of decay in the absence ( -# - )  and in the presence of 0.3p,M Ry 
(o), where Ry was added at #1 and 5|iM RuR was added at #4 (—o - ) .  The mean rates of decay 
were normalised to the control, (mean ± s.e.m., n=4). ANOVA with a Tukey post hoc test was used 
for multiple comparisons. The solution composition, bathing the cells prior to the Ryanodine and 
RuR additions indicated in the figure, is as follows; 0.05R (table 2.2), 20mM Oxalate, 10|iM Fura- 
2, 5mM ATP, 15mM CrP, 0.1 |iM DTT, 10|iM CCCP and 33|iM Oligomycin.
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Figure 5.10; The effects o f  3fjM  ryanodine on the rate o f  decay fo r  successive calcium transients. 
(A) Displays the mean raw data for the rate of decay in the absence ( #  ) and in the presence of 
3|iM Ry ( - □ - ) ,  where Ry was introduced at #1 and 5pM RuR at #4. (B) Displays the normalised 
mean data for the rate of decay in the absence ( -#  ) and in the presence of 3pM Ry (□). Ry was 
added at #1 and 5pM RuR at #4 (—□—). (mean ± s.e.m., * denotes P<0.05, ** denotes P<0.005). 
ANOVA with a Tukey post hoc test was used for multiple comparisons. The solution composition, 
bathing the cells prior to the Ryanodine and RuR additions indicated in the figure, is as follows; 
0.05R (table 2.2), 20mM Oxalate, lOpM Fura-2, 5mM ATP, 15mM CrP, 0.1 pM DTT, lOpM CCCP 
and 33pM Oligomycin.
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Figure 5.11: The effects o f  30f M  ryanodine on the rate o f  decay fo r  successive calcium  
transients. (A) Displays the mean raw data for the rate of decay in the absence ( - • - )  and in the 
presence of 30|iM Ry (—□—); Ry was introduced at #1 and 5|iM RuR at #4. (B) Displays the 
normalised mean data for the rate of decay in the absence ( - • - )  and in the presence of 30|iM Ry
(A );  Ry was added at #1 and 5pM RuR at #4 ( - A - ) .  (mean ± s.e.m, * denotes P<0.05, ** denotes 
P<0.005). ANOVA with a Tukey post hoc test was used for multiple comparisons. The solution 
composition, bathing the cells prior to the Ryanodine and RuR additions indicated in the figure, is 
as follows; 0.05R (table 2.2), 20mM Oxalate, lOpM Fura-2, 5mM ATP, 15mM CrP, 0.1 DTT, 
lOpM CCCP and 33|xM Oligomycin.
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Figure 5.12: The effects o f  300/jM  ryanodine on the rate o f  decay fo r  successive calcium  
transients. (A) Displays the mean raw data for the rate of decay in the absence ( #  ) and in the 
presence of 300|iM Ry (“♦ “ ); Ry was introduced at #1 and 5pM RuR at #4. (B) Displays the 
normalised mean data for the rate of decay in the absence ( -# - )  and in the presence of 300p.M Ry 
(♦); Ry was added at #1 and 5pM RuR at #4 (—*—). (mean ± s.e.m. * denotes P<0.05, ** denotes 
P<0.005). ANOVA with a Tukey post hoc test was used for multiple comparisons. The solution 
composition, bathing the cells prior to the Ryanodine and RuR additions indicated in the figure, is 
as follows; 0.05R (table 2.2), 20mM Oxalate, lOpM Fura-2, 5mM ATP, 15mM CrP, 0.1 pM DTT, 
lOpM CCCP and 33pM Oligomycin.
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Figure 5.13: The effects o f  3m M  ryanodine on the rate o f  decay fo r  successive calcium  
transients. (A) Displays the mean raw data for the rate of decay in the absence ( #  ) and in the 
presence of 3mM Ry (-A -);  Ry was introduced at #1 and 5pM RuR at #4. (B) Displays the 
normalised mean data for the rate of decay in the absence ( #  ) and in the presence of 3pM Ry 
(A );  Ry was added at #1 and 5pM RuR at #4 ( - A - ) .  (mean ± s.e.m., * denotes P<0.05, ** denotes 
P<0.005). ANOVA with a Tukey post hoc test was used for multiple comparisons. The solution 
composition, bathing the cells prior to the Ryanodine and RuR additions indicated in the figure, is 
as follows; 0.05R (table 2.2), 20mM Oxalate, lOpM Fura-2, 5mM ATP, 15mM CrP, 0.1 pM DTT, 
lOpM CCCP and 33pM Oligomycin.
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Figure 5.14: Summary o f  the effects o f  ryanodine on calcium transient rate o f  decay. (A) The 
mean raw rates of decay produced by the introduction of 0.3|xM, 3pM, 30pJM, 300|i,M and 3mM 
ryanodine at #1 and 5pM RuR at #4. (B) The normalised mean rates of decay for the above 
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CHAPTER SIX
CAFFEINE MEDIATED CALCIUM
LEAK
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6.L INTRODUCTION
Caffeine has been widely used as a pharmacological tool for releasing calcium from intracellular 
stores to study the role of the sarcoplasmic reticulum during excitation contraction coupling. The 
exact mechanism by which caffeine exerts its action is not fully understood. However, studies so far 
have shown caffeine to possess several actions: it releases calcium ions from the SR (Weber & 
Herz, 1968); it sensitises the contractile machinery to intracellular calcium concentrations (Wendt 
& Stephenson, 1983; Eisener & Valdeomillos, 1985); and acts to inhibit phosphodiesterase activity 
(Butcher & Sutherland, 1962; Robison et al„ 1968).
Caffeine induces calcium release from the SR by binding to a specific site on the cytosolic 
side of the RyR. Thus, increasing the apparent affinity of the calcium activation site for calcium 
causing a cooperative interaction between these sites, in a reversible manner (Rousseau et a l, 1989; 
Sitsapean & Williams, 1990; Meissner et a l ,  1997) and markedly increases the Po of the channel 
with no effect on single channel conductance. The Po of the channel is primarily regulated by free 
cytosolic calcium concentrations (Ashley & Williams, 1990; Williams & Ashley, 1989) but can be 
further increased in the presence of ATP, and reduced by magnesium and RuR (Ashley & Williams, 
1990; Williams & Ashley, 1989).
Cardiac muscle SR can accumulate a significant amount of calcium in the presence of ATP 
and high concentrations of caffeine (up to 20mM) and when caffeine is added in the absence of 
ATP, thus inhibiting the Ca^'^'-ATPase pump, a sustained calcium release occurs increasing towards 
a maximal level (Feher & Briggs, 1982). This leak pathway is independent of the RyR due to the 
receptor being inhibited in the absence of ATP (Alpert et a l, 1989) and under these circumstances 
the total calcium released from the SR can be quantified and used to calculate the calcium content 
of the SR accessed by caffeine. (Varro e ta l ,  1993; Bers, 1987; Smith & Steele, 1998).
Ritter et a l, (2000) hypothesised that caffeine induced calcium release from cardiac myocytes 
(especially when intracellular caffeine concentrations are low) may commence with events that 
resemble calcium sparks. Calcium sparks are local increases in intracellular calcium concentrations 
and the spatial and temporal summation of which have been suggested to contribute to E-C
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coupling (Cheng et a l,  1993; Cannell et a l,  1994). Spontaneous release of calcium occurs once a 
threshold level of SR calcium is reached (Diaz et a l ,  1997) and the frequency at which spontaneous 
release occurs depends on the rate at which calcium pumped out of the cell is replenished (Diaz et 
a l,  1997).
Sparks have been ascribed to RyR openings induced by influx of calcium from the L-type 
calcium channels or by spontaneous RyR openings. In the presence of caffeine, calcium release 
occurs at lower levels of SR calcium suggesting that caffeine lowers the critical level of SR calcium 
content at which spontaneous calcium is released (Trafford et a l,  2000b). Ritter et a l,  (2000) found 
that caffeine induced sparks are independent of the activation of the L-type calcium channel. This 
confirmed previous observations made by Cheng et a l ,  (1993) that initiation of sparks does not 
require calcium influx via the calcium channel and that the initiation is dependent on, the time to 
expose the cell to caffeine as well as diffusion of caffeine to the RyR. After the diffusion of 
caffeine, sparks first appeared close to the cell surface membrane before summation to produce a 
whole cell calcium transient. From these findings, Ritter suggested that caffeine induced calcium 
sparks originate from a cluster of RyR openings (Ritter et a l , 2000).
Work carried out by Sitsapesan and Williams (1990), showed that at least two distinct 
modes of action were responsible for caffeine induced calcium release from the SR: a calcium 
dependent mechanism seen with relatively low concentrations of caffeine (0.5-2.0mM) which can 
activate the SR calcium release channel by increasing the frequency of channel opening without 
significantly effecting the duration of open events; and a calcium independent mechanism requiring 
higher (>5mM) concentrations. Low doses of caffeine (0.5-2mM) have no effect on calcium 
induced calcium release when the cytosolic calcium level is below 80pm (Rousseau et a l, 1986). 
However, in the presence of high caffeine concentrations (>5mM) a second calcium independent 
activation of the RyR is revealed.
Sustained application of caffeine causes a concentration dependent release of calcium from
the RyR where the ability of the SR to re-accumulate calcium is inversely proportional to the
caffeine concentration applied in the range 5-40mM (Smith & Steele, 1998). High concentrations of
caffeine will therefore deplete the SR of calcium since the rate of calcium release is greater than the
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maximal rate of SERCA 2A mediated calcium re-uptake. The degree of calcium re-uptake in the 
presence of caffeine will depend on the cytosolic calcium concentration and the characteristics of 
the calcium pump (Smith & Steele, 1998). Where as sustained applications of low concentrations of 
caffeine are thought to stimulate calcium release without inhibiting the ability of the SR to re- 
accumulate calcium during diastole. Inesi & de Meis (1989) reported that a reduced luminal SR 
calcium content (as described above with the addition of low concentrations of caffeine) is known 
to stimulate SERCA 2A mediated calcium uptake (Inesi & de Meis, 1989; Weber, 1971). 
Decreasing luminal calcium concentrations as well as stimulating SR calcium uptake could prove to 
be an important modulator of calcium cycling and force development during excitation contraction 
coupling of cardiac muscle.
To date, the site(s) on the RyR responsible for the caffeine effect have not been elucidated, 
however studies conducted by Bhat et ah, (1997c) observed that caffeine induced release of calcium 
in a dose dependent manner from cells expressing the full length RyR. Therefore, the caffeine 
binding site(s) have been suggested to reside within the amino-terminal foot region of the RyR.
It is not clear from previous publications the extent to which caffeine mediated calcium leak 
is blocked by ryanodine and RuR. The purpose of this chapter is to describe experiments designed 
to study this in permeabilised rabbit cardiac myocytes preparations.
6.2 METHODS
Cardiac myocytes were prepared for calcium uptake/leak studies as previously described in chapter 
2. 1x10*^  permeabilised cells were transferred to the closed cuvette system where changes in the 
intracellular free calcium concentrations were detected using the fluorescent indicator fura-2. 
Following a 3minute incubation, allowing the cells to reach an equilibrium with the mock 
intracellular environment, a few boluses of 8-12fil lOmM calcium chloride were added to raise the 
free calcium concentration to l-2pM  which decayed in an exponential fashion. Three boluses, 
introduced at 12minute intervals, were found to be adequate for producing reproducible calcium 
transients.
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The analysis of the uptake time course was conducted in two ways: (1) The rate of decay at 
a set calcium concentration was used to assess the SR calcium uptake rate, (2) An exponential was 
fitted to the calcium decay and the time constant used as a measure of the rate of decay. This latter 
method was used in situations where the maximum and minimum calcium varied (e.g. in the 
presence of various caffeine concentrations). Under these circumstances, a single calcium 
concentration measurement was not reliable.
6.3 RESULTS
6.3.1. The Effects o f  Low Concentrations o f  Caffeine on SERCA2A
Figure 6.1 A is a typical experimental trace to display the effects of 300pM Ryanodine and 5pM 
RuR on calcium uptake in the presence of 2mM caffeine. Once a control transient was established 
and decayed back to diastolic levels, 2mM caffeine was introduced prior to a bolus of calcium 
(67pM) thus increasing the calcium leak from the SR. This was noted by a slower Ti compared with 
the control (2mM caffeine: Mean normalised Ti = 483% of the control. (Fig. 6.2A). After 15 
minutes, 300pM ryanodine was introduced prior to a calcium bolus resulting in an increase in Ti 
(Mean normalised Ti = 515% of the control. (Fig. 6.2A). 300pM ryanodine did not induce a block 
on the caffeine mediated SR leak but was observed to enhance the SR leak to a level similar to that 
produced by caffeine. Indicating that 2mM caffeine was insufficient to maximally stimulate an SR 
leak and that both caffeine and ryanodine have additive effects. On addition of 5pM RuR, at a 
15minute interval, a significant block on this leak was observed (5pM RuR: Mean normalised Ti = 
233% of control. (Fig. 6.2A). However, this block failed to decrease the Ti back to control levels, 
indicating that 5pM RuR did not completely block the SR leak under these conditions.
Figure 6. IB is a typical experimental trace to display the effects of 5pM RuR on 300pM 
ryanodine mediated leak and to investigate the effects of 2mM caffeine once the SR leak was 
blocked with 5pM RuR. After the established control decayed to diastolic levels, 300pM ryanodine, 
5pM RuR and 2mM caffeine were introduced to the preparation at 15minute intervals, prior to a
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calcium bolus (67pM). 300|iM ryanodine induced a significant slowing of Ti compared to the 
control (300pM Ryanodine: Mean normalised Ti = 150% of the control. (Fig. 6.2B), indicating that 
300pM Ryanodine increased the open probability of the RyR leading to an elevated SR leak. 5pM 
RuR significantly increased the rate of decay, noted by a Ti that was faster than the control (5pM 
RuR: Mean normalised Ti = 84% of the control), suggesting a substantial block of the RyR 
occurred and that an SR leak exists in the absence of RuR. 2mM caffeine did not significantly 
affect Ti in the presence of 5pM RuR (2mM Caffeine: Mean normalised Ti = 97% of control). 
Indicating that 5pM RuR was sufficient to block the ryanodine mediated SR leak as no further leak 
was observed in the presence of 2mM caffeine. It was also apparent that caffeine did not reverse the 
effects of the RuR block under these conditions.
6.3,2. Effects o f  Increasing Caffeine Concentrations on SERCA2A
From the previous results, 2mM caffeine alone has been shown to be insufficient at stimulating a 
sustained calcium leak from the SR and that calcium uptake was not impaired. The next step in this 
chapter involved investigating the effects of higher caffeine concentrations on SR calcium leak.
Figure 6.3A, shows a typical experimental trace for studying the effects of increasing 
caffeine concentrations on SR leak and how an increased leak affects SERCA2A. 5mM, lOmM, 
20mM and 40mM caffeine were injected into the preparation at 15minute intervals, prior to a 
calcium bolus (67pM) to increase the free calcium to IpM . Even although the increasing caffeine 
concentrations produced a slowing of Ti compared to the control (Fig. 6.3B) they did not produce a 
significant difference when compared with each other. Due to the non-significance of the Ti results, 
the steady state (Css) for each transient was calculated, normalised to the control and then an 
average was taken (Fig. 6.3C). A general trend of increasing Css with increasing caffeine 
concentrations was observed. Where the increase in Css levels between 5mM and lOmM as well as 
between 20mM and 40mM were non-significant under these conditions.
These results were repeated in the presence of low calcium concentrations (~100nM) to 
assess whether caffeine can induce a leak at resting calcium levels within permeabilised cardiac 
myocytes (Fig. 6.4A). After a control transient was established, increasing caffeine concentrations
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(5mM, lOmM, 20mM and 40mM caffeine) were introduced to the cuvette system at 15minute 
intervals in the absence of additional boli of calcium. From the mean normalised data displayed in 
Fig 6.5B, it was noted that the caffeine mediated calcium release was not apparent in our 
preparation until 20mM caffeine. Also, a substantial leak was only observed in the presence of 
40mM caffeine. These results suggest that in this preparation, 20raM caffeine is insufficient to 
maximally stimulate calcium release from the SR and that significant reuptake of calcium occurs in 
the presence of caffeine concentrations less than 20mM.
6.3.3. R uR  Inhibition o f  Caffeine Mediated Calcium Leak
From previous results, 40mM caffeine was found to stimulate a substantial calcium leak from the 
SR in the absence of additional calcium boli. In some preparations, this caffeine mediated leak 
increased to such high levels that calcium uptake was impaired (Figure 6.3A). In figure 6.5A, 
40mM caffeine was introduced to the preparation after the control transient was established. 
Caffeine was noted to increase the calcium leak with a steady state being reached after about 10 
minutes. Increasing concentrations of RuR (0.03, 0.3, 1, 2 and 5|liM ) were added at 15minute 
intervals. RuR had no apparent effect until IpM , with a substantial block occurring in the presence 
of 5pM (Fig. 6,7). Once a steady state calcium level was reached in 5pM RuR, a bolus of calcium 
was introduced to the preparation to assess the rate of decay after the RuR block on the caffeine 
mediated calcium release form the SR. Another bolus was added in the presence of 25pM, to 
determine whether a further block of the calcium release channel occurred. The rate of decay was 
plotted against calcium concentration for the control, 5pM RuR and 25pM RuR (Figure 6.5B). 
Compared to the control, 5pM RuR (in the presence of 40mM caffeine) increased the rate of decay 
where as no further increase was observed with 25pM (in the presence of 40mM caffeine). This 
concludes that 5pM RuR was sufficient to exert a full block on the caffeine mediated calcium leak 
from the SR.
6.3.4. Ryanodine Inhibition o f  Caffeine Mediated Calcium Leak
Following the same protocol as previously described in 6.3.3, replacing increasing concentrations of
RuR with Ryanodine (Figure 6.6A). It was observed that 40mM caffeine induced calcium release
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from the SR with a steady state being reached after about 10 minutes. Increasing concentrations of 
Ryanodine (0.3pM, 3pM, 30pM, 300pM and 3mM) were added at 15minute intervals to assess 
ryanodine inhibition on the caffeine mediated SR calcium leak. Ryanodine has a slight effect at 
3pM and 300pM but the most pronounced block occurred in the presence of 3mM ryanodine (Fig. 
6.7). Where 3mM lowered the cytoplasmic calcium concentration back to basal levels. This 
suggests that 3mM ryanodine induced a full block on the caffeine mediated calcium leak from the 
SR.
Once a steady state calcium level was reached in the presence of 3mM ryanodine, a bolus of 
calcium was added to assess the rate of decay after the ryanodine inhibition on the caffeine 
mediated SR calcium release. After ISminutes another bolus of calcium was added in the presence 
of 5pM RuR, to determine whether a further block of the calcium leak occurred. The rate of decay 
was calculated for the control, 3mM ryanodine (in the presence of 40mM caffeine) and 5pM RuR 
(in the presence of 3mM ryanodine and 40mM caffeine). The results were plotted against calcium 
concentration (Figure 6.4B). Compared with the control, 3mM Ryanodine (in the presence of 
40mM caffeine) increased the rate of decay where as no further increase was observed with 5pM 
RuR (in the presence of 3mM ryanodine and 40mM caffeine). This suggests that an SR leak exists 
in the absence of a ryanodine blocker. Also, 3mM Ryanodine was sufficient to block the caffeine 
mediated calcium release from the SR.
This experiment was repeated in the presence of 5mM oxalate (Fig 6.7) where 5mM oxalate 
produced a similar dose response curve to 20mM oxalate, thus indicating that oxalate did not 
significantly alter the ryanodine effects on caffeine mediated calcium leak.
6,4 DISCUSSION
As described in the introduction to this chapter, caffeine is widely used as a pharmacological tool 
for assessing calcium induced calcium release from the RyR. The effects exerted by caffeine are 
dose dependent. High concentrations of caffeine (40mM) deplete the SR of calcium and are thus 
used to assay the SR calcium content. Low concentrations of caffeine (<0.5-2mM) have been 
hypothesised to stimulate SR calcium recycling, thus increasing calcium uptake as well as release.
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The reduced luminal calcium associated with an increase SR leak, in this case caffeine mediated SR 
leak, stimulates SERCA 2A activity which in turn increases SR calcium uptake (Inesi & de Meis, 
1989).
In this study it was observed that caffeine mediated calcium release from the SR of 
permeabilised cardiac myocytes occurred in a dose dependent manner. Despite activation of the 
RyR by caffeine, the SR could still lower calcium in the cuvette to levels <100nM via calcium 
uptake. The ability of the SR to sequester significant amounts of calcium in the presence of 10- 
20mM caffeine and -IGOnM calcium was observed in permeabilised rat myocytes by Smith & 
Steele (1998). This suggests that the results seen in this study are unlikely to be species dependent. 
Only at caffeine concentrations above 20mM was calcium reuptake incomplete, where the 
maximum concentration of 40mM caffeine appeared to cause additional leak at cytosolic calcium 
concentration of ~l-2pM . The caffeine mediated calcium leak was further enhanced by 300pM 
ryanodine but completely blocked by 5pM RuR (Fig. 6.1 A). Since 5pM RuR was previously shown 
to maximally block the ryanodine receptor (chapter 5), the caffeine rate of decay after a RuR 
addition would have been expected to be similar to the rate of decay produced by RuR. However, 
the effect of 2mM caffeine after the RuR addition is small and not significant. Thus caffeine does 
not relieve the RuR block on calcium induced calcium release from the SR under these conditions. 
Also, the reagents added to the system do not appear to show order dependence.
When caffeine was added at a resting calcium concentration of -lOOnM an increase in
steady state calcium was not evident until the addition of 40mM caffeine. This suggests that SR
leak was not significantly affected until 40mM caffeine. However, in the presence of activating
calcium a slower rate of decay from 1.5pM calcium was noted in the presence of 2mM caffeine
where the SR was able to re-establish a low resting calcium concentration. This latter result
suggests that as little as 2mM caffeine can activate the RyR in the presence of ~ lpM  calcium. The
higher sensitivity to caffeine at IpM  calcium can be explained by calcium and caffeine acting
together to activate the RyR. The very low sensitivity of the RyR to caffeine in the presence of
-IGOnM calcium is consistent with the work on isolated RyR in lipid bilayers. Sitsapesan &
Williams (199G) work, carried out on SR incorporated into lipid bilayer showed that there is
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calcium dependent as well as a calcium independent mechanism for caffeine induced calcium 
release from the SR. Where the calcium independent mechanism requires high concentrations of 
caffeine (>0.5mM) to induce calcium release while the calcium dependent mechanism can release 
calcium from relatively low concentrations of caffeine (0.5-2mM). In this study lOmM caffeine 
only partially activates the RyR where as at 40mM caffeine induces a substantial release of calcium 
from the SR.
In the presence of 20mM oxalate, the sensitivity of calcium leak to caffeine was very much 
lower than that observed in intact cells (O’Neill & Eisner, 1990). The reason for this is unknown. 
Interestingly the caffeine sensitivity of the isolated RyR channels in lipid bilayer work has a 
similarly low sensitivity to caffeine (Rousseau & Meissner, 1989; Williams & Sitsapesan, 1990)
Another significant result of this work is the apparent low sensitivity of the SR calcium leak 
to ryanodine. Previous work on isolated channels suggest that -SOpM is sufficient to block the 
RyR but in this study 3mM was required. The reason for this discrepancy is unknown. Isolated 
channel experiments have revealed that the slow binding of ryanodine to the RyR is very 
temperature sensitive and depends on the holding potential (Smith et aL, 1988). These variables 
may explain some aspects of the apparently low ryanodine sensitivity observed in this study.
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Figure 6.1: The effects o f  ryanodine, RuR and caffeine on the rate o f  decay o f  successive calcium  
transients. (A) A typical experimental trace displaying the effects of 300|iM ryanodine (Ry) and 
5 i^M RuR in the presence of 2mM caffeine (Caff) on the rate of decay of the calcium transients. A 
control was established before 2mM Caff, 300)iM Ry and 5|iM RuR were introduced at 12minute 
intervals, prior to a boli of calcium chloride (67|iM). (B) A typical experimental trace to show the 
effect 300|iM Ry and 5pM RuR have on the rate of decay of the calcium transient and to assess if 
2mM Caff can induce an SR leak in the presence of a RuR block. The solution composition, bathing 
the cells prior to the additions of ryanodine, RuR and caffeine as indicated in the figure, is as 
follows; 0.05R (table 2.2), 20mM Oxalate, lOpM Fura-2, 5mM ATP, 15mM CrP, 0.1 pM DTT, 
lOpM CCCP and 33pM Oligomycin.
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Figure 6.2: The mean data fo r  the effects o f  caffeine, ryanodine and RuR on the calcium decay 
time constant (Ti). (A) A bar graph showing the mean normalised data for Ti, influenced by 
300|xM Ry and 5|iM RuR in the presence of 2mM Caff (mean ± s.e.m., n=3, * denotes P<0.002, ** 
denotes P<0.001). (B) Shows a bar graph of the mean normalised data for Ti influenced by 300pM 
Ry, 5|iM RuR and 2mM Caff (mean ± s.e.m., n=3, ** denotes P<0.005). Significance was tested 
using an unpaired students t-test.
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Figure 6.3: The effect o f  caffeine concentration on Tj and Css during successive calcium  
transients. (A) A typical experimental trace displaying the effects of caffeine (caff) (5mM, lOmM, 
20mM and 40mM) in the presence of repeated calcium challenges, to assess the ability of the SR to 
sequester calcium in the presence of an elevated SR calcium leak. Caffeine was introduced at 
12minute intervals, prior to an aliquot of calcium chloride (67|iM). Thus increasing the free calcium 
concentration in the preparation, which decayed exponentially. (B) A bar graph displaying the mean 
normalised data for the calcium decay time constant (TO produced with 5mM, lOmM, 20mM and 
40mM caffeine additions prior to a calcium boli (67|iM) as shown in the typical experimental trace
(A) (mean ± s.e.m., n=3, P>0.05). (C) The following bar graph displays the mean normalised steady 
state (Css) produced after each transient decayed in the presence of increasing caffeine 
concentrations (mean ± s.e.m., n=3, ** denotes P<0.01, * denotes P<0.05). Significance was tested 
using an unpaired students t-test. The solution composition, bathing the cells prior to the additions 
of caffeine as indicated in the figure, is as follows; 0.05R (table 2.2), 20mM Oxalate, lOfiM Fura-2, 
5mM ATP, 15mM CrP, 0.1 pM DTT, lOpM CCCP and 33pM Oligomycin.
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Figure 6.4: Effects o f  caffeine concentration on SR calcium leak. (A) A typical experimental 
trace displaying the effects of caffeine concentration (5mM, lOmM, 20mM and 40mM) introduced 
to the preparation at llminute intervals (in the absence of successive calcium boli) in order to 
induce a maximal release of calcium from the SR. (B) The following bar graph displays the mean 
normalised data for the steady state (Css) produced after each caffeine addition (mean ± s.e.m., n=5, 
** denotes PcO.OOl, * denotes P<0.05). Significance was tested using an unpaired students t-test. 
The solution composition, bathing the cells prior to the additions of caffeine as indicated in the 
figure, is as follows; 0.05R (table 2.2), 20mM Oxalate, lOpM Fura-2, 5mM ATP, 15mM CrP, 
0.1 p.M DTT, IGp-M CCCP and 33pM Oligomycin.
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Figure 6.5: The Effect o f  RuR inhibition o f  caffeine m ediated calcium release. (A) A control 
transient was established with the addition of a bolus of calcium (67|iM). 40mM caffeine induced a 
maximal release of calcium from the SR, which was subsequently subjected to increasing RuR 
concentrations (0.03|iM, 0.3pM, l|i.M, 2|iM). Then 5|0.M and 25|iM RuR were added prior to a 
calcium boli to assess the extent of the block on the caffeine mediated SR calcium release. (B) 
Displays the rate of change of calcium uptake against calcium concentration for the control, 5p.M 
RuR and 25pM RuR in the presence of 40mM caffeine. The solution composition, bathing the cells 
prior to the additions of caffeine and RuR as indicated in the figure, is as follows; 0.05R (table 2.2), 
20mM Oxalate, lO i^M Fura-2, 5mM ATP, 15mM CrP, 0.1 |iM DTT, lOpMCCCP 
and 33|iM Oligomycin.
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Figure 6.6: The effect o f  ryanodine inhibition o f  caffeine m ediated calcium release. (A) A control 
transient was established with the addition of a bolus of calcium (67pM). 40mM Caff induced a 
maximal release of calcium from the SR, which was subsequently subjected to increasing Ry 
concentrations (0.3, 3, 30, 300, 3000^M). Then a bolus of calcium was added in the presence of 
3mM Ry, which decayed back to diastolic levels before another bolus was added in the presence of 
5p.M RuR. (B) Displays the rate of change of calcium uptake against calcium concentration for the 
control along with 40mM Caff and 3mM Ry in the presence and in the absence of 5|xM RuR. The 
solution composition, bathing the cells prior to the additions of ryanodine, caffeine and RuR as 
indicated in the figure, is as follows; 0.05R (table 2.2), 20mM Oxalate, 10|iM Fura-2, 5mM ATP, 
15mM CrP, 0.1 p.M DTT, lOpM CCCP and 33p.M Oligomycin.
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Figure 6.7: The mean results o f  RuR and Ryanodine on 40m M  caffeine m ediated SR calcium  
release. The control transient (C) displays the calcium level prior to the addition of Caff and RuR 
(or Ry). 40mM Caff produced a significant calcium leak from the SR, which was subsequently 
inhibited with increasing concentrations of RuR ( - • - )  and Ry (-■-)• The Ry inhibition of caffeine 
mediated SR leak was repeated in the presence of 5mM oxalate ( a ) (mean ± s.e.m., n=7, * denotes 
P<0.05). Significance was tested using an unpaired students t-test.
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CHAPTER SEVEN
SR CALCIUM LEAK AND BASTADIN
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7.1. INTRODUCTION
As previously shown (Chapter 4), even in the presence of SERCA2 blockade, a calcium efflux from 
the SR occurs. The source of this remaining leak is unknown at present but one such theory arose 
from the work carried out with bastadin {Pessah, et ah 1997), a class of compounds that appear to 
affect SR calcium leak in skeletal muscle (Chapter 1). This chapter investigates the nature of the SR 
calcium leak in permeabilised cardiac myocyte preparations by observing the actions of RyR 
blockers, ryanodine and RuR in the absence and presence of bastadin mix (Bastadins 5-10), in order to 
assess the contribution of the RyR to the non-specific leak unmasked by thapsigargin.
7 J  METHODS
Cardiac myocytes were prepared for calcium leak studies as previously described in Chapter 2. 
1x10^ permeabilised cells were transferred to the closed cuvette system and changes in the 
intracellular free calcium concentrations were detected using the fluorescent indicator Fura-2. 
Following a three minute incubation to allow the cells to reach an equilibrium with the mock 
intracellular environment, 3 aliquots of 8-lOjxl of lOmM calcium chloride were added to raise the 
intracellular free calcium concentration to l-2pM  which decayed in an exponential fashion back to 
diastolic levels (~100nM). Three aliquots introduced at 12 minutes apart were found to be adequate 
to generate reproducible rates of calcium decay.
7.5. RESULTS
Figure 7.1 is a typical experimental trace showing the calcium uptake protocol. Three calcium
transients were introduced at 12 minute intervals before 5pM Thapsigargin was added to the
preparation. As stated in 4.1.2, thapsigargin allows the study of calcium leak from the SR by
inhibiting the Ca^^-ATPase pump, thus after its addition a slow increase in the intracellular calcium
concentration ensues and in this preparation represents the linear leak from the SR. The
thapsigargin induced leak plateaued after about 3 hours (data not included), a time course that was
considered unsuitable for this study and therefore lOpM ionomycin was introduced to induce a
rapid elevation in the calcium concentration that reached a steady state at approximately 2pM.
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From Figure 7.2 (A) it was observed that in the presence of low intracellular calcium (80- 
160nM) the SR leak is not affected, by the addition of 5}xM RuR (a known blocker of the RyR). This 
indicates that the RyR activity could not be detected at these low levels and that the majority of the 
leak could be the result of a non-specific leak rather than through the RyR. The dashed box 
represented in figure 7.1 was expanded (figure 7.2, panel A) to emphasise the point made earlier 
tliat the RyR does not significantly contribute to the SR calcium leak over this calcium 
concentration range. However, in the presence of a higher calcium concentration (>500nM) and in 
the presence of 5pM RuR, a marked reduction of the calcium leak was observed (figure 7.2, panel 
B), indicating that the RyR activity greatly contributes to the SR calcium leak under these 
conditions.
Another method for examining calcium leak involves comparing the time course of decay
for the individual calcium transients. The rate of the decay is influenced by calcium uptake (via the
SERCA pump) as well as leak through the RyR and the non-specific leak. Figure 7.3 shows a
typical experimental trace displaying the effects of RuR on the time course of the calcium
transients. As described previously an aliquot of calcium was introduced to the preparation,
increasing the total calcium concentration in the cuvette by 67pM. This caused a rapid increase in
free calcium concentration to approximately 3jJ.M that decayed back to diastolic levels after 10
minutes. The second aliquot of calcium was added in the presence of 600nM RuR. The rate of
decay reaching diastolic levels after 10 minutes and the third aliquot of calcium was injected in the
presence of 5|iM  RuR. The rate of decay for the calcium transient was significantly faster in the
presence of RuR, where 5pM  exerted the largest block on the RyR (Figure 7.3, panel A). To
emphasise these differences more clearly, the decays were superimposed onto one diagram (Figure
7.3, panel B). The control possessed the less steep gradient that corresponds to a slower rate of
decay. This rate of decay significantly increased with exposure to increasing RuR concentrations,
the fastest rate occurring in the presence of 5|iM  RuR. This increase is due to tlie inhibiting o f the
calcium leak fi*om RyR. RuR reduces the competition between pump and leak, favouring uptake
and therefore, the pump becomes more efficient at transporting calcium into the lumen of the SR
thus lowering intracellular calcium levels within the cell. Below 500nM the three transients are
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superimposable (Figure 7.3, panel B) suggesting that RuR failed to exert an increase in the rate of 
decay even at a concentration of 5pM, indicating that the RyR remains inactive at these low 
calcium levels. Tins strengthens the point made earlier that the RyR activity does not significantly 
contribute to the SR calcium leak during calcium levels below 500nM.
This ryanodine/RuR insensitive calcium leak unmasked by thapsigargin was found to be 
blocked by bastadin mix (Bastadin 5-12) but only in the presence of RuR or ryanodine. Figure 7.4 
displays the bastadin effects on SR leak both in the presence and in the absence of RuR over the 
calcium range 80-160nM. In panel B, 20|O.M bastadin mix had no significant effect on SR calcium 
leak in the presence of thapsigargin when compared to the control (98 ± 2%, n=4). However, in 
panel A, when bastadin mix was introduced to the preparation in the presence of 5pM RuR and 
thapsigargin (leak rate = 120 ± lOnM.lO^ s'\lO ^ cells; n=5), the calcium leak plateaued and thus 
reduced the calcium leak to 66 ± 2% (n=4).
Figure 7.5 (panel A), displays the effect of bastadin mix (Bastadins 5-10) on SR calcium leak 
after treatment with ryanodine. To investigate the effect of bastadin mix in presence o f ryanodine, 
the calcium level was increased to SOOnM. As discussed previously the RyR is inactive at calcium 
concentrations below SOOnM so in order to activate this system tlie calcium levels were elevated. 
Two aliquots of calcium were introduced to the preparation in order to produce reproducible 
transients. Thapsigargin inhibited the SERCA pump and after 8 minutes 300nM of calcium was 
added to increase the calcium concentration within the cuvette. On addition o f 3mM ryanodine a 
transient increase in the rate of calcium leak was observed, increasing the calcium from 500nM to 
approximately IpM  before plateauing. After 10 minutes, 20pM bastadin mix (Bastadins 5-10) was 
introduced to the cuvette and was observed to induce a further significant decrease in the rate of 
calcium leak from the SR. To emphasise the blocking effects of bastadin mix, the dashed line in 
panel A was amplified (Panel B). The solid line represents the rate of rise o f calcium concentration 
before ryanodine addition and the dotted lines represent the rate of rise of calcium concentration 
after ryanodine addition. These results clearly suggest that ryanodine blocks the RyR after an initial 
phase of increased RyR activity and that this block was further increased with the addition of 
bastadin mix (Bastadins 5-10).
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As described previously, another method for examining calcium leak involves comparing 
the time courses of decay for the individual calcium transients. The rate of the decay is influenced 
by calcium uptake (via the SERCA pump) as well as leak through the RyR and the non-specific 
leak. Figure 7.6 displays the effects o f bastadin mix (Bastadins 5-10) on the time course of decay 
after treatment with 3mM ryanodine. Initially 3mM ryanodine decreases the rate of decay due to an 
initial opening of the RyR before a subsequent block on the addition of a second aliquot of calcium, 
where the rate of uptake is enhanced indicating a block on the RyR. Further additions of calcium 
gave rise to superimposable transient decays. 20|xM bastadin mix (Bastadins 5-10) was introduced to 
the preparation after the ryanodine block. It was observed that bastadin mix (Bastadins 5-10) did not 
produce an increase in the rate of decay until an additional bolus of calcium was added. Panel B 
emphasises the point that bastadin mix (Bastadins 5-10) increases the rate of decay,
7.4 DISCUSSION
It was observed that even in the presence of SERCA2A blockers, calcium efflux from the SR 
occurred. The source of this leak is unknown at present but one such explanation came from the 
work with class of compotmds called Bastadins.
Pessah et ah, (1997) speculated that the RyR may be stuck in an open configuration even in 
the presence of RuR or high concentrations of ryanodine, therefore releasing calcium from tlie 
internal calcium stores and is observed as a linear leak in the calcium uptake preparations. To 
investigate tliis theory 5pM RuR was introduced to the cuvette system in the presence of 
thapsigargin. At low intracellular calcium concentrations the leak is unaffected by RuR indicating 
that the RyR activity cannot be detected at these low levels, that the majority of the leak could be 
the result of the non-specific leak rather than through the RyR and that the RyR does not 
significantly contribute to the SR calcium leak over this calcium concentration range. However, 
RuR added in presence of calcium concentrations greater than 500nM caused a marked reduction on 
calcium leak, suggesting that the RyR activity greatly contributes to the SR calcium leak under 
these conditions. Similar results occurred with 3mM Ryanodine, where increasing the basal calcium 
levels above 5(X)nM induced a block on the RyR after an initial increase in calcium leak.
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RuR in Üie presence o f 20pM bastadin mix (Bastadins 5-10) was observed to induce a block 
on the SR leak that was previously shown to be insensitive to RuR. Bastadin mix (Bastadins 5-10) 
also enhanced the 3mM ryanodine block in the presence of a calcium concentration >500nM. 
However, adding bastadin mix (Bastadins 5-10) alone did not exert a block on the SR leak. This is 
consistent with the suggestion that a component o f the SR leak maybe be due to the RyR being in 
an open configuration (Pessah et al., 1997) and only after binding o f bastadin can these blockers 
induce an effect on the fraction of the SR calcium leak that remains in the presence of a RuR or a 
ryanodine block.
The earlier studies on bastadin suggest that they act on FKBP 12.0-RyRl interaction in 
skeletal muscle SR (Pessah et al., 1997), but this study has not been confirmed by other groups. 
Furthermore FKBP12.0 is not thought to bind to cardiac RyR (RyR2), instead the isomer FKBP12.6 
is thought to be involved (Timerman et ah, 1994). Therefore it would be interesting to examine 
whether FKBP12.6 modulates the effects o f bastadin in cardiac muscle SR.
7Â CONCLUSIONS
In isolated cardiac muscle preparations, thapsigargin unmasks an SR calcium leak. This leak is 
insensitive to blocks on the RyR at calcium concentrations below 500nM but is attenuated by 3mM 
ryanodine and 5pM RuR at calcium concentrations above 500nM. (Fig. 7.2 & Fig. 7.5). This was 
confirmed by measurements of calcium uptake where SERCA2 is active and thus a blocking effect 
was only observed at calcium concentrations above SOOnM (Fig. 7.3).
Bastadin mix (Bastadins 5-10) have no effect on thapsigargin mediated SR calcium leak in 
the absence of RuR or ryanodine (Fig 7.4A) but have a prominent effect on SR leak after the 
addition o f 5pM RuR (Fig. 7.4B) and after a complete block with 3mM ryanodine (Fig. 7.5). Its 
actions are still present during SERCA2 activity (Fig. 7.6).
A fraction of the SR calcium leak that remains after blocking with RuR and ryanodine is blocked by 
bastadin mix (Bastadins 5-10). This suggests that a component of the SR leak is due to the RyR being in an 
open configuration that can be blocked by bastadin (Pessah et a l, 1997). However, further work is required 
to confirm these preliminary observations on the action of bastadin on SR calcium leak.
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Figure 7.1: Experim ental trace showing the effects o f  thapsigargin, RuR and Ionomycin on SR  
calcium leak. After three successive calcium challenges, 5|iM thapsigargin (thaps) was introduced 
to the cuvette system, producing a linear leak from the SR. To test whether RyR activity is 
detectable at calcium concentrations below 500nM, 5|iM RuR was added 5 mins after thapsigargin. 
lOjiM ionomycin increased SR calcium leak, which increased diastolic calcium levels until an 
equilibrium with the intraluminal SR was reached. The solution composition, bathing the cells prior 
to the additions of thapsigargin, RuR and ionomycin as indicated in the figure, is as follows; 0.05R 
(table 2.2), 20mM Oxalate, lOpM Fura-2, 5mM ATP, 15mM CrP, 0.1 pM DTT, lOpMCCCP 
and 33pM Oligomycin.
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Figure 7.2: The effects o f  RuR on SR leak unmasked by thapsigargin in the presence o f  calcium  
concentrations below and above SOOnM. (A) 5jxM RuR was added in the presence of 5pM 
thapsigargin during calcium concentrations below 500nM. No detectable blocking effect was 
observed under these conditions. (B) 5p,M RuR was added in the presence of thapsigargin during 
calcium concentration above 500nM. Under these conditions, RuR decreased the SR leak 
unmasked by thapsigargin. The solution composition, bathing the cells prior to the additions of 
thapsigargin and RuR as indicated in the figure, is as follows; 0.05R (table 2.2), 20mM Oxalate, 
lOpM Fura-2, 5mM ATP, 15mM CrP, 0.1 pM DTT, lOpM CCCP and 33pM Oligomycin.
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Figure 7.3: Experim ental trace showing the effects o f  RuR on the rate o f  calcium decay. (A) 
660nM RuR and 3.3|iM RuR were introduced 8 minutes apart to the cuvette system in the presence 
of separate calcium challenges to assess the RuR block on the SR leak, (B) Compares the rates of 
decay for the calcium challenges in the presence and in the absence of RuR. 3.3|iM RuR induced 
the fastest rate of decay, indicating a significant block of the SR leak occurred. The solution 
composition, bathing the cells prior to the additions of RuR as indicated in the figure, is as follows; 
0.05R (table 2.2), 20mM Oxalate, lOpM Fura-2, 5mM ATP, 15mM CrP, 0.1 pM DTT, lOpM CCCP 
and 33pM Oligomycin.
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Figure 7.4; The effects o f  Bastadin mix in the presence and in the absence o f  RuR and low 
calcium concentrations. (A) 20p.M Bastadin mix (Bastadins 5-10) was added in the presence of S^ iM 
thapsigargin during low calcium concentrations. Showing Bastadin mix has no effect on the SR leak 
unmasked by thapsigargin. (B) 20|iM Bastadin mix was added in the presence of 5p.M RuR and 
thapsigargin. It was noted that an SR leak exists even in the presence of RyR blockers such as RuR 
and that Bastadin mix reduced this leak in the presence of RuR. The solution composition, bathing 
the cells prior to the additions indicated in the figure, is as follows; 0.05R (table 2.2), 20mM 
Oxalate, IGjiM Fura-2, 5mM ATP, 15mM CrP, 0.1 p.M DTT, 10p,M CCCP and 33|xM Oligomycin.
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Figure 7.5: The experim ental trace displaying the effects o f  Bastadin m ix in the presence o f  
ryanodine on the SR leak unm asked by thapsigargin. (A) 300pM calcium chloride was used to 
raise the calcium concentration above SOOnM. Once a steady state was reached, 3mM ryanodine 
was introduced to the thapsigargin mediated leak. 20|iM Bastadin mix (Bastadins 5-10) further 
decreased this leak. (B) The dashed line in panel A was amplified. The solid line represents the rate 
of rise of calcium concentration before ryanodine where as the dotted line represents the rate of rise 
of calcium concentration after ryanodine. The solution composition, bathing the cells prior to the 
drug additions indicated in the figure, is as follows; 0.05R (table 2.2), 20mM Oxalate, 10|iM Fura- 
2, 5mM ATP, 15mM CrP, 0.1 pM DTT, lOpM CCCP and 33pM Oligomycin.
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Figure 7.6: Experimental trace displaying the effects o f Bastadin mix on the rate o f calcium decay in the 
presence o f 3mM Ryanodine. (A) Ryanodine was introduced after a control transient was established. 20pM 
Bastadin mix (Bastadins 5-10) was added after a block on SR leak occurred with ryanodine. Once the 
transient decayed to minimum levels another calcium challenge was introduced in the presence of Bastadin 
mix. (B) Comparing the rates of decay before and after Bastadin mix. A control was established in the 
presence of ryanodine block; Bastadin 1 represents the rate of decay after the first calcium challenge in the 
presence of Bastadin mix, and Bastadin 2 represents the rate of decay after the second calcium challenge in 
the presence of Bastadin mix. The solution composition bathing the cells prior to the drug additions as 
indicated in the figure is as follows; 0.05R (table 2.2), 20mM Oxalate, lO^ iM lO^ iM Fura-2, 5mM ATP, 
15mM CrP, 0.1 pM DTT, 1 OpM CCCP and 33pM Oligomycin.
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8.1. Balling o f  Rod Shaped Cells
Balled-up cells are rod shaped cells that are balled-up. The mechanism by which they become 
contracted is uncertain but may reflect calciurn overload and hypercontracture due to membrane 
damage during dissociation that can ultimately lead to apoptosis and programmed cell death.
From the findings of this study it was revealed that balled cells may contribute to SR 
regulation and were therefore included in the experiment as viable cells. From the protein 
measurements we noted that the method of counting cells using a haemocytometer was accurate and 
consistent throughout the experimental protocols and that balled cells contributed to the protein 
content in this study. The rod cell count does not influence the total protein concentration to a 
significant degree, but that the total cell number has a linear relationship with total protein. This 
implies that balled-up cells contribute to the total protein concentration. Overall, the yield of rods 
does not influence total protein, where as total cell number does; therefore the number of balled
cells was taken into consideration during cell counting.
A higher number of cells within an experimental preparation lead to an increase in the rate 
constant for calcium uptake. Therefore the greater the number of cells within a preparation, the 
greater the amount of functional pumps available to take up calcium, thereby increasing the rate 
constant for calcium uptake into the SR. However, no relationship was detected between total 
number of rods and the rate of calcium uptake, thus the increase in the rate constant observed was 
not due to an increase in the number of rod shaped myocytes within the preparation.
From the evidence in this study, balled-up cells contribute to total protein and increasing the 
total cell number leads to an increase in the rate of calcium uptake which suggests that balled-up
cells may contain functional pumps, and will therefore contribute to SR regulation and can be
considered as viable cells within this preparation.
8.2. Effects o f  R uR  on Permeabilised Myocytes
In permeablised cardiac myocytes, 5^M RuR induced a rapid increase in the rate of calcium decay 
(i.e. greater sequestration of calcium into the SR lumen) regardless of when it was introduced to the 
preparation, suggesting that under control conditions a significant leak exists through the RyR at
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IjiM calcium. 5|xM RuR was observed to have a maximal inhibition on the CRC as a further block 
was not observed with higher concentrations of RuR (Fig. 6.5A) and was not reversed with 2mM 
caffeine (Fig. 6.2). This is emphasized in the results taken from chapter 5.3.1; where the late 
addition of RuR induced a rapid increase in the rate of decay to a value similar to that seen with the 
early RuR addition suggesting that the RyR activity is not significantly affected during this 
protocol.
However, the continued presence of 5p,M RuR, during increasing calcium challenges, 
caused a progressive decrease in the rate of decay especially after the last calcium challenge (Fig 
5.4A) and in the presence of a ryanodine block (Fig. 5.13B). This was not due to increased RyR 
activity since additional RuR did not reverse this effect. It is suspected that this result arose from a 
progressive effect of RuR on SERCA2 (Kargacin & Kargacin, 1998). This is supported by the 
observation that higher concentrations of RuR (25|xM) introduced to the preparation after the 5pM 
block, in the presence of ryanodine, depressed the rate of decay further and was therefore more 
effective at slowing calcium uptake (data not shown). Although with a subsequent late addition of 
RuR in the presence of an early addition in the same preparation (Fig, 5.6), no significant decrease 
in the rate of decay was observed when compared to the preparation where a late addition of RuR 
was absent (Fig. 5.4). This suggests that 5|iM RuR does not produce a significant effect on 
SERCA2A. However, as stated above, higher concentrations of RuR did produce a decline in the 
rate of decay. For this reason, lower concentrations of RuR were used in this study to minimise the 
side effects on SERCA.,
It was also observed that successive calcium challenges in the absence of RuR led to an 
initial increase in the rate of decay of the calcium transient. This progressive increase could arise 
from the gradual phosphorylation of PLB and as discussed in chapter 1, PLB is the phosphoprotein 
that regulates the activity of SERCA2. In its dephosphorylated state, PLB is an inhibitor of the 
cardiac SR calcium pump (Simmerman et al., 1998) but upon phosphorylation, this inhibition is 
overcome (Jencks, 1989; Katz, 1996) thereby stimulating calcium uptake into the lumen of the SR. 
Bhogal & Colyer (1998) reported that an enzyme capable of sensing the luminal calcium 
concentration can regulate the phosphorylation of PLB in response to changes in calcium load. This
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enzyme is called a state of filling kinase (SOF kinase). The phosphorylation of PLB in response to 
the depletion of the luminal calcium concentration (store depletion) would accelerate calcium 
uptake into the SR (Colyer & Wang, 1991) to facilitate store refilling. Upon loading of the SR, a 
burst of phosphorylation of PLB was observed at low intraluminal calcium concentrations but as the 
SR reached Css, a gradual decline in PLB phosphorylation occurred. This is consistent with the 
activation of the SOF kinase activity during low luminal calcium concentrations (<2.5p,M) and the 
inhibition at high luminal calcium concentrations (35|0,M). Suggesting a direct link between SR 
luminal calciurn concentration and the phosphorylation of PLB and that SOF is regulated by the 
luminal calcium concentration in the SR. This is consistent with the findings in this study observed 
in chapter 4 and 5, of the gradual increase in the rate of decay occurring over the three successive 
calcium challenges before declining over the remaining challenges. Therefore a SOF kinase could 
be regulating the phosphorylation of PLB via luminal calcium concentrations in this preparation.
8.3. RuR/ryanodine insensitive leak
In this preparation, a significant SR leak exists in the presence of an SR calcium load and that three 
calcium challenges were sufficient to produce reproducible calcium transients as well as sufficiently 
loading up the SR. A component of this leak can be blocked by RuR although a significant leak 
remains, suggesting that there exists a leak pathway in cardiac muscle SR that is independent of 
conventional RyR activity. Little is known about this RuR/ryanodine insensitive leak unmasked by 
thapsigargin, although a few theories have arisen. It was discovered that in this preparation, RyR 
activity was not detected at low calcium concentrations (<500nM) but on addition of calcium, 
increasing calcium level >500nM, RuR/ryanodine caused a marked reduction of calcium leak. 
Therefore, the RyR activity greatly contributes to the SR calcium leak under these conditions.
Interestingly, a compound called Bastadin was found to induce a block on the SR leak that
was previously shown to be insensitive to RuR/ryanodine. Adding Bastadin mix alone did not exert
a block on the SR leak which suggests that a component of the SR leak maybe due to the RyR being
in an open configuration (Pessah et a l,  1997), thus releasing calcium from the internal calcium
stores and seen as a linear leak in the calcium uptake preparations. This RyR configuration is
insensitive to RyR blockers and only in the presence of Bastadin can these blockers induce an effect
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on the fraction of the SR calcium leak that remains in the presence of a RuR or a ryanodine block. 
This mechanism is complementary to work carried out by Pessah et aL, (1997), stating that through 
the modulatory actions of Bastadin on FKBP12-RyRl complex, it converts the RuR/ryanodine 
insensitive leak unmasked by thapsigargin into a state that is recognized RuR/ryanodine in order to 
induce a block on the leak. Therefore, it would be interesting to examine whether FKBP12.6 
modulates the effects of Bastadin in cardiac muscle SR.
8.4. Intraluminal Calcium
The calcium concentration within the lumen of the SR plays a vital role in calcium regulation 
(Bassani et a i,  1995; Sitsapesan & Williams, 1994; Lukyanenko et a i ,  1996; Gyorke et aL, 1997; 
Gyorke & Gyorke, 1998). In uptake experiments, oxalate effectively clamps intraluminal calcium 
concentrations to facilitate SR calcium uptake that would otherwise slow the rate of net uptake, as 
crystallization of calcium-oxalate inside the SR does not reach equilibrium at any time during 
calcium uptake (Feher & Briggs, 1980), and will thus continue to buffer intraluminal calcium. In 
this preparation it was noted that lOmM and 20mM oxalate sufficiently clamped luminal calcium in 
this preparation and that 3 calcium challenges were sufficient to load the SR resulting in 
reproducible calcium transients.
Caffeine has been widely used as a pharmacological tool for releasing calcium from 
intracellular stores to study the role of the sarcoplasmic reticulum during excitation contraction 
coupling. In agreement with the literature, high concentrations of caffeine (40mM) deplete the SR 
of calcium and are thus used to assay the SR calcium content. Low concentrations of caffeine (<0.5- 
2mM) have been hypothesised to stimulate SR calcium recycling, thus increasing calcium uptake as 
well as release. In this study it was observed that caffeine mediated calcium release from the SR of 
permeabilised cardiac myocytes occurred in a dose dependent manner and that even in the presence 
of high concentrations of caffeine (up to 20mM) the SR accumulated a significant amount of 
calcium but only in the presence of ATP. At caffeine concentrations above 20mM calcium reuptake 
was observed to be incomplete.
At low intracellular calcium concentration (in the absence of calcium challenges) 40mM
was required to induce a significant release of calcium from the SR, a release that was greater than
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that produced with 20mM caffeine. However, in the presence of activating calcium concentrations, 
as low as 2mM caffeine was observed to induce an SR leak, indicating that the effects of caffeine 
are dependent on calcium concentration and that calcium and caffeine act together to activate the 
RyR under these conditions.
3mM ryanodine and 5|xM RuR have been observed to block caffeine mediated SR leak in 
this preparation and that varying the oxalate concentration had no effect on the ryanodine block of 
the caffeine mediated leak. This indicates that a similar blocking effect occurs independent of the 
intraluminal calcium concentration.
In this study 0.3|xM-30p,M ryanodine induced the release of calcium from the RyR and that 
3mM ryanodine was found to inhibit calcium leak from the SR. This is consistent with ryanodine 
increasing the Po of the RyR at lower concentrations where as 3mM ryanodine induced a Use- 
dependent block of calcium release. The requirement of such high concentrations of ryanodine 
suggest that the sensitivity of RyR for ryanodine was lower than that observed in SR vesicle 
preparations although the results in this study complement the literature with RyR possessing two 
binding sites for ryanodine, a high affinity and a low affinity binding site. However, the sensitivity 
of permeabilised cells to RuR was compatible to that observed in SR vesicles. Further work is 
required to determine whether the RyR activity in this preparation is significantly different to that 
observed in SR vesicles and isolated channel studies.
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Smith, G. L., A. M. D uncan, P. N eary, L. B ruce, and  
F. L. Burton. ?£ inhibits the SR Ca^ "^  pump and stim u­
lates pump-mediated Ca®"^  leak in rabhit cardiac myo­
cytes. Am J  P hysio l H eart C ire P hysio l 279: H 577-H 585, 
2000.—Measurements of sarcoplasmic reticulum (SR) 
uptake were made from aliquots of dissociated per- 
meabilized ventricular myocytes using fura 2. Equilibra­
tion with 10 mM oxalate ensured a reproducible exponen­
tial decline of [Ca^ "**] from 600 nM to a steady state of 
100-200 nM after addition of Ca^ "^ . In the presence of 5 
)xM ruthenium red, which blocks the ryanodine receptor, 
the time course of the decline of [Ca^ "^ ] can be modeled by 
a Ca^^-dependent uptake process and a fixed Ca^ "*" leak. 
Partial inhibition of the Ca^ '*' pump with 1 |xM cyclopia- 
zonic acid or 50 nM thapsigargin reduced the time con­
stant for Ca^^ uptake but did not affect the SR leak. 
Addition of 10 mM inorganic phosphate (Pi) decreased the 
rate of accumulation by the SR and increased the
Ca^^ leak rate. This effect was reversed on addition of 10 
mM phosphocreatine. 10 mM p£ had no effect on Ca^+ leak  
from the SR after complete inhibition of the Ca^ '*' pump. In 
conclusion, Pj decreases the Ca^^ uptake capacity of car­
diac SR via a decrease in pump rate and an increase in 
Ca^ "^  pump-dependent Ca^ '*' leak.
cardiac; heart; sarcoplasmic reticulum; calcium; phosphate; 
calcium-adenosine 5 '-triphosphatase; rabbit; inorganic phos­
phate
INTRACELLULAR INORGANIC PH OSPHATE c o n c e n t r a t i o n  ([PJ)
increases to —10 mM a t the onset of hypoxia or 
ischemia in cardiac muscle (8, 26) and is accompa­
nied by a rapid  fall in contractility. A lthough other 
metabolic changes m ay occur a t th e  sam e tim e (19, 
33), the increased in tracellu la r [PJ is thought to be a 
significant cause of reduced contractility  w ith in  the 
first 1 -2  min. P  ^ acts directly on the  contractile 
proteins to reduce Ca^^-activated force (13, 22). F u r­
therm ore, studies have shown th a t  m illim olar levels 
of Pi reduce the am ount of Ca^^ available for release 
from the  sarcoplasmic reticulum  (SR) of cardiac m us­
cle (37, 42), and these studies suggest th a t  the in ­
hibitory action of Pj on the SR may be an  im portan t
contributor to the rap id  fall in  contractility. Pi may 
inhib it SR function by actions w ithin the SR lum en, 
on SR Ca^^ channels, or SR Ca^^ pumps. Fryer e t al. 
(12) suggest th a t  Pi may inh ib it Ca^"  ^ release from 
skeletal muscle SR by precip itating Ca^"  ^ inside the 
SR lum en. B ut sim ilar experim ents on cardiac m us­
cle failed to find evidence th a t  precipitation lim its SR 
Ca^ "*" release (39). I t  has been shown th a t  p£ directly 
activates the cardiac ryanodine receptor and may 
increase Ca^"  ^ efflux from th e  SR via th is route (23). 
Pi may also activate a Ca^^ efflux pathw ay th a t  is 
independent of the ryanodine receptor (39). D irect 
effects of Pi on the SR Ca '^*' pump to reduce the Ca^^ 
sensitivity of Ca^^ uptake w as suggested by work on 
cardiac SR vesicles (25), b u t th a t  study demon­
stra ted  th a t Pi-induced increase of Ca '^*' uptake was 
also possible. A lternatively, Pi may reduce only the 
m axim um  up take capacity(41). T hat Pi can cause 
reversal of skeletal and cardiac SR Ca^"  ^ pumps has 
been dem onstrated amply in SR vesicle preparations 
(15, 40). U nder these circum stances, Ca^^ efflux via 
the Ca^"  ^ pump is linked to ATP synthesis from ADP 
and Pi. However, although evidence exists to suggest 
th a t  Ca^"'' pump reversal may lim it the maximum 
Ca^^ content of cardiac muscle SR (35), Pi-induced 
pum p reversal has not been dem onstrated directly in 
native SR a t concentrations of Pi, ATP, Mg, and pH 
norm ally observed in the  early stages of hypoxia and 
ischemia.
The purpose of this study was to examine the effects 
of Pi on Ca^+ fluxes across cardiac SR membrane under 
conditions where both Ca^^ precipitation by Pi and 
Ca^"  ^ leak via the ryanodine receptor are prevented. 
The actions of Pj are compared with those of specific 
Ca^^ pump inhibitors and a Ca^^ ionophore (ionomy- 
cin). The results show th a t Pi decreases the SR 
Ca^^ uptake ra te  and activates a Ca^^ leak from the 
SR. Pi-induced Ca "^  ^ leak from the SR was not present 
when the SR Ca "^  ^ pump was inhibited by thapsigargin. 
Possible mechanisms linking Pi-induced Ca^’*' pump in­
hibition to activation of a Ca^^ leak are discussed.
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METHODS
Cell isolation. New Zealand White rabbits (2.5-3.0 kg) 
were given an intravenous injection of 500 U heparin to­
gether with an overdose of pentobarbital sodium (100 mg/kg). 
Isolated hearts were perfused retrogradely (25 ml/min, 37“C) 
with a nominally Ca^'^-lree Krebs-Henseleit solution for 10 
min. This was followed by perfusion for 10-17 min with 
recirculated Krebs-Henseleit solution supplemented with 0.6 
mg/ml collagenase (type 1, Worthin^on Chemical), 0.1 
mg/ml protease (type XIV, Sigma), and 80 |xM CaClg. The left 
ventricular free wall was isolated and incubated separately 
for 5 min in enzyme solution containing 80 p,M CaCla and 4% 
bovine serum albumin (BSA, fraction V, Sigma). The cell 
suspensions obtained at the end of the incubation period 
were filtered into Krebs-Henseleit solution without added 
Ca'^ "'". This procedure routinely produced a 80-90% yield of 
rod-shaped myocytes. Myocyte concentration was deter­
mined by use of a hemacytometer. Cells were lightly centri­
fuged (2 g  for 1 min), and the supernatant was replaced with 
a mock intracellular solution. This procedure was repeated 
three times, and the cells were resuspended in a mock intra­
cellular solution to give a final concentration of 5 X  10® 
cells/ml.
Cell perm eabilization and fluorescence measurements. A 
0.3-ml aliquot of cell suspension was exposed to 0.1 mg/ml 
P-escin (Sigma) and gently stirred for 1 min. The p-escin was 
removed by centrifuging and resuspending the cells in mock 
intracellular solution. The cells were then placed in a cu­
vette, and further solutions were added to give a final volume 
of 1.5 mM containing 5 mM ATP, the mitochondrial inhibi­
tors carbonyl cyanide (20 |ulM) and oligomycin (20 fxM, Cal- 
biochem), 10 mM oxalate (Sigma), 5 p,M ruthenium red 
(Sigma), and 10 p,M fura 2 (Molecular Probes). Cells were 
maintained in suspension by gentle stirring, and the fura 2 
fluorescence within the cuvette was recorded at 30 Hz with a 
spinning wheel spectrophotometer (Cairn Research). All ex­
periments were done at room temperature (20~22°C).
Solution composition and calibration o f  fura 2 fluorescence 
signal. A mock intracellular solution was used to mimic the 
intracellular environment. It had the following composition 
(in mM): 130 K+, 10 Na+, 1 Mg^+, 25 HEPES, 140 Cl", and 
0.05 EGTA; pH 7.0. Solutions to measure the maximum and 
minimum fluorescence ratios (Rmax and R^;,i) and the affinity 
constant of fura 2 contained 10 mM EGTA, 5 mM ATP, 5 jxM 
ruthenium red, and permeabilized cells (at a concentration of 
1 X 10® cells/ml). The presence of cells at this concentration 
did not affect these values. The equilibrium concentrations of 
metal ions in the calibration solutions were calculated by 
means of a computer program with the affinity constants for 
H+, Ca^"-, and Mg^+ for EGTA (taken from Ref. 36). The 
affinity constants used for ATP and creatine phosphate (CrP) 
were those quoted by Fabiato and Fabiato (9). Corrections for 
ionic strength, details of pH measurement, allowance for 
EGTA purity, and the principles of the calculations are de­
tailed elsewhere (30). Free Mg^ "^  concentration was 0.9-l.G  
mM in all solutions. Under the conditions used in this study, 
the apparent affinity constant of fura 2 for Ca^ '*' was 110 ± 
20 nM, and the buffer value (p) was 14.0 ± 0.1, values close 
to that measured by Grynkiewicz et al. (14) and as noted by 
Kargacin et al. (21). As described above, ruthenium red was 
used to block Ca^  ^ leak via the ryanodine receptor, and 
initial experiments determined that the block achieved with 
5 |xM was complete, and higher concentrations (20 p,M) 
provided no further block. However, the 20 jxM concentration 
was not used in this study, because previous work suggested 
that at this concentration, ruthenium red reduced cardiac SR
Ca^ '*’ pump activity (2, 11, 20). Furthermore, ruthenium red 
quenches the fluorescence signal from fura 2 (20). However, 
at 5 |xM ruthenium red, the quench appeared to affect the 
fluorescence at both excitation wavelengths equally, with no 
effect on the values of the dissociation constant and p. 
Ca^ **' uptake measurements were made by resuspending the 
cells in a solution of the following composition (in mM): 120 
KCl, 5 NagATP, 5.4 MgCl^, 25 HEPES, 0.05 K^EGTA, 0.02 
carbonyl cyanide m-clorophenylhydrazone, 0.02 oligomycin, 
10 Kg-oxalate, 0.005 ruthenium red, and 0.01 fura 2; pH 7.0. 
Addition of 10 mM P^  was accompanied by 0.25 mM MgClg. 
The added Mg ensured that free Mg^ '^ ' levels remained be­
tween 0,9 and 1.0 mM in the mock intracellular solution.
D ata recording and analysis. The fluorescence ratio signal 
and the individual 340- and 380-nm wavelength signals were 
low-pass filtered (—3dB at 30 Hz) and digitized at 10 Hz for 
later analysis. Sections of the trace were converted to plots of 
[Ca^U against time. Fitting of [Ca^ "'"] decay curves to Eq. 3 
(Fig. 1C) and linear increases were performed with Origin 
(Version 5.0, Microcal). SR uptake rate constant (k) and leak 
rate (/) are expressed with the asymptotic standard error- 
computed error of the parameter (a measure of the uncer­
tainty of the parameter estimate). Where appropriate, curve 
fits were compared using an F-test, based on the sum-of- 
squares (SSQ) difference between the fitted curve and data 
values. Changes in k and I are calculated relative to the 
preceding control value. Changes in these parameters are 
expressed as means ± SE. (-Tests were used to compare the 
relative changes; P  <  0.05 was considered statistically sig­
nificant.
RESULTS
uptake and release from oxalate-equilibrated 
permeabilized cardiac myocytes. Figure lA shows a 
typical trace of [Ca '^ '^l recorded from a cell suspension. 
Addition of an aliquot of CaClg (10 p,l of 10 mM) 
increases the total [Ca '^*'] w ithin the cuvette by 67 |xM 
and causes a rapid increase of the free [Ca^^l to ~0.8 
p,M. Over the next 10 min, the (Ca^^l decayed to below 
100 nM. This procedure could be repeated up to five 
times before changes in the time course of the decay 
became detectable. Addition of thapsigargin (20 fcM) 
caused an increase in the [Ca^’*'] within the cuvette, 
representing Ca^^ leak from the SR in the absence of 
an active Ca '^*' uptake process. The rise of [Ca '^*'] after 
thapsigargin was approximately linear below 600 nM; 
above this value, the ra te  of leak decreased. On further 
addition of Ca^^, there was no evidence for SR Ca^^ 
uptake (results not shown). High concentrations of 
thapsigargin (20 (jlM )  were used to ensure effective 
inhibition of Ca '^*' pump activity. This thapsigargin 
concentration was equivalent to 20 nmol/mg total cell 
protein. Previous work (17) has shown complete pump 
inhibition a t 1 -1 0  nM/mg total protein. A higher con­
centration of thapsigargin (50 |xM) produced no further 
increase in the rate of Ca '^*' leak from the SR (not 
shown). In all cases, the rise of [Ca "^ ]^ after high 
concentrations of thapsigargin (>1 |xM; n = 11) and 
cyclopiazonic acid (CPA) (>100 p,M; n = 4) was initially 
linear up to 650-700 nM. At 600 nM, the [Ca '^"'] was 
still within the standard  error of the best-fit linear 
relationship in all 11 experiments. This remained the 
case in 9 of the 11 experiments a t 650 nM and in 5 of
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Fig. 1. A: records of [Ca^  ^] against time recorded from a cuvette 
containing 1.5 ml 1 X 10®/ml permeabilized myocytes suspended in 
mock intracellular solution by continuous stirring equilibrated with 
10 mM oxalate. Additions of aliquots of CaCla are indicated above the 
trace as increases in total [Ca®'*'] within the cuvette, Thapsigargin 
(20 (j-M) was added at the point indicated. B: the record of [Ca®'*'] 
from a section of the trace shown in (A). The broken line through the 
decay phase indicates the best-fit single exponential curve to the 
record from 600 nM to the steady state. The broken line through the 
trace after addition of thapsigargin represents the best-fit straight 
line to the record £600 nM. Values of rate constant and calculated 
and measured leak rate are shown on the record. C: a simplified 
model of the sarcoplasmic reticulum (SR) with Ca^ "'' pump and Ca®"*^  
leak indicated. Ca'^  ^ chelation/precipitation within the SR lumen is 
also indicated (CaOx). Below the diagram are equations describing 
the role of Ga^+ leak and uptake in determining the rate of change of 
cytosolic [Ca® '■] (Eg. 1) and the time course of change in [Ca® ]^ from 
a starting [Ca®+] (Ca[Q]). [88], 8teady state; t, time.
the 11 experiments a t 700 nM. For this reason, 600 nM 
was taken as the maximum [Ca '^*‘] for the subsequent 
pump leak modeling.
A section of the record in Fig. lA  is expanded in Fig. 
IB to illustrate the time course of the decay of [Ca^’*'] 
and the increase of [Ca^"''] on addition of thapsigargin. 
The broken line shown passing through the decay of 
[Ca "^ ]^ is the best-fit single exponential decay with a
ra te  constant of 9.9 ± 0.06 m/s (see figure legend) and 
a steady-state [Ca^’^ l of 105 nM. The addition of thap­
sigargin caused an immediate increase in [Ca^'''] 
within the cuvette with an  approximately linear time 
course (100-600 nM) a t a ra te  of 0.56 nM/s. Figure 1C 
shows a schematic of the uptake and release
pathways in a simplified model of cardiac SR, where 
the ra te of Ca^^ uptake by the SR is determined by the 
cytosolic ICa^^l alone (k X [Ca^"'']). The leak of Ca "^  ^
from the SR (in the absence of ryanodine receptor 
activity) is expressed as a constant value (/). Therefore, 
a t any time, the ra te  of change of [Ca^^] outside the SR 
(dCa/d() is determined by the relative rates of these 
two processes (Eq. 1). In the steady state, i.e., when 
dCa/d( = 0, the leak and uptake rates are equal (Eq. 2). 
Integrating Eq. 1 generates an  expression th a t de­
scribes the variation of [Ca^‘^1 with time (Eq. 3). Fitting 
the time course of the decay of [Ca^"'‘] below 600 nM 
with Eq. 3, the values for SR Ca^ "'" uptake rate constant 
(k) and linear leak ra te  (I) can be calculated. The 
calculated leak rate (0.57 nM/s) was close to the values 
m easured after addition of thapsigargin (0.56 nM/s). 
These m easurem ents suggest th a t below 600 nM, the 
characteristics of Ca^ "*" uptake and release by cardiac 
SR is accurately modeled by the simplified model of SR 
Ga '^*' fluxes shown in Fig. 1C. In this study, the aver­
age calculated background leak ra te  varied between 
0.5 and 1.5 nM/s (mean 1.03 ± 0.09 nM/s, n = 15). Despite this interexperim ent variation, the leak rate- 
m easured thapsigargin was not significantly different 
from the calculated values (103 ± 2%, n = 7). The 
reason for the variation in background leak is un­
known, but factors such as percentage of rod-shaped 
cells w ithin the aggregate preparation may be impor­
tant. These m easurem ents also strongly suggest that, 
under control conditions, there is no significant SR- 
dependent Ca^’^  leak from the SR.
Pharmacological alterations o f SR  Ca^'^ uptake and 
leak characteristics. Figure 2 shows the effects of par­
tial inhibition of the pump on the calculated uptake 
and leak ra te  constants. Figure 2A shows two Ca^^ 
uptake curves superimposed, one before ^control) and 
one after addition of a submaximal dose of thapsigar­
gin (50 nM), a value th a t would be expected to approx­
imately halve the ra te  of Ca '^'" uptake by the SR Ca^^ 
pump (17). The ra te of fall of [Ca^^] was slower, and 
the steady state [Ca^ "*"] higher, in the presence of thap­
sigargin. F itting this individual decay to Eq. 3 (Fig. 1C) 
indicates th a t the ra te constant for Ca^^ uptake was 
approximately one-half of the control value. However, 
the calculated leak ra te  constant was not significantly 
different from control. Figure 2J5 shows curves and 
fitted model param eters to the decay of [Ca '^*'] before 
and after adding 1 juuM CPA. As with thapsigargin, 
partial inhibition of the pump reduced the Ca^^ uptake 
ra te  constant by ~50% but caused no significant 
change in the leak rate. Figure 2C shows the effects of 
addition of the Ca^^ ionophore ionomycin (1 jxM). The 
best-fit Ca^^ uptake ra te  constant was not altered, but 
the higher steady-state [Ca^ *^ ] was modeled by an 
increased leak rate. These results are consistent with
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Fig. 2. Effects of thapsigargin (A), cyclopiazonic acid (B), and iono- 
mycin (C) on the time course of decay of [Ca® l^ in oxalate-equili­
brated permeabilized cardiac myocytes. In each panel, the broken 
lines indicate the best fit to Eq. 3 (Fig. 1C) with a starting [Ca®+] 
(Ca[OJ) of 600 nM. The uptake rate (k) and leak (I) associated with 
each curve are shown.
the simplified model for uptake and release pro­
posed in this study and indicate th a t  SR Ca^"’" uptake is 
normally independent of Ca '^*' leak.
Effects o f Pi on uptake and leak rate constants. 
Figure 3A shows a continuous record of [Ca^’’’] from 
permeabilized cell aggregates during repetitive addi­
tions of Ca^^. The addition of 10 mM Pj to the cuvette 
solution caused a small increase in steady-state [Ca^^]. 
On subsequent addition of Ca^^, the ra te  of decay was 
slower, and the steady-state [Ca^'’'] was increased. 
Addition of 10 mM CrP caused a fall in the steady-state 
[Ca^ "*"], and upon subsequent addition of Ca^’’’, the rate 
of Ca^^ uptake and the steady-state [Ca '^ '^] were re­
stored to values close to the control values. In  Fig, 3B,
left, the Ca^’’’ decay curves before and after addition of 
Pi are superimposed. After addition of Pi, a decrease in 
the Ca^^ uptake ra te  constant and an increase in the 
leak are required to provide an  accurate fit to the Ca^^ 
decay. The sensitivity of the decay curve to the fitted 
param eters is shown in Fig. 3B, right. The trace is the 
recorded time course of uptake in 10 mM Pi. The 
curve lying mainly above the trace is the best fit gen­
erated with the Ca '^*' uptake ra te  fixed a t the control 
value (i.e., only the leak ra te  was allowed to vary). The 
curve lying mainly below the trace is the best fit gen­
erated w ith the leak ra te  fixed a t the control value (i.e., 
only the Ca^'’' uptake ra te  was allowed to vary). Com­
parison of SSQ from these curves with th a t from the 
more complex model in which both uptake ra te  and 
leak were allowed to vary (Fig. 3B, left) indicated th a t 
the more complex model fit the data significantly better 
(P < 0.001). This suggests th a t both increased leak and 
uptake rates are necessary to explain the effects of 10 
mM Pi. Experiments were done to examine the effects 
of 1 mM Pi. No significant effect of this lower concen­
tration of Pi on either uptake ra te  or leak was observed; 
the mean values of these m easurem ents are shown 
below.
Figure 3C shows the three uptake curves superim­
posed to illustrate the time course of Ca^^ uptake after 
addition of 10 mM CrP. The ra te  of Ca^’’" uptake is 
greater and the steady-state [Ca^" ]^ is lower than  con­
trol and 10 mM Pi record. Furtherm ore, in the presence 
of CrP, the decay of [Ca '^*‘] had more than  one expo­
nential component and was poorly fitted by a single 
exponential decay. Despite the poor fit, a similar leak- 
uptake analysis was performed in the presence of CrP, 
On average, the ra te  constant for uptake increased to 
124 ± 2% {n ~ 6) and the steady-state [Ca '^*'] decreased 
to 89 ± 5% of control values on addition of 10 mM CrP, 
but calculated leak was unchanged (102 ± 0.4%).
Figure 4 shows the averaged relative change in  up­
take ra te  constant and leak ra te  after addition of CPA, 
thapsigargin, ionomycin, and Pi (1 and 10 mM). CPA 
and thapsigargin reduced the uptake ra te  constant to 
~60% (Fig. 4A). N either agent altered the leak signif­
icantly, although a small decrease was observed in 
both cases (Fig. 4B). The uptake rate constant was 
unaffected by ionomycin, but the leak ra te  was in­
creased to —130% of control values. As described 
above, 1 mM Pi had no significant effect on uptake or 
leak rate. 10 mM Pi caused a significant decrease in the 
uptake ra te constant to 79 ± 1.2% (P <  0.05) and 
increased the leak ra te  to 117 ± 0.6% of control levels 
(P <  0.05).
Pi does not affect the rate o f Ca^'^ uptake in the 
presence o f CrP. Figure 3, A and C, show th a t addition 
of CrP (10 mM) effectively reversed the effects of Pi on 
the SR. Another im portant aspect of this effect is 
shown in Fig. 5. Addition of 10 mM to the medium (in 
the absence of P,) caused a significant increase in the 
ra te  constant and a decrease in steady-state [Ca^’’'], 
i.e., the effect of CrP was not dependent on the pres­
ence of 10 mM Pi. Of direct relevance to this study was 
the subsequent lack of effect of Pi on the ra te  of decay
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Fig. 3. A: records of [Ca®’*'] against time recorded from 
a cuvette containing 1.5 ml 1 X 10®/ml permeabilized 
myocytes suspended in mock intracellular solution 
(with 10 mM oxalate). Additions of aliquots ofCaClg are 
indicated above the trace as increases in total [Ca® ' ] 
within the cuvette. Pj (10 mM) and creatine phosphate 
(CrP, 10 mM) were added at the points indicated. B, 
left, shows the superimposed records of the decay of 
[Ca® ]^ from 600 nM. The broken line through each 
Ca® ' decay indicates the best-fit single exponential 
curve; the associated parameters of uptake rate and 
leak are shown beside each curve. Sum-of-squares 
(SSQ) values for the fit were the following: control, 
4.20 X 10“ '^^ ; 10 mM Pj, 5.12 X 10“ ®^. B, right, shows 
the decay of [Ca® ]^ recorded in the presence of 10 mM 
Pi. The two broken lines represent 1) a best-fit curve 
calculated by fixing the Ca® ' uptake rate at the control 
value (7.3 m/s) and allowing the leak rate to be adjusted 
(SSQ = 3.2 X 10“ and 2) a best-fit curve calculated 
by fixing the leak rate at the control value (1.24 nM/s) 
and allowing the Ca®' uptake rate to be adjusted 
(SSQ = 5.6 X 10“ ^^ ). C: superimposed records of the 
decay of [Ca® ' ] from 600 nM for the control (o), 10 mM 
Pj (•), and 10 mM P/10 mM CrP (□). The broken line is 
the best-fit curve to the latter curve; the uptake and 
leak rates are indicated.
of in the continued presence of CrP. This is
highlighted in Fig. 5B, where the decay curves before 
and after are superimposable. Thus Pj had no dis­
cernible effects on SR Ca^^ fluxes in the presence of 
CrP.
Sensitivity o f Pi~induced S R  leak to thapsigar­
gin. To test whether 10 mM Pj could increase the SR 
leak rate after Ca^^ pump inhibition, the effect of P  ^
was studied in the presence of a high concentration of 
thapsigargin. As shown in Fig, 6iA, 10 mM P, had no 
obvious effect on the background SR Ca^^ leak rate 
revealed by the addition of 20 p,M thapsigargin. The 
best-fit straight lines through the record before and 
after addition of P  ^have gradients th a t are not differ­
ent. Addition of 1 |xM ionomycin significantly increased 
the ra te  of loss of Ca^^ from the SR. On average, the 
background leak of Ca^^ in 10 mM P; was 101 ± 1.4% 
in = 4) of the control value in  the presence of 20 fxM 
th ^ s ig a rg in . This suggests th a t 10 mM P  ^ induces a 
Ca leak from the SR th a t is dependent on a func­
tional Ca^^ pump. I t  follows that, in the continued 
presence of Pi, the SR pump serves as a route for Ca^^ 
leak and uptake; therefore, submaximal doses of thap­
sigargin should reduce leak and uptake ra tes (assum­
ing the drug has equal ability to inhibit the SR Ca^'^ 
pump in leak and uptake mode). To te s t this hypothe­
sis, Ca^^ uptake and leak were assessed before and 
after partial pump inhibition by thapsigargin (50 nM)
in the continued presence of 10 mM Pi (Pig. 6B). Under 
these circumstances, 50 nM thapsigargin slowed the 
ra te  of Ca '^*' uptake by the SR, but unlike in Fig. 2A, 
there was only a lim ited increase in steady-state 
[Ca^’’]. According to the model, 50 nM thapsigargin 
significantly decreased the ra te  of Ca^’’’ uptake and 
decreased the leak rate . On average, 50 nM thapsigar­
gin did not change the steady-state [Ca^’*‘] (103 ± 3%; 
n = 6), but it reduced the Ca uptake ra te  constant to 
68 ± 4% of the control value and leak rate to 72 ± 3% 
in = 6) in the presence of 10 mM Pi.
D IS C U S S I O N
Quantification ofCa^'^ uptake and leak pathways in 
permeabilized cardiac myocytes. The experiments de­
scribed in this study were designed to investigate the 
direct effects of Pi on SR Ca^^ pump function. For this 
reason, the experimental conditions were arranged to 
minimize any indirect effects th a t would complicate 
analysis. Modulation of SR pump activity via low- 
affinity Ca '^*' binding sites w ithin the SR has been 
previously dem onstrated in SR vesicles from cardiac 
and skeletal muscle (18). Pi is known to enter the SR 
and, under some conditions, chelate and/or precipitate 
luminal Ca '^*', and in doing so, it may indirectly affect 
Ca^^ pump activity. To prevent this, these experi­
ments were done in  the presence of 10 mM oxalate.
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Inhibition of the SR pump by high concentra­
tions of thapsigargin caused a gradual increase in 
[Ca^^] within the cuvette, representing a background 
Ca^"'' leak from the SR. When [Ca '^*'] was below 600 
nM, the increase in [Ca^" ]^ had an  approximately linear 
time course, suggesting th a t luminal [Ca^^] is consid­
erably higher than  the cytosolic values. Equilibration 
of the permeabilized myocytes with oxalate ensures a 
constant luminal [Ca^^] determined by the solubility 
product of calcium oxalate (5, 27). Based on this, one 
would predict th a t the lum inal [Ca^^l would be unable 
to increase above ~10 |xM in  the presence of 10 mM 
oxalate. The nature of the background Ca '^*' leak from 
cardiac SR is unknown, but previous measurements 
suggest th a t the leak depends simply on the trans-SR 
[Ca^+l gradient [reviewed in  (10)]. Assuming th a t ox­
alate-equilibrated SR would act as a reservoir for Ga'^ "*", 
a constant background leak would generate a rise of 
[Ca^^l th a t approached the SR luminal [Ca^" ]^ asymp­
totically. Over a sufficiently limited range of [Ca^+l 
(between 100 and 600 nM), this Ca^"  ^leaks from the SR 
a t a ra te  of ~1  nM/s (per 10® cells). This ra te  reflects a 
resting permeability of the SR (with a luminal 
[Ca^^l of —10 p.M). This leak is not limited by the 
dissociation of from oxalate, because increasing 
the Ca^^ permeability of the SR (with ionomycin) 
markedly increases the ra te  of Ca^"  ^ leak.
Fig, 4. Relative change in uptake rate (A) and leak rate (JB) in 10 pM 
cyclopiazonic acid (CPA), 50 nM thapsigargin (Thaps), 10 p,M iono­
mycin (lono), and 1 mM and 10 mM Pj. Values are expressed as 
means ± SE. *Significant difference from control (P <  0.05; n = 6); 
ns, no significant difference.
Previous studies (e.g., Ref. 5) have shown th a t in  the 
presence of both oxalate and Pi, only Ca-oxalate pre­
cipitates are formed when the ratio of [oxalate] to [PJ is 
<2. Ruthenium red (5 |xM) ensures th a t Ca^"'' leak via 
the ryanodine receptor was inhibited (11, 28, 29). Un­
der these conditions, the steady-state [Ca^^] in this 
system (1.0 X 10® cells/ml) was normally between 100 
and 150 nM, a value th a t represents a balance between 
a background Ca^"  ^ leak from the SR and a  m aintained 
Ca^^ uptake. Addition of aliquots of Ca^^ caused an 
initial increase in  [Ca '^*'], which decreased over the 
subsequent 5-10 min to the same steady state. The 
time course of the decrease in [Ca^ "*"] from 600 nM to 
the steady state followed a  single exponential decay, 
suggesting th a t over this range of [Ca 1 (between 600 
and 100 nM), the ra te  of Ca^^ uptake is a  function of 
[Ca^^]. This is a simplification of the Ca^'^ dependence 
of SR Ca^ "*" uptake anticipated on the basis of the 
known stoichiometry and affinity of the pump for Ga^ "*" 
in permeabilized rabbit myocytes [2 Ga^+ w ith an af­
finity of —0.3 (xM (17, 21)]. The alteration in time 
course of Ga^^ uptake by CrP suggests th a t this me­
tabolite may alter the affinity and/or the stoichiometry 
of the SR Ga^^ pump and is discussed in more detail 
below.
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Fig. 5. A: records of [Ca“ ' ] against time recorded from a cuvette 
containing 1.5 ml 1 X 10^/ml permeabilized myocytes suspended in 
mock intracellular solution (with 10 mM oxalate). Additions of ali­
quots of CaClg are indicated above the trace as increases in total 
[Ca“ ]^ within the cuvette. CrP (10 mM) and P; (10 mM) were added 
at the points indicated. JB: the superimposed records of the decay of 
[Ca^ '*'] from 600 nM.
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Fig. 6. A: records of [Ca  ^' ] against time recorded from a cuvette 
containing 1.5 ml 1 X 10®/ml permeabilized myocytes suspended 
in mock intracellular solution (with 10 mM oxalate), Bars indicate 
when 20 pM thapsigargin, 10 mM ?i, and 1 pM ionomycin were 
added at the points indicated. The broken lines are the best-fit 
linear regression lines to the last 120 s before and the first 120 s 
after addition of Pi. B\ top, records of [Ca’^ *■) against time recorded 
from a cuvette containing 1.5 ml 1 X 10°/ml permeabilized myo­
cytes suspended in mock intracellular solution (with 10 mM ox­
alate) in the continuous presence of 10 mM Pj. Additions of 
aliquots of CaClg are indicated above the trace as increases in 
total [Ca^ '*'l within the cuvette. Thapsigargin (50 nM and 20 pM) 
was added at the points indicated. Bottom, the superimposed 
records of the decay of [Ca®'*'] from 600 nM in 5 mM ATP/10 mM 
P, and after addition of 50 nM thapsigargin. The broken lines are 
the best-fit curves to the individual decays with the associated 
uptake and leak rates.
Limitations o f the method o f analysis o f SR  Ca^'^ 
flux. The model of the SR, expressed as equations in 
Fig. 1C, suggests th a t knowledge of the ra te  constant 
for Ca^^ uptake and the steady-state [Ca^^l is suffi­
cient to estim ate the Ca^^ leak rate. I t  should be 
emphasized th a t this method of analysis is valid only 
for the experimental conditions used in this study. The 
range of [Ca '^^] studied m ust be in the range (between 
200 and 600 nM) in which SR Ca '^*' uptake is linear for 
forward transport via the SR Ca^^ pump. F urther­
more, the [Ca ] w ithin the SR lumen m ust be con­
stant; this ensures th a t the activity of the SR Ca^^ 
pump is not modulated by changes in [Ca^^] within the 
SR lumen. In addition to this, a constant SR [Ca^ "*"] will 
ensure a constant passive leak, thus simplifying this 
aspect of the analysis. One further simplification in­
herent in this model is the neglect of Ca^^ buffering by 
the cells and constituents of the bathing solution. The 
Ca '^*' binding properties of permeabilized cardiac myo­
cytes have been studied in detail (16). These m easure­
m ents suggest th a t the presence of myocytes (10®/ml) 
would bind -0 .1  pM Ca^+ a t 600 nM [Ca^+l. EOTA (50 
|xM) and fura 2 (10 |xM) provide additional buffering 
w ith minor contributions from ATP and oxalate. Under 
the conditions of this study, these buffers would pro­
vide an approximately constant Ca^^ buffer within the 
range between 100 and 600 nM. In term s of the calcu­
lation of Ca^^ fluxes, buffering would have an identical 
scaling effect on both uptake and leak pathways and 
can therefore be ignored for the current purposes.
Pharmacological alterations o f SR  Ca '^*' uptake and 
leak characteristics. The validity of this model was 
tested by selective inhibition of the Ca^^ pump with 
CPA and thaspigargin. Both agents are specific inhib­
itors of sarco(endo)plasmic reticulum Ca^+ pumps in 
muscle and nonmuscle cells (4, 34). At submaximal 
concentrations, these agents reduced the rate constant 
of Ca^^' uptake by the SR (17). Using the uptake-leak 
analysis shown in Fig. 1C, the calculated leak after 
partial inhibition of the pump was not significantly 
different from control values. This suggests that, in the 
absence of Pi, background Ca '^*’ leak was unaffected by 
an —50% reduction of Ca^^ pump activity. Increased 
leak by addition of ionomycin increased the 
steady-state [Ca^" ]^ b u t did not affect the rate constant 
for decay. This further validates the simple model of 
the SR described quantitatively in Fig, 1C and indi­
cates th a t changes in SR Ca^^ efflux th a t are indepen­
dent of the Ca^+ pump do not affect the SR Ca^^ 
uptake ra te  constant. Moreover, the results from Figs. 
1 and 2 indicate that, under control conditions, Ca^+ 
leak from the SR is independent of SR Ca^ "*" pump 
activity, consistent w ith the absence of significant 
pump-mediated Ca^^ leak in the absence of P .^Effects o f Pi on uptake and leak rate constants. 
Previous studies using permeabilized cardiac muscle 
have m easured Ca^"  ^ release on application of caffeine 
(37-39, 42). Results of these experiments are difficult 
to in terpret in term s of actions on the SR, because 
chelation and/or precipitation of calcium phosphate 
within the SR and effects of Pj on the ryanodine recep­
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tor cannot be excluded. However, these studies clearly 
showed th a t 10 mM Pj reduced the Ca^"  ^ released by 
caffeine to —60% of the control value. This action was 
accompanied by a transien t release of Ca^^ from the 
SR (37, 38). The transien t release was not blocked by 
ryanodine (39), suggesting th a t a release pathway 
other than the active ryanodine receptor was involved. 
However, a link between a functional Ca^^ pump and 
Pi-induced Ca^^ release was not established.
In the present study, addition of 10 mM P  ^had two 
effects on cardiac SR: 1) it reduced the ra te  constant for 
Ca^^ uptake; and 2) it  increased the ra te  of Ca^^ leak 
from the SR (Fig. 3). That Pi-induced increase in Ca '^*’ 
efflux from the SR is m ediated by the Ca^^ pump is 
supported by the following. D  On inhibition of the Ca^^ 
pump, Pi caused no significant increase in SR leak rate 
(Fig. 6A). 2) In the continued presence of 10 mM P,, 
when pump-mediated Ca^"  ^ leak exists, low concentra­
tions of thapsigargin reduced Ga^^ leak from the SR 
and decreased the ra te  of Ca^^ uptake (Fig. 5B).
The effect o f CrP on SR  Caf'^ uptake. The effect of Pi 
could be reversed by the addition of 10 mM CrP (Fig. 
3C). Furthermore, in the continued presence of CrP, 10 
mM Pi had no significant effects on either flux process 
(Fig. 4). A sim ilar dependence on CrP was described 
previously (38). This effect was attributed to the ability 
of CrP to rephosphorylate ADP via the enzyme creatine 
phosphokinase (CK), because inhibition of CK abol­
ished the effect of CrP (38). There is good evidence th a t 
an SR-bound CK exists spatially close to the Ca^"  ^
pump ATPase and preferentially rephosphorylates the 
ADP produced by the Ca^"  ^ pump (82). These results 
suggest that, the ability of Pj to affect the SR Ca^^ 
pumps requires high concentrations of ADP. The re­
sults from this study also support the view th a t CrP 
can significantly increase the Ca^^ uptake ra te  of the 
SR and may have significant effects on the Ca^^ affin­
ity and/or stoichiometry of the pump (6, 24). In  this 
study, background SR Ca^^ leak (in the absence of Pj) 
was unaffected by CrP, suggesting that, under control 
conditions, there was no pump-mediated leak from 
the SR.Potential mechanism(s) o f action o f Pi on the SR  Ca '^*' 
pump. There are two mechanisms by which P^  may 
induce a Ca^ *  ^ pump-mediated SR Ca '^*' leak, "pump 
reversal” and “pump-channel transition.” It has been 
shown that, in SR vesicle preparations, millimolar lev­
els of Pi can phosphorylate the SR Ca^^ pump directly 
(31). In the presence of ADP, this form of the pump can 
generate a Ca '^*' efflux from the SR accompanied by the 
synthesis of ATP, i.e., pump reversal (15). In the 
present study, in the absence of CrP, ADP concentra­
tion within the cuvette would be expected to continu­
ously increase during the experiment because of the 
cellular ATPases associated w ith permeabilized myo­
cytes. Separate m easurem ents of the cellular ATPase 
ra te  suggest th a t 1 X 10® cells/ml lower the ATP 
concentration a t —10 nM/s (A. Pagliocca and G. L. 
Smith, unpublished observation). This gives a pre­
dicted concentration range of ADP from —60 to 120 pM 
a t the time of Pi addition. These values are sim ilar to
the intracellular values m easured during hypoxia and 
ischemia in cardiac muscle (1, 33) and are close to 
optimal for pump reversal (3). However, it is unclear 
from previous studies w hether pump reversal occurs to 
a significant extent in the presence of millimolar con­
centrations of cytosolic ATP. Cytosolic ATP can also 
phosphorylate the SR Ca^^ pump as part of the normal 
sequence of events in  Ca^"  ^transport. Pump reversal in 
the presence of ATP may be possible if the concentra­
tion of the phosphorylated interm ediate of the pump 
increases above the level normally achieved by ATP. 
The ability of P  ^to induce SR Ca^^ leak and decrease 
the uptake ra te  constant of the pump may be linked. 
While operating in the reverse mode, the pump would 
be unavailable for Ca^ "*" uptake, thereby reducing the 
num ber of active Ca '^*' pumps. This could account for 
the decrease in the uptake ra te  constant. As mentioned 
earlier, the absence of CrP and increased levels of ADP 
may also alter the stoichiometry and Ca^^ affinity of 
the fraction of pumps operating in the normal mode 
(18). This effect could not be distinguished from a 
reduced maximal ra te  of pumping in these studies.
Alternatively, some studies suggest th a t under cer­
tain  conditions, the SR Ca^^ pump can mediate a fast 
efflux of Ca^^ from the SR in an "uncoupled” or sub­
strate-free state (7). U nder these conditions, the SR 
Ca^^ pump acts as a channel and can mediate Ca^^ 
leak from the SR. I t  is unlikely th a t this is the mech­
anism for Pi-induced Ca^^ leak. This mode of the SR 
Ca^^ pump is seen only in substrate-free conditions or 
in the presence of agents th a t inhibit substrate binding 
(e.g., arsenate). Furtherm ore, Pj concentrations below 
4 mM appear to block the uncoupled mode of the Ca '^*' 
pump (7).In summary, the results presented in this study 
suggest that, in the presence of 10 mM P{ and in the 
absence of CrP, a significant Ca '^*' efflux from the SR 
occurs via the pump in cardiac muscle. The char­
acteristics of the CaL ^ efflux suggest th a t it is caused 
by reversal of the SR Ca^'^ pump.
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Overexpression of FK506-Binding Protein FKBP12.6 in Cardiomyocytes Reduces Ryanodine Receptor-Mediated Ca®'*' Leak From the Sarcoplasmic Reticulum and Increases Contractility
Jürgen Prestle, Paul M.L. Janssen, Anita P. Janssen, Oliver Zeitz, Stephan E. Lehnart, Lorraine Bruce,
Godfrey L. Smith, Gerd Hasenfuss
Abstract—The FK506-binding protein FKBP12.6 is tightly associated with the cardiac sarcoplasmic reticulum (SR) 
Ca®^-release channel (ryanodine receptor type 2 [RyR2]), but the physiological function of FKBP12.6 is unclear. We 
used adenovirus (Ad)-mediated gene transfer to overexpress FKBP12.6 in adult rabbit cardiomyocytes. Western 
immunoblot and reverse transcriptase-polymerase chain reaction analysis revealed specific overexpression of 
FKBP12.6, with unchanged expression of endogenous FKBP12. FKBP12.6-transfected myocytes displayed a signifi­
cantly higher (21%) fractional shortening (FS) at 48 hours after transfection compared with Ad-GFP-infected control 
cells (4.8±0.2%  FS versus 4±0.2%  FS, respectively; n=79  each; f =0.001). SR-Ca®^ uptake rates were monitored in 
j3-escin-permeabilized myocytes using Fura-2. Ad-FKBP12.6-infected cells showed a statistically significant higher 
rate of Ca®  ^ uptake of 0.8±0.09 nmol/s“VlO® cells (n=8, P<0.05) compared with 0.52±0.1 nmol/s“ VlO® cells in 
sham-infected cells (n=8) at a [Ca® ]^ o f 1 jumol/L. In the presence of 5 /xmol/L ruthenium red to block Ca®  ^efflux via 
RyR2, SR-Ca®^ uptake rates were not significantly different between groups. From these measurements, we calculate 
that SR-Ca®^ leak through RyR2 is reduced by 53% in FKBP 12.6-overexpressing cells. Caffeine-induced contractures 
were significantly larger in Ad-FKBP 12.6 -infected myocytes compared with Ad-GFP-infected control cells, indicating 
a higher SR-Ca®^ load. Taken together, these data suggest that FKBP 12.6 stabilizes the closed conformation state of 
RyR2. This may reduce diastolic SR-Ca®^ leak and consequently increase SR-Ca®^ release and myocyte shortening. 
(Circ Res. 2001;88:188-194.)
Key W ords; cardiac myocytes ■ calcium ■ sarcoplasmic reticulum ■ adenovirus ■ gene transfer
In striated muscles, excitation-contraction (E-C) coupling involves depolarization of the plasma membrane to open 
voltage-gated calcium (Ca® )^ channels (known as dihydro­
pyridine receptors [DHPRs]). This event in turn triggers the 
release of a larger amount of Ca®^  from the sarcoplasmic 
reticulum (SR) to initiate muscle contraction.^ Ca®^  efflux 
from the SR is mediated by the SR-Ca®  ^ release channel 
(known as ryanodine receptor [RyR]), which is a tetramer 
comprised of 4 identical subunits. cDNA cloning revealed the 
existence of 3 different subtypes of RyRs; the skeletal muscle 
isoform RyRl, the heart muscle isoform RyR2, and the brain 
and smooth muscle isoform RyRB. The 3 isoforms share 
=66% sequence homology at the amino acid level and are the 
largest ion channels presently known.
Ca®'*' release from the SR is a finely regulated process that 
involves not only the RyR itself but also several accessory 
proteins modulating RyR activity. Among these proteins are
the FK5 06-binding protein FKBP 12 and the orthologous 
protein FKBP12.6. The immunosuppressive drug FK506 
binds to FKBP 12 and FKBP 12.6 and pentamerizes with 
calcineurin, calmodulin, and Ca®'*', resulting in the inhibition 
of cytokine induction and the subsequent immune response.® 
The physiological function of these proteins was unclear until 
the finding that FKBP 12 associates with the RyRl and 
modulates channel function.®-  ^There is clear evidence from 
single-channel and lipid-bilayer studies that FKBP 12 alters 
the kinetics of the channel activity and induces coupled 
gating of individual RyRl channels in a junction.* -^® Although 
FKBP 12 can bind to both RyRl and RyR2, FKBP 12.6 
specifically associates with RyR2.*°-‘® However, the data 
described so far regarding the putative physiological function 
of FKBP 12.6 are conflicting. Single-channel recordings of 
RyR2 activity incorporated into planar-lipid bilayers sug­
gested that removal of FKBP12.6 from the RyR2 by FK506
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TABLE 1. DNA Primers Used for PCR
PCR Prim er Gene
Nucleotide Posllion/DNA 
F ragm ent Size
NIH GenBank 
A ccession No.
Forward; 5'-CAGCAGCAGAGATCTGCCAGAGGC-3' Human FKBP12.6 (full length) 2 5 -4 8 L37086
Reverse: 5'-nCCTCAA6CAAGATGTCGCATGAACAC-3' 5 8 9 -5 6 3 ; 564  bp
Forward: 5'-TTCATCCAGAGACAGAAACAAACC-3' FKBP12.6  (Internal) 1 8 0 -2 0 3 L37086
Reverse: 5'-ATTGGGAG6GATGAGACG-3' 3 3 4 -3 5 1 ; 172 bp
Forward: 5'-CCGA6GCTGGGAAGAAGG-3' Rabbit FKBP12 1 7 1 -1 8 8 M 89928
Reverse: 5'-TCACCCCAAAAGGAGAAGAGA-3' 6 0 1 -5 8 1 ; 431 bp
Forward: 6'-ACCCTCGG CnGnCCTTAC-3' Rabbit ryanodine recep tor 3 3 9 9 -3 4 1 8 U50465
Reverse: 5'-GCGCCCATAGTGGTGGTT-3' 3 7 7 5 -3 7 5 8 ; 377 bp
Forward: 5 '-AGCCGAGTGGCATGGGCAAGA-3' Rabbit calsequestrin 7 5 3 -7 7 3 X55040
Reverse: 5'-GTCAGCGTGCGTCACATTCACCA-3' 1 1 0 5 -1 0 8 3 ; 353  bp
Forward: 5'-GGGGGGGGAGAAGATCATGG-3' Rabbit GAPDH 6 7 1 -6 9 0 L23961
Reverse: 5'-GTCTGGGTGGG6GGGGTGGTTTG-3' 1 1 0 0 -1 0 8 4 ; 43 6  bp
NIH indicates National Institu tes of Health.
PCR prim ers u sed  to amplify th e  full-length cDNA of th e  hum an FKBP12.6 gene  w ere  modified to c re a te  an Internal Bg/ll site 
(underlined). Identity of all PCR fragm ents  w a s  verified by sequencing.
or rapamycin increases the open probability of the channel 
and induces the appearance of long-lasting subconductance 
s t a t e s . I n  comparable in vitro studies, however, removal 
of FKBP12.6 from the RyR2 or addition of recombinant 
FKBP12.6 to stripped cardiac SR preparations did not alter 
channel behavior.‘Lis Even more puzzling, FKBP12-deficient 
mice, which have unchanged FKBP12.6 levels, display a 
severe cardiac phenotype but have normal skeletal muscle.*® 
The majority of the FKBP 12-knockout mice died between 
embryonic day 14 and birth because of severe dilated cardio­
myopathy. Both the skeletal and the cardiac-muscle RyRs 
from these mice showed similar alterations in single-channel 
behavior compared with RyRs from wild-type mice, ie, an 
increased open probability of the channel and the appearance 
of subconductance states.
Binding of FKBP 12.6 to the RyR2 was shown to be 
regulated by phosphorylation of the channel subunits. Phos­
phorylation by protein kinase A, which is associated with the 
RyR2 via the anchoring protein mAKAP, dissociates 
FKBP 12.6 from the channel, resulting in destabilization of 
the channel complex. Hyperphosphorylation of RyR2 in the 
failing human heart results in defective channel function and 
may thus account for dysregulated SR-Ca®'*' handling during 
heart failure.*®
In the present study, single-cell shortening, SR-Ca®'*' up­
take rates, and caffeine-evoked contractions reflecting SR- 
Ca®^  content were measured in rabbit cardiomyocytes over- 
expressing FKBP 12.6 on adenovirus-mediated gene transfer. 
The results suggest that FKBP12.6 overexpression can mod­
ulate E-C coupling in cardiomyocytes.
M ateria l and M ethods
Recombinant Adenovirus Vector Construction
Full-length  cD N A  o f  th e hum an F K B P  12.6  g en e  w as c lon ed  by  
polym erase chain  reaction  (P C R ) from  a hum an h ea rt-m u sc le -  
sp ec ific  cD N A  sam p le  b y  the u se  o f  P C R  prim ers that span  the w h o le  
cod in g  region o f  FK B P 12.6 cD N A  (se e  T ab le 1). R ecom binant  
adenoviruses w ere  generated b y standard procedures.
Primary Culture of Rabbit Ventricular Myocytes 
and Adenoviral Gene Transfer
F em ale C hinch illa  bastard rabbits (C harles R iver, Su lzfeld , G er­
m any; 2 .5  to 3 k g , n = 9 )  w ere  heparin ized  and anesthetized  with  
sodium  thiopental (5 0  m g /k g  IV ). O utlines o f  this study w ere  
d esign ed  and carried ou t in  accord ance w ith  institutional gu id elin es  
regarding care and u se  o f  an im als. V entricular m yocy tes  w ere  
iso lated  b y  the en zym atic  m ethod  as described.*® M yocy te s  w ere  
counted , and adenoviral in fec tion  w ith  indicated  m u ltip licity  o f  
in fection  (M C I) w as perform ed during p lating o f  the m yocy tes  at a 
d ensity  o f  0 .5  X 10’ rod-shaped  cells/cm® onto lam inin (2 0  p g /m L )-  
coated  tissue-cu lture d ish es. A fter 3 hours, unattached ce lls  w ere  
rem oved  b y  3 w ash  step s, and m y o cy tes  w ere cultured in su p p le­
m ented  M l 99  m edium  (S igm a).
Verification of Transgene Expression and Virus 
Transfection Efficiency
R everse  transcriptase-PC R  (R T -P C R ) analysis o f  transfected m y o ­
cy tes  w a s perform ed w ith  g en e -sp ec ific  prim er pairs (see  T able 1) by  
the u se  o f  a hot-start T aq p o lym erase (Perkin Elm er) w ith  33 cy c les  
each.
W estern im m u n oblot an a lysis  w as perform ed w ith  a p o lyclon a l 
an ti-FK B P12 (C -19 ) antibody (Santa C ruz B io tech n o lo gy ) and an 
enhanced  ch em olu m in escen ce d etection  system  (A m ersham ) accord­
ing to the m anufacturer’s instructions.
Single-Cell Shortening Measurements
M yocyte  shortening w a s m easured  b y  an ed ge-d etec tion  system  
(C rescen t E lectron ics) at a  stim u lation  frequency o f  1 H z and a 
sam plin g rate o f  24 0  H z. O n lin e  and o fflin e  ana lysis  w as perform ed  
w ith  cu stom -d esign ed  L ab v iew  so ftw are (N ational Instrum ents).
C affein e-in d u ced  contractions re flectin g  SR-Ca®*" load w ere m ea­
sured after a stim ulation  train at 1 H z  b y  rapidly sw itch in g  the 
superfusing so lu tion  to on e con ta in in g  10 m m ol/L  caffein e for 5 to 
6 secon d s.
Measurements of SR-Ca®"*" Uptake Rates
Isolated  rabbit card iom yocytes w ere in fected  w ith  A d-F K B P  12.6 or 
A d-L acZ  at an M C I o f  10 and w ere harvested  after 48-hour culture 
tim e by gen tle  scrap ing o f f  the culture d ish. A n aliquot o f  0.1 m L  o f  
ce ll susp en sion  (1 .5 X 1 0 *  ce lls /m L ) w as exp osed  to 0.1 m g/m L  
)3-escin (S igm a) and g en tly  stirred for 30  secon d s. J3-Escin w as  
rem oved  b y  centrifu gin g and resu spend in g the ce lls  in  m ock  intra­
cellu lar so lu tion  (see  the o n lin e  data supplem ent available at http://
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www.circresaha.org). Cells were then placed in a cuvette, and 
additional solutions were added to give a final volume o f 0.15 mL, 
containing 50 jxmol/L EGTA, 5 mmol/L ATP, 10 mmol/L CrP 
(Sigma), the mitochondrial inhibitors carbonyl cyanide (20 pmol/L) 
and oligomycin (20 p,mol/L) (Calbiochem), 10 mmol/L oxalate 
(Sigma), and 10 p.mol/L Fura-2 (Molecular Probes). Cells were 
maintained in suspension by gentle stirring, and the Fura-2 fluores­
cence within the cuvette was recorded at 100 Hz using a dual­
wavelength spectrophotometer (lonOptix). All experiments were 
done at room temperature (20°C to 22®C).
Statistics
All data are presented as m ean±SEM . Myocyte-shortening data 
were analyzed by Student's t test for unpaired data. Ca®* uptake rates 
were tested for statistically significant differences between experi­
mental groups by 2-way repeated-measure ANOVA followed by 
Student-Newman-Keuls test. P < 0 .05  was accepted as statistically 
significant.
An expanded Materials and Methods section can be found in an 
online data supplement available at http://www.circresaha.org.
Results
Adenoviral Gene Transfer of FKBP12.6 in Isolated 
Rabbit Ventricular Myocytes
Two different recombinant adenoviruses expressing human 
FKBP 12.6, Ad-FKBP 12.6, and Ad-FKBP 12.6-GFP and 2 
control adenoviruses, Ad-LacZ and Ad-GFP, were used in 
this study. Efficiency of adenoviral gene transfer in isolated 
rabbit ventricular myocytes was initially verified using the 
green fluorescent protein (GFP) and LacZ viruses. The 
transfection protocol resulted in transfection efficiencies of 
typically more than 95% at an MOI of 10 (data not shown).
Western immunoblot analysis using an antibody that cross- 
reacts with both FKBP12 and FKBP12.6 was used to verify 
transgene protein expression in the transfected myocytes. 
Although both proteins consist of 108 amino acid residues, 
FKBP 12.6 migrates slower during denaturing electrophoresis 
than FKBP12.‘° Interestingly, as shown in Figure lA, 
FKBP 12 is the prominent isoform in rabbit cardiomyocytes. 
FKBP 12.6 can be detected only in the transfected cells. 
Similar results were obtained with the RT-PCR analysis 
(Figure IB). Endogenous mRNA expression of FKBP 12.6 in 
control cells was found to be much lower than endogenous 
FKBP 12 expression. Adenovirus-mediated overexpression of 
FKBP 12.6 resulted in a 5-fold increase in relative FKBP 12.6 
mRNA levels at 24 hours after transfection and a 6-fold 
increase at 48 hours after transfection compared with control. 
FKBP 12 mRNA expression was unchanged on FKBP 12.6 
overexpression, as was mRNA expression of RyR2.
The DNA sequence of the 172-bp PCR fragment amplified 
by primers. FKBP 12.6 internal (see Table 1) in rabbit 
cardiomyocytes was found to be 94.2% homologous to rat 
FKBP 12.6 cDNA and 97.6% homologous to human 
FKBP12.6 cDNA.
Contractile Parameters of Isolated Cardiomyocytes
Single-cell shortening of Ad-FKBP 12.6-GFP-infected and 
Ad-GFP-infected myocytes was measured at 24 and 48 hours 
after adenoviral transfection by a video-edge detection sys­
tem (Figure 2). At 48 hours after transfection, myocyte 
fractional shortening (FS, expressed in percentage of diastolic 
cell length) was 21% higher in Ad-FKBP 12.6-GFP-infected
cells compared with Ad-GFP-infected cells (4.8±0.2% FS 
versus 4±0.2% FS, respectively; n=79 cells each, P = 0.001). 
At 24 hours after transfection, at a lower level of FKBP 12.6 
overexpression (see Figure IB), FS was 15% higher in 
FKBP 12.6 cells compared with GFP control cells (5.3 ±0.2% 
FS versus 4.6±0.3% FS, respectively; n=55 cells each, 
P = 0.034). Shortening-time characteristics of both groups of 
myocytes are given in Table 2. FKBP 12.6 overexpression 
slightly but statistically significantly prolonged time to peak 
shortening after 2 days of culture time. Time to 50% 
relengthening was unchanged in both groups of myocytes at 
both time points.
SR-Ca®'*’ Uptake Rates in 
Permeabilized Cardiomyocytes
SR-Ca®* uptake rates were monitored in /3-escin-permeabil- 
ized cardiomyocytes with the use of the fluorescent dye 
Fura-2 (Figure 3). The measurements of SR-Ca®^  uptake rates
A)
kDa
FKBP12.6 LacZ
0.1 10 10 MOI
29.0 -
FKBP12.6
FKBP12
B)
-  GAPDH
-  FKBP12
FKBP12.6
-  RyR2
Figure 1. A, W estern Immunoblot analysis of Ad-LacZ (LacZ)- 
Infected and Ad-FKBP12.6-GFP (FKBP12.6)-infected myocytes. 
Cells were infected with indicated MOI and harvested after 48 
hours of culture time. FKBP12.6 protein expression increases 
with increasing virus titers. The fact that FKBP12.6 migrates as 
a  broad band during eiectrophoresis and could not be clearly 
separa ted  from endogenous FKBP12 Is m ost likely attributable 
to the lysis procedure of the cells under high-salt conditions. B, 
RT-PCR analysis of Ad-GFP (GFP)-infected and Ad-FKBP12.6- 
GFP (FKBP12.6)-infected m yocytes. Cells were infected at an 
MOI of 10 and were harvested for RT-PCR analysis with gene- 
specific primers (see Table 1) after 24 and 48 hours of culture 
time. Size of DNA m arkers are indicated on the left. 4- indicates 
positive control with FKBP12.6 plasmid DNA as tem plate. 
Duplex RT-PCR with GAPDH- and calsequestrin-specific prim­
ers using the sam e probes indicates equal cDNA load in each 
PCR. FKBP12.6 mRNA expression in Ad-FKBP12.6-GFP-in- 
fected cells increases with culture time, w hereas endogenous 
FKBP12 and RyR2 mRNA expression remains unchanged. A 
representative of n = 3  experim ents is shown.
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Figure 2. SIngle-cell shortening of Ad-GFP-infected and 
Ad-FKBP12,6-GFP-infected rabbit ventricuiar m yocytes (MOI 10 
each). A, Representative tracings of shortening experim ents with 
Ad-GFP-infected and Ad-FKBPI2.6-G FP-infected myocytes. 
Cells were electrically stim ulated a t 1 Hz a t 37°C in M l99 
medium. B, Statistical analysis of FS in Ad-G FP-infected and 
Ad-FKBP12.6-GFP-infected m yocytes after 24 hours (n=55 
each) and after 48 hours of culture time (n=79 each). FS in 
FKBP12.6-overexpressing cells w as 15% higher (P=0.034, Stu­
dent’s  t test) com pared with GFP control cells a t 1 day after 
transfection and 21% higher (P=0.001, S tuden t’s  t test) at 2 
days after transfection.
were done in the presence of 10 mmol/L oxalate. Oxalate 
enters the SR and acts as a Ca^  ^ sink, maintaining a constant 
[Ca^^] in the SR. A typical fluorescence signal is shown in 
Figure 3 A. Addition of aliquots of Ca^^ at the times indicated 
increased the [Ca^ '^ ] within the cuvette to ^ 3  p.mol/L. The 
time course of the decay of [Ca^ "^ ] represents a balance 
between Ca^ "^  uptake by the SR-Ca^^-ATPase pump and 
SR-Ca^^ leak. Addition of 5 /xmol/L ruthenium red (RuR) 
caused the subsequent decay of [Ca^ '*'] to be faster because of
TABLE 2. Shortenlng-TIme Parameters of 
Ad-FKBP12.6-GFP-lnfected and Ad-GFP-lnfected Rabbit 
Ventricular Myocytes
24  Hours After 
Transfection
48 Hours After 
T ransfection
GFP FKBP12.6 GFP FKBP12.6
n 55 55 79 79
TTPS, m s 2 0 5 + 6 2 1 2 ± 6 2 2 9 ± 6 2 4 6 ± 6 *
RTso. m s 9 0 ± 4 8 6 ± 4 1 2 8 + 1 2 1 2 8 + 1 1
Rabbit cardiom yocytes w ere  Infected with either Ad-FKBP12.8 or Ad-GFP a t 
an MOi of 10. Ceils w ere paced  a t a  stim ulation frequency of 1 Hz a t 37°C. 
Values rep resen t m ean±S E M  of n m yocytes. TTPS Indicates tim e to  peak 
shortening; RTjoi tim e to 50%  relengthening.
0 .0 49  vs GFP.
block of Ca^  ^ leak through SR-Ca^^ release eliannels. In a 
series of experiments, we observed no differences in SR-Ca^^ 
uptake characteristics between noninfected (control) and 
Ad-LacZ-infected cells (summarized in Table 3). Myocytes 
overexpressing FKBP 12.6 showed a significant higher rate of 
Ca^  ^uptake at 1 /jimol/L Ca '^'' than LacZ-infected myocytes. 
Figures 3B (i) and 3C (i) show superimposed traces of [Ca^^ 
arranged to intersect at 1 /xmol/L Ca^ "^  to illustrate the 
difference in the rate of uptake. These differences in 
Ca^  ^ uptake rates are more clearly distinguished when ex­
pressed as the rate of change of [Ca^^] (d[Ca^^]/dt) plotted 
against the associated [Ca^^] (Figure 3B [ii] and 3C [ii]). 
From these plots, it is evident that comparable rates of Ca^  ^
uptake were achieved at <0.5 /xmol/L Ca^ '*' in both cell types 
and in the presence of RuR. However, at [Ca^^] >0.5 
/xmol/L, d[Ca^^]/dt values were lower in the absence of RuR, 
consistent with activation of a significant RyR2-mediated 
leak. As described in Materials and Methods, the values of 
d[Ca '^^]/dt that were measured at 1 /xmol/L Ca^  ^ were 
converted to a net Ca^  ^flux using the Ca^  ^buffer power, and 
the mean values of Ca^  ^ uptake are shown in Table 3. In the 
presence of RuR, Ca^’*' uptake rates in the 3 experimental 
groups were not significantly different. This result indicates 
that the 3 groups of myocytes have comparable rates of Ca^ "^  
pump activity and background Ca^ "^  leak. The markedly 
different uptake rates in the absence of RuR (ie, in the 
presence of RyR2 activity) indicate that SR-Ca^ "  ^ leak 
through RyR2 is <=50% lower in FKBP 12.6-overexpressing 
cardiomyocytes at 1 /xmol/L Ca^^. This difference between 
experimental groups is most clearly seen when the change in 
Ca^  ^ efflux rate is expressed relative to the control rate. 
Addition of RuR increased the rate of Ca^  ^uptake ®=2-fold in 
noninfected and Ad-LacZ-infected cells (1.79±0.14-fold and 
2.02±0.11-fold, respectively). The relative increase in Ca^  ^
uptake rate was significantly less in Ad-FKBP 12.6-infected 
cells (1.3 ±0.16-fold, P<0.05) compared with control cells.
The effects of rapamycin on RyR-mediated Ca^  ^leak from 
the SR was studied in noninfected myocytes (control) and 
FKBP12.6-overexpressing cells. In the noninfected control 
group, rapamycin (5 /xmol/L) had no significant effect on the 
magnitude of the RuR-sensitive leak (Table 4). When nor­
malized to control conditions, Ca^  ^ uptake rate was not 
significantly altered in the presence of rapamycin 
(1.11±0.07-fold increase, not significant). However, when 
rapamycin was applied to myocytes overexpressing 
FKBP 12.6, there was a statistically significant slowing of the 
rate of Ca^ "^  uptake to 0.74±0.1 of the value under control 
conditions. This was significantly different from the effect of 
rapamycin on noninfected cells ( f =0.021). Because compa­
rable rates of Ca^ '*' uptake are achieved in the presence of 
RuR, these results suggest that rapamycin increased the 
RuR-sensitive leak in rabbit myocytes overexpressing 
FKBP 12.6.
Caffeine-Induced Contractures in 
Isolated Cardiomyocytes
To investigate whether the differences in shortening ampli­
tude and SR-Ca^^ uptake rates between FKBP 12.6- 
overexpressing myocytes and control myocytes were associ­
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TABLE 3. Oxalate Facilitated Ca^^ Uptake Rates Measured From ^-Escin-Permeabllized 
Rabbit Ventricular Myocytes
Noninfected (n = 4 ) 
(nmol/10“ c e lls /s” ’)
Ad-LacZ (n = 8 ) 
(nmol/10® c e lls /s“ *)
Ad-FKBP12.6 (n = 8 ) 
(nmol/10® ce lls /s~ ’)
(A) up take  rate  (1 /xmo!/L Ca^‘ ) 0 .5 9 ± 0 .0 7 * 0 .5 2 ± 0 .1 * 0 ,8 ± 0 .0 9
(B) Ga^+ up take rate  (1 /xmol/L C a '‘ , 
5 /xmol/L RuR) (5 /xmol/L RuR)
1 .0 6 ± 0 .2 7 t 1 .0 5 ± 0 .1 3 t 1 .0 4 ± 0 .3 7
(C) Calculated RuR-sensitive, Ca^+ 
efflux (1 /xmol/L Ga'+) (B -A )
0 .47 0.53 0.24
Rabbit cardiom yocytes w ere  infected with Ad-LacZ or Ad-FKBP12.6 a t an MOI of 10. Ceils w ere  analyzed a t 20"G 
after 48  hours of culture tim e, a s  described  In M aterials and M ethods. Values In row C a re  calcu lated  by subtracting 
m ean values In row B and A; positive values rep resen t n e t S R -C a'^  efflux. Values rep resen t m ean±S E M . 
‘Significantly different value from th e  Ad-FKBP12.6 group (P < 0 ,05 ),
tSIgniflcantly d ifferent value from th e  corresponding values In th e  ab sen ce  of RuR (row A, P < 0 .0 5 ).
ated with differences in SR-Ca^^ load, we analyzed caffeine- 
induced contractures in Ad-GFP-infected and Ad-FKBP12.6- 
GFP-infected cardiomyocytes during steady-state shortening 
at a stimulation frequency of 1 Hz in a separate set of 
experiments. The amplitude of caffeine-induced contractures
A
' 200 ■ '
(pmoHL)
(ii)
Figure 3. SR-Ca®‘ uptake rates in permeabilized rabbit ventricu­
lar myocytes at 48 hours after transfection. A, Representative 
records of [Ca^+] against time recorded from a cuvette contain­
ing 1.5xlO®/mL permeabilized m yocytes susp en d ed  In a mock 
Intracellular solution by continuous stirring (Initial total volume 
150 juL). Addition of aliquots of CaCIa are Indicated above the 
trace a s  Increases in total [Ca®‘ ] within .the cuvette. RuR (5 
fimol/L) w as added  at the point Indicated. Panels B (I) and C (I) 
show superim posed sections of records (Intersecting at 1 
jurmol/L Ca^^) of the decline of [Ca^+] taken after the addition of 
CaCIa from 2 separa te  experim ents: panel B from cells Infected 
with Ad-LacZ (MOI 10) and panel C with cells Infected with 
Ad-FKBP12.6 (MOI 10). Panels B (II) and C (II) show  plots of rate 
of change of [Ca^+] (d[Ca^+]/dt) against [Ca^+] for the records 
shown In panel B (I) and 0  (I).
provides an index of the SR-Ca^^ content.^ ** As shown in 
Figure 4, caffeine-evoked contractures were statistically sig­
nificantly larger in FKBP 12.6-overexpressing myocytes com­
pared with control myocytes (18.8±1.2% FS, n=23, versus 
15.2±1.1% FS, n=26, respectively, 0.037) at 48 hours 
after transfection. Overexpression of FKBP 12.6 increased 
Ca^  ^ load of the SR by 20% compared with control cells.
Discussion
Role of FKBP12.6 in Modulation of E-C Coupling 
in Cardiac Muscle
The present study, using adenoviral gene transfer to specifi­
cally overexpress FKBP 12.6 in rabbit myocytes, indicates 3 
significant effects of FKBP 12.6 overexpression; (1) reduction 
of RyR2-mediated Ca^^ efflux from cardiac muscle SR; (2) 
higher SR-Ca^^ load; and (3) increased amplitude of twitch 
shortening in single myocytes.
The relationship between modulation of RyR2 activity and 
contractility is an active area of research. Contradictory 
evidence exists concerning the steady-state effects of changes 
in RyR activity. Cyclic ADP ribose is thought to increase the 
open probability of RyR, increase peak systolic [Ca^^],, and 
increase twitch shortening in guinea pig myoctes.^i In con­
trast, tetracaine, a drug that decreases Ca^ '*' sensitivity of 
RyR2, had no effects on rat-myocyte shortening in the steady 
state.22 Furthermore, caffeine, a drug that increases the Ca^  ^
sensitivity of the RyR2, can decrease the peak systolic 
Therefore, it is difficult to extrapolate directly 
from the effects of FKBP 12.6 overexpression to the increased 
twitch shortening observed in this study. Yet our data 
strongly suggest that overexpression of FKBP12.6 reduces 
Ca^ "^  leak from the SR during diastole, thereby increasing 
SR-Ca^ '*' content, and thus increases the amount of Ca^  ^
available for release, which in turn increases twitch shorten­
ing amplitude. In a way analogous to that described recently 
for FKBP 12 and RyRl, FKBP12.6 overexpression may alter 
not only the Ca^ '*' efflux through RyR2 but also the degree of 
cooperative activity of the RyR2 cluster.®
Effects of FKBP12.6 Ligands on Cardiac 
E-C Coupling
A range of effects of rapamycin and FK506 have been 
reported. McCall et aP^ observed increased Ca^  ^ transient
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TABLE 4, Oxalate-Facllitated Ga'+ Uptake Rates Measured From /3-Escin-Permeabilized 
Rabbit Ventricular Myocytes In the Presence of Rapamycin
Noninfected (n = 6 ) 
(nmol/10® ce lls /s“ ')
Ad-FKBP12.6 (n = 3 ) 
(nmol/10® c e lls /s“ ')
(A) Ca''+ up take  ra te  (1 /tm ol/L  Ca^^) 0 .5 5 ± 0 .1 2 0 .7 4 ± 0 .1 3 *
(B) Ca^+ up take ra te  (1 /xmol/L Ga^‘ , 5 /xmol/L Rap) 0.61 ± 0 .2 0 .5 5 ± 0 .1 6
(C) Calculated R ap-sensltlve Ga^‘  efflux (1 /xmol/L 
G a '+ )(A -B )
- 0 .0 6 0 .19
(D) Ca^+ up take  rate  (1 /xmol/L C a " ,  5  /xmol/L RuR) 0 .9 8 ± 0 .2 f 1 .0 9 ± 0 .2 4 t
Rabbit card iom yocytes w ere  infected with Ad-FKBP12.6 a t an  MOI of 10. Calls w ere analyzed a t 20°C  after 48
hours of culture tim e, a s  described in M aterials and M ethods. Values in row C are  calculated by sub tracting  m ean
values In row  A and  B; positive values rep resen t n e t SR-Ca' '^® efflux, Values rep resen t m ean ± S E M . Rap Indicates 
rapam ycin.
‘Significantly different value from th e  nontransfected  group (F*<0.05}.
tSIgniflcantly different value from th e  corresponding values in th e  a b se n c e  of RuR (row A, P < 0 ,0 5 ).
amplitude in isolated rat myocytes exposed to FK506, with no 
obvious change in SR-Ca^^ content. High concentrations (50 
/xmol/L) of FK506 caused prolonged openings of RyR2 and 
prolongation of the Ca^  ^ transient in rat myocytes. Yet 
similar concentrations of FK506 had no dramatic effect on 
the Ca^  ^transient in voltage-clamped rat cardiac myocytes.
Ad-GFP Ad-FKBP12.6-GFP
120-
s3
£ 115-
aM
% 110-0
106-
Caffeine (10 mmol/L) I
c m  Ad-GFP ■ ■  Ad-FKBP12.6-GFP
0.037
p x  0.011
Steady s ta te  Caffeine
Figure 4. Caffeine-Induced con tractu res in isolated rabbit ven­
tricular myocytes. A, R epresentative twitch contractions of myo­
cytes Infected with Ad-GFP (n=23) and Ad-FKBP12.6-GFP 
(n=26) after 48 hours of culture time during steady-sta te  electri­
cal stimulation at 1 Hz and after caffeine application (10 mmol/ 
L). B, Statistical analyses of fractional shortening (FS) In 
Ad-GFP-infected and Ad-FKBP12.6-GFP-lnfected myocytes. 
Shortening amplitude after caffeine application Increased by 
20%  In Ad-FKBP12 .6-infected  cells com pared with control cells 
(18.8±1.2%  FS versus 15 .2±1.1%  FS, respectively, P=0.037, 
S tudent’s  t test). During steady -sta te  shortening without caf­
feine, FS w as 4.1 ± 0 .2  in Ad-GFP control cells and 5 .5± 0 .3  In 
FK8P12.6-overexpresslng cells (P=0.011, S tuden t’s  f test).
To date, there seems to be no information available concern­
ing the effect of either of these ligands on the E-C coupling 
of isolated rabbit ventricular myocytes. In the present study, 
5 /xmol/L rapamycin had no significant effect on the SR of 
noninfected myocytes. In contrast, rapamycin significantly 
decreased the rate of Ca^ "® uptake at 1 /xmol/L in myocytes 
overexpressing FKBP 12.6. These results suggest that the 
decreased Ca^  ^ flux through RyR2 observed on overexpres­
sion of FKBP 12.6 could be reversed by rapamycin. This is 
consistent with the interpretation that increased cytosolic 
levels of FKBP 12.6 are the cause of altered RyR2 properties 
with reduced Ca^  ^ leakage through RyR2.
Molecular Studies of RyR2 and FKBP12.6
Each RyR subunit contains only one FKBP-binding site, 
resulting in the structural formulas (RyRl protomer)^- 
(FKBP12)4 and (RyR2 protomer)4(FKBPl2 .6 )4, respective­
l y  4,10 However, from in vitro binding studies using ®^S- 
labeled FKBP 12.6 and purified SR vesicles, Timerman et al" 
calculated that =^«17% of the total FKBP 12.6-binding sites in 
dog SR vesicles seem to be unoccupied. Marx et aP® recently 
showed that association of FKBP12.6 to RyR2 depends on 
phosphorylation state of RyR2 subunits.
Previous studies regarding the functional relevance of 
FKBPs (either FKBP12 or FKBP12.6) for RyR2 function are 
inconsistent. Single-channel analyses of RyR2 activity in 
planar-lipid bilayers are conflicting. In some studies, neither 
FKBP 12 nor FKBP12.6 affects channel behavior,"-*^ 
whereas other studies show marked changes in channel 
activity on dissociation of FKBP.'^-" In contrast, our data 
indicate that FKBP 12.6 plays an important role in cardiac 
SR-Ca^^ release, which in turn depends on RyR2 function. 
This discrepancy may be explained by differences in the 
complexity of E-C-coupling mechanisms between cardiac 
and skeletal muscle in vivo. In cardiac myocytes, SR-Ca^^ 
release via RyR2 is triggered by depolarization-dependent 
Ca '^"'-influx through DHPRs, a phenomenon referred to as 
Ca^ ■‘■-induced Ca^  ^ release.' In skeletal muscle cells, a 
voltage-induced change in DHPR conformation directly ini­
tiates RyRl receptor opening without a requirement for Ca^ "® 
influx.^® Moreover, there is a functional diversity among the 
RyR subtypes despite their structural homology of ‘=^66%.
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RyR2 is not capable of supporting skeletal muscle-type E-C 
coupling in RyRl knockout mice4* Furthermore, keeping in 
mind that several other accessory proteins besides FKBP 12 or 
FKBP 12.6, such as sorcin, calmodulin, and calsequestrin, and 
phosphorylation of the RyR itself may be involved in proper 
RyR function, it is reasonable to speculate that the complex 
nature of the SR-Ca^ "® release process in cardiac and skeletal 
muscle cells is difficult to reconstitute in vitro.
It is still an open question as to whether FKBP 12 and 
FKBP12.6 are exchangeable with respect to function. Al­
though a physical and functional association of FKBP 12 and 
RyRl has been demonstrated for animal species from all 5 
classes of vertebrates,^® RyR2 can bind both FKBP 12.6 and 
FKBP 12, and both are expressed in myocardial tissue from 
different species, including humans (unpublished data, May 
2000). Our data support the hypothesis that FKBP 12.6 can 
modulate rabbit RyR2 in a similar manner as FKBP 12 
modulates RyRl activity.
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